US6630328B2
(en)
|
1909-07-15 |
2003-10-07 |
Genencor International, Inc. |
Increasing production of proteins in gram-positive microorganisms
|
US4199559A
(en)
*
|
1974-08-12 |
1980-04-22 |
Syva Company |
Fluorescence quenching with immunological pairs in immunoassays
|
US4174384A
(en)
*
|
1975-06-30 |
1979-11-13 |
Syva Company |
Fluorescence quenching with immunological pairs in immunoassays
|
GB1573212A
(en)
*
|
1976-04-15 |
1980-08-20 |
Technicon Instr |
Immunoassay for gentamicin
|
JPS5836308B2
(ja)
*
|
1977-02-10 |
1983-08-08 |
大塚製薬株式会社 |
抗体の製造方法
|
IT1079045B
(it)
*
|
1977-05-16 |
1985-05-08 |
Syva Co |
Analisi imuunologica fluorescente a doppio ricettore
|
US4208479A
(en)
*
|
1977-07-14 |
1980-06-17 |
Syva Company |
Label modified immunoassays
|
US4160645A
(en)
*
|
1977-07-14 |
1979-07-10 |
Syva Company |
Catalyst mediated competitive protein binding assay
|
USRE34394E
(en)
*
|
1978-01-23 |
1993-09-28 |
Baxter Diagnostics Inc. |
Method and composition for double receptor, specific binding assays
|
US4215102A
(en)
*
|
1979-01-05 |
1980-07-29 |
Lee Sin H |
Cytochemical agents and methods for the detection of steroid hormone receptors in human tissues
|
US4331590A
(en)
*
|
1978-03-13 |
1982-05-25 |
Miles Laboratories, Inc. |
β-Galactosyl-umbelliferone-labeled protein and polypeptide conjugates
|
US4235869A
(en)
*
|
1978-05-16 |
1980-11-25 |
Syva Company |
Assay employing a labeled Fab-fragment ligand complex
|
US4193983A
(en)
*
|
1978-05-16 |
1980-03-18 |
Syva Company |
Labeled liposome particle compositions and immunoassays therewith
|
US4318707A
(en)
*
|
1978-11-24 |
1982-03-09 |
Syva Company |
Macromolecular fluorescent quencher particle in specific receptor assays
|
US4238195A
(en)
*
|
1979-01-18 |
1980-12-09 |
Miles Laboratories, Inc. |
Fluorescer-labeled specific binding assays
|
CA1121345A
(fr)
*
|
1979-03-05 |
1982-04-06 |
Robert A. Yoshida |
Methode pour les epreuves de dosage par radiocompetition a l'aide de proteines liantes inhibant les interferences non specifiques
|
US4256834A
(en)
*
|
1979-04-09 |
1981-03-17 |
Syva Company |
Fluorescent scavenger particle immunoassay
|
US4284412A
(en)
*
|
1979-07-13 |
1981-08-18 |
Ortho Diagnostics, Inc. |
Method and apparatus for automated identification and enumeration of specified blood cell subclasses
|
US4287300A
(en)
*
|
1979-07-26 |
1981-09-01 |
Syva Company |
Charge effects in enzyme immunoassays
|
US4351760A
(en)
*
|
1979-09-07 |
1982-09-28 |
Syva Company |
Novel alkyl substituted fluorescent compounds and polyamino acid conjugates
|
NL8000173A
(nl)
*
|
1980-01-11 |
1981-08-03 |
Akzo Nv |
Toepassing van in water dispergeerbare, hydrofobe kleurstoffen als label in immunochemische testen.
|
US4329461A
(en)
*
|
1980-01-11 |
1982-05-11 |
Syva Company |
Fluorescent thyroid hormone conjugates and their uses
|
US4401764A
(en)
*
|
1980-02-07 |
1983-08-30 |
Technicon Instruments Corporation |
Immunoassays employing labeled reagent and a conjugate having two binding sites
|
US4318981A
(en)
*
|
1980-04-24 |
1982-03-09 |
Miles Laboratories, Inc. |
Homogeneous specific binding assay employing an intramolecularly modulated photogenic enzyme substrate label
|
EP0050684B1
(fr)
*
|
1980-10-27 |
1986-01-22 |
Syva Company |
Dérivés de fluorescéine substitués par des groupements éthers utilisés comme agents fluorescents et extincteurs
|
JPS5782387A
(en)
*
|
1980-10-29 |
1982-05-22 |
Syva Co |
Novel ether substituted fluorescein compound
|
US4385126A
(en)
*
|
1980-11-19 |
1983-05-24 |
International Diagnostic Technology, Inc. |
Double tagged immunoassay
|
US4785080A
(en)
*
|
1981-03-30 |
1988-11-15 |
Baker Instruments Corporation |
Labeled analytes
|
US4378458A
(en)
*
|
1981-03-30 |
1983-03-29 |
Baker Instruments Corporation |
Novel chromogenic and/or fluorogenic substrates for monitoring catalytic or enzymatic activity
|
US4378428A
(en)
*
|
1981-03-30 |
1983-03-29 |
Baker Instruments Corporation |
Method for carrying out non-isotopic immunoassays, labeled analytes and kits for use in such assays
|
US4442218A
(en)
*
|
1981-05-27 |
1984-04-10 |
Corning Glass Works |
Method of measuring degree of partitioning
|
JPS585659A
(ja)
*
|
1981-06-24 |
1983-01-13 |
ハイブリテツク インコ−ポレ−テツド |
単クロ−ン性抗体を使用する免疫学的、抑制試験
|
AU9094982A
(en)
*
|
1982-02-01 |
1983-08-11 |
Miles Laboratories Inc. |
Photogenic labels to alleviate quenching in immuno assays
|
US4472301A
(en)
*
|
1982-05-27 |
1984-09-18 |
Miles Laboratories, Inc. |
Propranolol immunogen and antibodies
|
US4687732A
(en)
*
|
1983-06-10 |
1987-08-18 |
Yale University |
Visualization polymers and their application to diagnostic medicine
|
US4719176A
(en)
*
|
1983-10-31 |
1988-01-12 |
Klotz Irving M |
Enzyme-free diagnostic binding reagents
|
US4865997A
(en)
*
|
1984-02-23 |
1989-09-12 |
Becton Dickinson And Company |
Assay for ligands by separating bound and free tracer from sample
|
US4708929A
(en)
*
|
1984-10-29 |
1987-11-24 |
Microgenics Corporation |
Methods for protein binding enzyme complementation assays
|
US4645828A
(en)
|
1984-03-23 |
1987-02-24 |
Oncogen |
Platelet related growth regulator
|
US4791068A
(en)
*
|
1984-06-22 |
1988-12-13 |
Scripps Clinic And Research Foundation |
Diagnostic assay for inhibitor of tissue-type and urokinase-type plasminogen activators
|
US4666862A
(en)
*
|
1984-08-14 |
1987-05-19 |
Ortho Diagnostic Systems Inc. |
Fluorescent energy transfer with phycobiliproteins
|
US5221605A
(en)
*
|
1984-10-31 |
1993-06-22 |
Igen, Inc. |
Luminescent metal chelate labels and means for detection
|
US5238808A
(en)
*
|
1984-10-31 |
1993-08-24 |
Igen, Inc. |
Luminescent metal chelate labels and means for detection
|
US5310687A
(en)
*
|
1984-10-31 |
1994-05-10 |
Igen, Inc. |
Luminescent metal chelate labels and means for detection
|
US4743561A
(en)
*
|
1985-03-05 |
1988-05-10 |
Abbott Laboratories |
Luminescent assay with a reagent to alter transmitive properties of assay solution
|
IE64785B1
(en)
|
1985-04-08 |
1995-09-06 |
Genetic Systems Corp |
Expression of immunologically reactive viral proteins
|
JPH0672883B2
(ja)
*
|
1985-06-19 |
1994-09-14 |
コニカ株式会社 |
分析素子
|
FR2585836B1
(fr)
*
|
1985-08-02 |
1987-11-27 |
Commissariat Energie Atomique |
Procede homogene de detection et/ou de determination par luminescence d'un analyte dans un milieu susceptible de le contenir
|
US5279943A
(en)
*
|
1985-08-02 |
1994-01-18 |
Compagnie Oris Industrie |
Homogeneous process for the detection and/or determination by luminescence of an analyte in a medium in which it may be present
|
US4689397A
(en)
*
|
1985-08-12 |
1987-08-25 |
Scripps Clinic And Research Foundation |
Synthetic polypeptides for detecting mycobacterial infections
|
US5384241A
(en)
*
|
1987-09-11 |
1995-01-24 |
Enzo Diagnostics, Inc. |
Specific binding assay compound with inhibitive self-quenching characteristics
|
US5334513A
(en)
*
|
1988-05-17 |
1994-08-02 |
Syntex (U.S.A.) Inc. |
Method for immunochromatographic analysis
|
US5039607A
(en)
*
|
1988-05-17 |
1991-08-13 |
Syntex (U.S.A.) Inc. |
Method for immunochromatographic analysis
|
US5053054A
(en)
*
|
1988-09-12 |
1991-10-01 |
Ortho Pharmaceutical Corporation |
Methods and reagents for staining intracellular components
|
US5135863A
(en)
*
|
1988-12-23 |
1992-08-04 |
Syntex (U.S.A.) Inc. |
Compositions and methods for determining the presence of amphetamines in a sample suspected of containing amphetamine and/or methamphetamine
|
US5132432A
(en)
*
|
1989-09-22 |
1992-07-21 |
Molecular Probes, Inc. |
Chemically reactive pyrenyloxy sulfonic acid dyes
|
JP3184894B2
(ja)
*
|
1989-10-05 |
2001-07-09 |
エックスオックスエミス, インコーポレイテッド |
ハロペルオキシターゼ酸至適化学的発光分析系
|
US5108899A
(en)
*
|
1989-10-31 |
1992-04-28 |
Exoxemis, Inc. |
Chemiluminescence assay of in vivo inflammation
|
US5532138A
(en)
*
|
1990-04-26 |
1996-07-02 |
Behringwerke Ag |
Method and kits for determining peroxidatively active catalysts
|
US5614504A
(en)
*
|
1990-08-01 |
1997-03-25 |
The University Of South Florida |
Method of making inosine monophosphate derivatives and immunopotentiating uses thereof
|
US5340716A
(en)
*
|
1991-06-20 |
1994-08-23 |
Snytex (U.S.A.) Inc. |
Assay method utilizing photoactivated chemiluminescent label
|
US5578498A
(en)
|
1991-05-22 |
1996-11-26 |
Behringwerke Ag |
Metal chelate containing compositions for use in chemiluminescent assays
|
US6251581B1
(en)
|
1991-05-22 |
2001-06-26 |
Dade Behring Marburg Gmbh |
Assay method utilizing induced luminescence
|
US5279937A
(en)
*
|
1992-04-30 |
1994-01-18 |
Detechnology Canada |
Use of macroglobulins to improve the signal-to-background ratio in affinity binding assays
|
WO1994003812A1
(fr)
*
|
1992-07-31 |
1994-02-17 |
Syntex (U.S.A.) Inc. |
Matrices chimioluminescentes photoactivables
|
US5874423A
(en)
*
|
1992-09-10 |
1999-02-23 |
Yissum Research Development Co. Of The Hebrew University Of Jerusalem |
Digitalis-like compounds
|
US6033898A
(en)
*
|
1992-12-30 |
2000-03-07 |
Abbott Laboratories |
Enhanced yeast expression using regulatory control sequences from yeast sorbitol dehydrogenase gene
|
US5801005A
(en)
|
1993-03-17 |
1998-09-01 |
University Of Washington |
Immune reactivity to HER-2/neu protein for diagnosis of malignancies in which the HER-2/neu oncogene is associated
|
US6953573B1
(en)
|
1993-03-17 |
2005-10-11 |
University Of Washington |
Compounds for eliciting or enhancing immune reactivity to HER-2/neu protein for prevention or treatment of malignancies in which the HER-2/neu oncogene is associated
|
US5869445A
(en)
*
|
1993-03-17 |
1999-02-09 |
University Of Washington |
Methods for eliciting or enhancing reactivity to HER-2/neu protein
|
AU679008B2
(en)
*
|
1993-05-06 |
1997-06-19 |
Chiron Diagnostics Corporation |
Mixed luminescent conjugate test assays
|
US6562333B1
(en)
|
1993-06-14 |
2003-05-13 |
Schering Corporation |
Purified mammalian CTLA-8 antigens and related reagents
|
US5516639A
(en)
*
|
1993-07-22 |
1996-05-14 |
Mayo Foundation For Medical Education And Research |
Antibodies specific for human prostate glandular kallkrein
|
US6103237A
(en)
*
|
1993-07-22 |
2000-08-15 |
Hybritech Incorporated |
Stable variant hK2 polypeptide
|
US20040259113A1
(en)
*
|
1993-07-22 |
2004-12-23 |
Mayo Foundation For Medical Education And Research, Hybritech Incorporated |
Method for detection of metastatic prostate cancer
|
US5684144A
(en)
*
|
1993-07-28 |
1997-11-04 |
University Of North Texas |
Escherichia coli csrA gene, protein encoded thereby, and methods of use thereof
|
US7083984B2
(en)
|
1993-09-24 |
2006-08-01 |
Biosite, Inc. |
Hybrid phthalocyanine derivatives and their uses
|
US6251687B1
(en)
|
1993-09-24 |
2001-06-26 |
Biosite Diagnostics, Inc. |
Fluorescence energy transfer and intramolecular energy transfer in particles using novel compounds
|
US5824799A
(en)
*
|
1993-09-24 |
1998-10-20 |
Biosite Diagnostics Incorporated |
Hybrid phthalocyanine derivatives and their uses
|
US7322927B2
(en)
|
1993-09-24 |
2008-01-29 |
Biosite, Inc. |
Hybrid phthalocyanine derivatives and their uses
|
US6238931B1
(en)
*
|
1993-09-24 |
2001-05-29 |
Biosite Diagnostics, Inc. |
Fluorescence energy transfer in particles
|
US6406855B1
(en)
|
1994-02-17 |
2002-06-18 |
Maxygen, Inc. |
Methods and compositions for polypeptide engineering
|
US6335160B1
(en)
|
1995-02-17 |
2002-01-01 |
Maxygen, Inc. |
Methods and compositions for polypeptide engineering
|
AU699748B2
(en)
*
|
1994-05-10 |
1998-12-10 |
Hybritech Incorporated |
Recombinant HK2 polypeptide
|
AU2635295A
(en)
*
|
1994-06-13 |
1996-01-05 |
Henry Ford Health System |
A novel neuronal-neonatal gene: neuronatin
|
EP0705902B2
(fr)
|
1994-08-12 |
2008-08-06 |
The University of Utah Research Foundation |
Sondes d'acide nucléique comprenant un fragment gène de susceptibilité du cancer du sein et des ovaires associé à 17Q
|
CA2196797C
(fr)
|
1994-08-12 |
2000-10-10 |
Donna M. Shattuck-Eidens |
Polymorphismes et mutations in vivo chez le gene de susceptibilite 17q associe au cancer du sein et des ovaires
|
US6974666B1
(en)
*
|
1994-10-21 |
2005-12-13 |
Appymetric, Inc. |
Methods of enzymatic discrimination enhancement and surface-bound double-stranded DNA
|
US8236493B2
(en)
|
1994-10-21 |
2012-08-07 |
Affymetrix, Inc. |
Methods of enzymatic discrimination enhancement and surface-bound double-stranded DNA
|
US5843673A
(en)
*
|
1994-10-25 |
1998-12-01 |
Curators Of The University Of Missouri |
Method of screening for endometriosis
|
US6531277B2
(en)
|
1994-10-25 |
2003-03-11 |
The Curators Of The University Of Missouri |
Endometriosis-specific secretory protein
|
US20030152909A1
(en)
*
|
1994-11-16 |
2003-08-14 |
Mitrani Eduardo N. |
In vitro micro-organs, and uses related thereto
|
US5633149A
(en)
*
|
1994-12-07 |
1997-05-27 |
Incyte Pharmaceuticals, Inc. |
Polynucleotide encoding novel chemokine expressed in inflamed adenoid
|
US6692920B1
(en)
*
|
1994-12-07 |
2004-02-17 |
Incyte Corporation |
Antibodies to a chemokine expressed in inflamed adenoid
|
ATE235514T1
(de)
*
|
1994-12-28 |
2003-04-15 |
Univ Kentucky |
Monoklonaler anti-idiotypischer antikörper 3h1 aus maus
|
US6949244B1
(en)
|
1995-12-20 |
2005-09-27 |
The Board Of Trustees Of The University Of Kentucky |
Murine monoclonal anti-idiotype antibody 11D10 and methods of use thereof
|
US5952238A
(en)
*
|
1995-02-02 |
1999-09-14 |
Chugai Seiyaku Kabushiki Kaisha |
Method of assaying specimen substance by controlling dose of chemiluminescence
|
US7005509B1
(en)
|
1995-02-17 |
2006-02-28 |
Incyte Corporation |
Chemokine PANEC-1 polynucleotides and compositions and methods related thereto
|
US5777093A
(en)
*
|
1995-05-16 |
1998-07-07 |
Ramot-University Authority For Applied Research & Industrial Development Ltd. |
cDNAs associated with ataxia-telangiectasia
|
US5728807A
(en)
*
|
1995-05-16 |
1998-03-17 |
Ramot-University Authority For Applied Research And Industrial Development, Ltd. |
Mutated proteins associated with ataxia-telangiectasia
|
US5858661A
(en)
|
1995-05-16 |
1999-01-12 |
Ramot-University Authority For Applied Research And Industrial Development |
Ataxia-telangiectasia gene and its genomic organization
|
GB0112226D0
(en)
*
|
2001-05-18 |
2001-07-11 |
Danisco |
Method of improving dough and bread quality
|
AU6113396A
(en)
|
1995-06-14 |
1997-01-15 |
Regents Of The University Of California, The |
Novel high affinity human antibodies to tumor antigens
|
WO1997022689A1
(fr)
|
1995-12-18 |
1997-06-26 |
Myriad Genetics, Inc. |
Gene de predisposition au cancer du sein lie au chromosome 13
|
US5741662A
(en)
*
|
1995-12-18 |
1998-04-21 |
Quidel Corporation |
Direct stain specific binding assays for microorganisms
|
US5837492A
(en)
|
1995-12-18 |
1998-11-17 |
Myriad Genetics, Inc. |
Chromosome 13-linked breast cancer susceptibility gene
|
US6965020B2
(en)
|
1996-01-23 |
2005-11-15 |
Affymetrix, Inc. |
Nucleic acid labeling compounds
|
US20010018514A1
(en)
*
|
1998-07-31 |
2001-08-30 |
Mcgall Glenn H. |
Nucleic acid labeling compounds
|
EP0880598A4
(fr)
|
1996-01-23 |
2005-02-23 |
Affymetrix Inc |
Evaluation rapide de difference d'abondance d'acides nucleiques, avec un systeme d'oligonucleotides haute densite
|
US7291463B2
(en)
*
|
1996-01-23 |
2007-11-06 |
Affymetrix, Inc. |
Nucleic acid labeling compounds
|
US20040210045A1
(en)
*
|
1996-01-23 |
2004-10-21 |
Mcgall Glenn |
Nucleic acid labeling compounds
|
US6864059B2
(en)
*
|
1996-01-23 |
2005-03-08 |
Affymetrix, Inc. |
Biotin containing C-glycoside nucleic acid labeling compounds
|
US7423143B2
(en)
*
|
1996-01-23 |
2008-09-09 |
Affymetrix. Inc. |
Nucleic acid labeling compounds
|
US7282327B2
(en)
*
|
1996-01-23 |
2007-10-16 |
Affymetrix, Inc. |
Nucleic acid labeling compounds
|
US6924094B1
(en)
*
|
1996-02-08 |
2005-08-02 |
Affymetrix, Inc. |
Chip-based species identification and phenotypic characterization of microorganisms
|
EP1728875A3
(fr)
|
1996-02-08 |
2007-05-09 |
Affymetrix, Inc. |
Spéciation de micro-organismes à partir de micro plaquettes et caractérisation des phénotypes de ceux-ci
|
JP2000504575A
(ja)
|
1996-02-08 |
2000-04-18 |
アフィメトリックス,インコーポレイテッド |
微生物のチップベースの種分化および表現型特徴付け
|
DE69733650T2
(de)
*
|
1996-03-01 |
2006-04-20 |
Beckman Coulter, Inc., Fullerton |
System zum simultanen Durchführen einer Vielzahl von Ligandenbindungs-Untersuchungen
|
US5882644A
(en)
*
|
1996-03-22 |
1999-03-16 |
Protein Design Labs, Inc. |
Monoclonal antibodies specific for the platelet derived growth factor β receptor and methods of use thereof
|
JP2000507245A
(ja)
*
|
1996-03-22 |
2000-06-13 |
ユニバーシティー オブ ジョージア リサーチ ファウンデーション,インコーポレイテッド |
Porphyromonas gingivalisペプチドを含む免疫原性組成物および方法
|
US6942862B2
(en)
*
|
1996-04-01 |
2005-09-13 |
University Of Washington |
Methods and compositions to generate immunity in humans against self tumor antigens by immunization with homologous foreign proteins
|
US6162931A
(en)
|
1996-04-12 |
2000-12-19 |
Molecular Probes, Inc. |
Fluorinated xanthene derivatives
|
DE69738868D1
(de)
*
|
1996-05-22 |
2008-09-11 |
Viventia Biotech Inc |
Odieren, und deren verwendung zur vorbeugung und zum nachweis von krebs
|
US6331275B1
(en)
|
1996-07-08 |
2001-12-18 |
Burstein Technologies, Inc. |
Spatially addressable, cleavable reflective signal elements, assay device and method
|
AU725065B2
(en)
|
1996-07-08 |
2000-10-05 |
Burstein Technologies, Inc. |
Cleavable signal element device and method
|
US6342349B1
(en)
|
1996-07-08 |
2002-01-29 |
Burstein Technologies, Inc. |
Optical disk-based assay devices and methods
|
US20050069923A1
(en)
*
|
1996-07-08 |
2005-03-31 |
Mullis Kary Banks |
Dual bead assays using cleavable spacers and/or ligation to improve specificity and sensitivity including related methods and apparatus
|
US5866336A
(en)
*
|
1996-07-16 |
1999-02-02 |
Oncor, Inc. |
Nucleic acid amplification oligonucleotides with molecular energy transfer labels and methods based thereon
|
US6117635A
(en)
*
|
1996-07-16 |
2000-09-12 |
Intergen Company |
Nucleic acid amplification oligonucleotides with molecular energy transfer labels and methods based thereon
|
ES2203815T3
(es)
*
|
1996-07-18 |
2004-04-16 |
Dade Behring Marburg Gmbh |
Reactivos para analisis de acido micofenolico.
|
ES2198583T3
(es)
|
1996-07-18 |
2004-02-01 |
Dade Behring Marburg Gmbh |
Reactivos para ensayos del acido micofenolico.
|
US5853990A
(en)
*
|
1996-07-26 |
1998-12-29 |
Edward E. Winger |
Real time homogeneous nucleotide assay
|
AU4055697A
(en)
|
1996-08-16 |
1998-03-06 |
Schering Corporation |
Mammalian cell surface antigens; related reagents
|
US20070299005A1
(en)
*
|
1996-09-24 |
2007-12-27 |
Tanox, Inc. |
Family of genes encoding apoptosis-related peptides, peptides encoded thereby and methods of use thereof
|
WO1998013493A2
(fr)
|
1996-09-24 |
1998-04-02 |
Lxr Biotechnology, Inc. |
Famille de genes codant les peptides lies a l'apoptose, peptides ainsi codes et leurs procedes d'utilisation
|
US6808880B2
(en)
*
|
1996-10-01 |
2004-10-26 |
Geron Corporation |
Method for detecting polynucleotides encoding telomerase
|
US7585622B1
(en)
|
1996-10-01 |
2009-09-08 |
Geron Corporation |
Increasing the proliferative capacity of cells using telomerase reverse transcriptase
|
US6261836B1
(en)
|
1996-10-01 |
2001-07-17 |
Geron Corporation |
Telomerase
|
SG94355A1
(en)
*
|
1996-10-01 |
2003-02-18 |
Geron Corp |
Human telomerase catalytic subunit
|
US6610839B1
(en)
*
|
1997-08-14 |
2003-08-26 |
Geron Corporation |
Promoter for telomerase reverse transcriptase
|
US6093809A
(en)
*
|
1996-10-01 |
2000-07-25 |
University Technology Corporation |
Telomerase
|
US6475789B1
(en)
*
|
1996-10-01 |
2002-11-05 |
University Technology Corporation |
Human telomerase catalytic subunit: diagnostic and therapeutic methods
|
GB9907461D0
(en)
|
1999-03-31 |
1999-05-26 |
King S College London |
Neurite regeneration
|
US6479263B1
(en)
|
1996-11-14 |
2002-11-12 |
Baylor College Of Medicine |
Method for detection of micrometastatic prostate cancer
|
EP1803816A3
(fr)
|
1996-12-13 |
2007-09-26 |
Schering Corporation |
Antigènes de surface de céllules mammaliennes et réactifs qui y sont liés
|
US5840322A
(en)
*
|
1996-12-19 |
1998-11-24 |
Ramot-University Authority For Applied Research & Industrial Devel. Ltd. |
Anti-oral-microbial adhesion fraction derived from vaccinium
|
DK0966533T3
(da)
|
1997-02-07 |
2010-01-04 |
Us Gov Health & Human Serv |
Aktivitetsafhængig neurotrof faktor III (ADNF III).
|
WO1998035012A2
(fr)
|
1997-02-12 |
1998-08-13 |
Chan Eugene Y |
Procedes et produits permettant d'analyser des polymeres
|
US7413864B2
(en)
*
|
1997-04-18 |
2008-08-19 |
Geron Corporation |
Treating cancer using a telomerase vaccine
|
US20050013825A1
(en)
*
|
1997-04-18 |
2005-01-20 |
Geron Corporation |
Vaccine containing the catalytic subunit of telomerase for treating cancer
|
US7622549B2
(en)
*
|
1997-04-18 |
2009-11-24 |
Geron Corporation |
Human telomerase reverse transcriptase polypeptides
|
US6103536A
(en)
|
1997-05-02 |
2000-08-15 |
Silver Lake Research Corporation |
Internally referenced competitive assays
|
ES2279572T3
(es)
|
1997-05-07 |
2007-08-16 |
Schering Corporation |
Proteinas receptoras humanas de tipo toll, reactivos y metodos relacionados.
|
US7115722B1
(en)
|
1997-05-22 |
2006-10-03 |
Viventia Biotech, Inc. |
Antigen binding fragments that specifically detect cancer cells, nucleotides encoding the fragments, and use thereof for the prophylaxis and detection of cancers
|
US7314711B2
(en)
*
|
1997-05-23 |
2008-01-01 |
Bioveris Corporation |
Assays employing electrochemiluminescent labels and electrochemiluminescence quenchers
|
US20020098190A1
(en)
*
|
1997-06-13 |
2002-07-25 |
Malaya Chatterjee |
Compositions and methods for treating tumors bearing HMFG and CEA antigens
|
US6235486B1
(en)
|
1997-06-20 |
2001-05-22 |
Mayo Foundation For Medical Education & Research |
Method for detection of breast cancer
|
US20020122807A1
(en)
*
|
1998-07-07 |
2002-09-05 |
Dan Michael D. |
Antigen binding fragments, designated 4B5, that specifically detect cancer cells, nucleotides encoding the fragments, and use thereof for the prophylaxis and detection of cancers
|
CN100391973C
(zh)
|
1997-07-09 |
2008-06-04 |
先灵公司 |
分离树突状细胞膜蛋白基因
|
WO1999002721A1
(fr)
|
1997-07-11 |
1999-01-21 |
University Of North Texas |
GENE csrB DE L'ESCHERICHIA COLI, ARN CODE PAR CE GENE ET PROCEDES D'UTILISATION
|
US6762039B2
(en)
*
|
1997-07-15 |
2004-07-13 |
Genencor International, Inc. |
Bacillus subtillis with an inactivated cysteine protease-1
|
US6723550B1
(en)
*
|
1997-07-15 |
2004-04-20 |
Genencor International, Inc. |
Proteases from gram-positive organisms
|
US6506579B1
(en)
|
1997-07-15 |
2003-01-14 |
Genencor International, Inc. |
Increasing production of proteins in gram-positive microorganisms using SecG
|
US20030157642A1
(en)
*
|
1997-07-15 |
2003-08-21 |
Caldwell Robert M. |
Increasing production of proteins in gram-positive microorganisms
|
US6521421B1
(en)
|
1997-07-16 |
2003-02-18 |
Genencor International, Inc. |
Expression vectors encoding Bacillus subtilis disulfide bond isomerase and methods of secreting proteins in gram-positive microorganisms using the same
|
CO4810232A1
(es)
|
1997-07-25 |
1999-06-30 |
Schering Corp |
Citoquinas de mamiferos y sus secuencias codificadoras
|
US6180411B1
(en)
|
1997-08-01 |
2001-01-30 |
The Regents Of The University Of California |
Light-triggered indicators that memorize analyte concentrations
|
WO1999006557A2
(fr)
|
1997-08-01 |
1999-02-11 |
Schering Corporation |
Proteines de membrane cellulaire mammalienne et reactifs associes
|
US5929049A
(en)
*
|
1997-08-08 |
1999-07-27 |
Dade Behring Marburg Gmbh |
Polysaccharide conjugates of biomolecules
|
US7973156B2
(en)
*
|
1997-08-21 |
2011-07-05 |
Quark Pharmaceuticals Inc. |
Hypoxia-regulated genes
|
WO1999009046A1
(fr)
|
1997-08-21 |
1999-02-25 |
Quark Biotech, Inc. |
Genes regules au niveau de l'hypoxemie
|
US20030104973A1
(en)
*
|
1997-08-21 |
2003-06-05 |
Quark Biotech, Inc. |
Hypoxia-regulated genes
|
US7252950B1
(en)
|
1997-09-04 |
2007-08-07 |
The Regents Of The University Of California |
Assays for detecting modulators of cytoskeletal function
|
US6300117B1
(en)
*
|
1997-09-15 |
2001-10-09 |
Genencor International, Inc. |
Proteases from gram-positive organisms
|
US6521440B1
(en)
*
|
1997-09-15 |
2003-02-18 |
Genencor International, Inc. |
Proteases from gram-positive organisms
|
US7745142B2
(en)
|
1997-09-15 |
2010-06-29 |
Molecular Devices Corporation |
Molecular modification assays
|
US7632651B2
(en)
|
1997-09-15 |
2009-12-15 |
Mds Analytical Technologies (Us) Inc. |
Molecular modification assays
|
US7070921B2
(en)
|
2000-04-28 |
2006-07-04 |
Molecular Devices Corporation |
Molecular modification assays
|
US7378244B2
(en)
*
|
1997-10-01 |
2008-05-27 |
Geron Corporation |
Telomerase promoters sequences for screening telomerase modulators
|
WO1999018438A1
(fr)
*
|
1997-10-02 |
1999-04-15 |
Aclara Biosciences, Inc. |
Analyses capillaires impliquant la separation d'especes libres et liees
|
US6284496B1
(en)
|
1997-10-03 |
2001-09-04 |
University Of South Florida |
DNA vector for determining the presence of out-of-reading-frame mutations
|
DE19745001A1
(de)
*
|
1997-10-11 |
1999-05-06 |
Evotec Biosystems Ag |
Verfahren zur Affinitätsmarkierung von Oligo- oder Polymeren
|
AU748467B2
(en)
|
1997-10-17 |
2002-06-06 |
University Of South Florida |
Method to diagnose and monitor cellular immune deficiencies
|
US6607829B1
(en)
*
|
1997-11-13 |
2003-08-19 |
Massachusetts Institute Of Technology |
Tellurium-containing nanocrystalline materials
|
US6322901B1
(en)
|
1997-11-13 |
2001-11-27 |
Massachusetts Institute Of Technology |
Highly luminescent color-selective nano-crystalline materials
|
GB9724629D0
(en)
*
|
1997-11-20 |
1998-01-21 |
Genencor Int Bv |
Alpha/beta hydrolase-fold enzymes
|
GB9724627D0
(en)
|
1997-11-20 |
1998-01-21 |
Genencor Int Bv |
Gram positive microorganism formate pathway
|
US6316241B1
(en)
*
|
1997-11-20 |
2001-11-13 |
Genencor International, Inc. |
Alpha/beta hydrolase-fold enzymes
|
US6306642B1
(en)
*
|
1997-11-24 |
2001-10-23 |
Quidel Corporation |
Enzyme substrate delivery and product registration in one step enzyme immunoassays
|
US6699723B1
(en)
|
1997-11-25 |
2004-03-02 |
The Regents Of The University Of California |
Organo luminescent semiconductor nanocrystal probes for biological applications and process for making and using such probes
|
US6207392B1
(en)
|
1997-11-25 |
2001-03-27 |
The Regents Of The University Of California |
Semiconductor nanocrystal probes for biological applications and process for making and using such probes
|
US5990479A
(en)
|
1997-11-25 |
1999-11-23 |
Regents Of The University Of California |
Organo Luminescent semiconductor nanocrystal probes for biological applications and process for making and using such probes
|
DE19756782A1
(de)
|
1997-12-19 |
1999-06-24 |
Dade Behring Marburg Gmbh |
Nachweis und Bestimmung festphasenassoziierter Faktoren
|
DE19756773A1
(de)
*
|
1997-12-19 |
1999-06-24 |
Dade Behring Marburg Gmbh |
Neues Verfahren und Diagnosemittel zur Hämostase-Diagnostik
|
AU1944699A
(en)
*
|
1997-12-23 |
1999-07-12 |
Vicam, L.P. |
Generic signalling mechanism for detection of analytes
|
US6528255B1
(en)
*
|
1997-12-30 |
2003-03-04 |
Genencor International, Inc. |
Proteases from gram positive organisms
|
US6465186B1
(en)
*
|
1997-12-30 |
2002-10-15 |
Genecor International, Inc. |
Proteases from gram positive organisms
|
US6599731B1
(en)
*
|
1997-12-30 |
2003-07-29 |
Genencor International, Inc. |
Proteases from gram positive organisms
|
GB9727470D0
(en)
|
1997-12-30 |
1998-02-25 |
Genencor Int Bv |
Proteases from gram positive organisms
|
US7687057B2
(en)
|
1998-01-09 |
2010-03-30 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem |
In vitro micro-organs, and uses related thereto
|
US6780609B1
(en)
|
1998-10-23 |
2004-08-24 |
Genome Therapeutics Corporation |
High bone mass gene of 1.1q13.3
|
US6759243B2
(en)
|
1998-01-20 |
2004-07-06 |
Board Of Trustees Of The University Of Illinois |
High affinity TCR proteins and methods
|
US6673914B1
(en)
|
1998-01-22 |
2004-01-06 |
John Wayne Cancer Institute |
Human tumor-associated gene
|
WO2000018885A1
(fr)
|
1998-09-29 |
2000-04-06 |
Gamida Cell Ltd. |
Procedes de regulation de la proliferation et de la differentiation de cellules souches et precurseurs
|
US6596501B2
(en)
|
1998-02-23 |
2003-07-22 |
Fred Hutchinson Cancer Research Center |
Method of diagnosing autoimmune disease
|
CN1249226C
(zh)
|
1998-03-04 |
2006-04-05 |
金克克国际有限公司 |
支链淀粉酶的修饰形式
|
CA2323812C
(fr)
|
1998-03-20 |
2011-05-10 |
The Curators Of The University Of Missouri |
Diagnostic precoce de grossesse au moyen de glycoproteines associees a la grossesse
|
US6303081B1
(en)
|
1998-03-30 |
2001-10-16 |
Orasure Technologies, Inc. |
Device for collection and assay of oral fluids
|
ATE328278T1
(de)
*
|
1998-03-30 |
2006-06-15 |
Orasure Technologies Inc |
Sammelapparat für einschrittigen test von mundflüssigkeiten
|
US8062908B2
(en)
*
|
1999-03-29 |
2011-11-22 |
Orasure Technologies, Inc. |
Device for collection and assay of oral fluids
|
US6337200B1
(en)
*
|
1998-03-31 |
2002-01-08 |
Geron Corporation |
Human telomerase catalytic subunit variants
|
ATE546544T1
(de)
*
|
1998-03-31 |
2012-03-15 |
Esoterix Genetic Lab Llc |
Verfahren zur diagnose und behandlung von lungenkrebs
|
US6683173B2
(en)
|
1998-04-03 |
2004-01-27 |
Epoch Biosciences, Inc. |
Tm leveling methods
|
US6949367B1
(en)
|
1998-04-03 |
2005-09-27 |
Epoch Pharmaceuticals, Inc. |
Modified oligonucleotides for mismatch discrimination
|
US7715989B2
(en)
*
|
1998-04-03 |
2010-05-11 |
Elitech Holding B.V. |
Systems and methods for predicting oligonucleotide melting temperature (TmS)
|
US7108968B2
(en)
*
|
1998-04-03 |
2006-09-19 |
Affymetrix, Inc. |
Mycobacterial rpoB sequences
|
US7045610B2
(en)
*
|
1998-04-03 |
2006-05-16 |
Epoch Biosciences, Inc. |
Modified oligonucleotides for mismatch discrimination
|
WO1999051702A1
(fr)
*
|
1998-04-08 |
1999-10-14 |
Terpetschnig Ewald A |
Composes luminescents
|
US6538129B1
(en)
|
1999-04-07 |
2003-03-25 |
Ewald A. Terpetschnig |
Luminescent compounds
|
US20030235846A1
(en)
*
|
1998-04-08 |
2003-12-25 |
Terpetschnig Ewald A. |
Luminescent compounds
|
US7411068B2
(en)
*
|
1998-04-08 |
2008-08-12 |
Terpetschnig Ewald A |
Luminescent compounds
|
US7250517B2
(en)
*
|
1998-04-08 |
2007-07-31 |
Ewald A. Terpetschnig |
Luminescent compounds
|
WO1999053295A1
(fr)
|
1998-04-14 |
1999-10-21 |
The Regents Of The University Of California |
Dosages de detection d'inhibiteurs de depolymerisation de microtubules
|
US6699969B1
(en)
|
1998-04-14 |
2004-03-02 |
The Regents Of The University Of California |
Assays for the detection of microtubule depolymerization inhibitors
|
US6872537B1
(en)
|
1998-04-14 |
2005-03-29 |
Regents Of The University Of California |
Assays for the detection of microtubule depolymerization inhibitors
|
US7875440B2
(en)
|
1998-05-01 |
2011-01-25 |
Arizona Board Of Regents |
Method of determining the nucleotide sequence of oligonucleotides and DNA molecules
|
US6780591B2
(en)
|
1998-05-01 |
2004-08-24 |
Arizona Board Of Regents |
Method of determining the nucleotide sequence of oligonucleotides and DNA molecules
|
US20080206206A1
(en)
|
1998-05-07 |
2008-08-28 |
University Of South Florida |
Bone marrow-derived neuronal cells
|
US6153442A
(en)
*
|
1998-05-20 |
2000-11-28 |
Dade Behring Inc. |
Reagents and methods for specific binding assays
|
US6303325B1
(en)
|
1998-05-29 |
2001-10-16 |
Dade Behring Inc. |
Method for detecting analytes
|
CA2329948A1
(fr)
*
|
1998-06-09 |
1999-12-16 |
Vijay Kumar |
Technique elisa pour phase en solution
|
ES2245108T3
(es)
|
1998-07-03 |
2005-12-16 |
Precisense As |
Sensor optico biodegradable para la medida in situ de analitos.
|
USRE38525E1
(en)
|
1998-07-03 |
2004-06-08 |
Torsana Diabetes Diagnostics A/S |
Optical sensor for in situ measurement of analytes
|
GB9814506D0
(en)
*
|
1998-07-03 |
1998-09-02 |
Stanley Christopher J |
Optical sensor for insitu measurement of analytes
|
US6344443B1
(en)
|
1998-07-08 |
2002-02-05 |
University Of South Florida |
Peptide antagonists of tumor necrosis factor alpha
|
WO2000002561A1
(fr)
|
1998-07-13 |
2000-01-20 |
University Of South Florida |
Modulation de la voie de phospholipase a2 utilisee comme procede therapeutique
|
DK1098988T4
(da)
|
1998-07-21 |
2007-09-03 |
Danisco |
Födevare
|
EP1097378A2
(fr)
*
|
1998-07-21 |
2001-05-09 |
Burstein Laboratories Inc. |
Dispositifs de dosage utilisant des disques optiques et methodes correspondantes
|
CA2303855A1
(fr)
|
1998-07-22 |
2000-02-03 |
Jin Po Lee |
Dispositif permettant de deceler differents composants
|
US6187563B1
(en)
|
1998-08-07 |
2001-02-13 |
Yale University |
βIV-spectrin-polypeptides and nucleic acids encoding same
|
SE9803099D0
(sv)
|
1998-09-13 |
1998-09-13 |
Karolinska Innovations Ab |
Nucleic acid transfer
|
US6251303B1
(en)
|
1998-09-18 |
2001-06-26 |
Massachusetts Institute Of Technology |
Water-soluble fluorescent nanocrystals
|
US6306610B1
(en)
|
1998-09-18 |
2001-10-23 |
Massachusetts Institute Of Technology |
Biological applications of quantum dots
|
US6617583B1
(en)
*
|
1998-09-18 |
2003-09-09 |
Massachusetts Institute Of Technology |
Inventory control
|
AU6246199A
(en)
|
1998-09-21 |
2000-04-10 |
Schering Corporation |
Human interleukin-b50, therapeutic uses
|
EP1115888B1
(fr)
|
1998-09-24 |
2008-03-12 |
Indiana University Research and Technology Corporation |
Points quantiques luminescents soluble dans l'eau et leurs conjugues biomoleculaires et compositions apparentees et procedes d'utilisation
|
EP0997476A3
(fr)
|
1998-09-25 |
2000-07-19 |
Schering-Plough |
Anticorps contre un antigène de cellules Langerhans mammifères et leurs utilisations
|
US6153411A
(en)
|
1998-10-30 |
2000-11-28 |
American Water Works Company, Inc. |
Methods and kits for detection of Cryptosporidium parvum using immunomagnetic separation and amplification
|
NZ511991A
(en)
|
1999-01-11 |
2004-03-26 |
Schering Corp |
Interleukin-17 related mammalian cytokines. Polynucleotides encoding them. uses
|
ATE452181T1
(de)
|
1999-02-04 |
2010-01-15 |
Pluristem Ltd |
Verfahren und vorrichtung zur haltung und expansion von hematopoietischen stammzellen und/oder vorläuferzellen
|
US6156515A
(en)
*
|
1999-02-09 |
2000-12-05 |
Urocor, Inc. |
Prostate-specific gene for diagnosis, prognosis and management of prostate cancer
|
ATE420894T1
(de)
|
1999-03-11 |
2009-01-15 |
Schering Corp |
Cytokine aus säugetieren, verwandte reagenzien und verfahren
|
AU774662B2
(en)
|
1999-04-20 |
2004-07-01 |
Target Discovery, Inc. |
Polypeptide fingerprinting methods, metabolic profiling, and bioinformatics database
|
WO2000070045A1
(fr)
|
1999-05-13 |
2000-11-23 |
Medical Research Council |
Homologues de recepteur ox2
|
AU5011200A
(en)
|
1999-05-14 |
2000-12-05 |
Arbor Vita Corporation |
Molecular interactions in hematopoietic cells
|
US6440682B1
(en)
*
|
1999-05-28 |
2002-08-27 |
Detroit R&D Inc. |
Detection of hypertension using immunoreactive metabolic products
|
US6787318B1
(en)
|
1999-06-01 |
2004-09-07 |
Roskamp Research Institute, Llc |
Assay for evaluating the therapeutic effectiveness of agents in reducing Alzheimer's disease pathology
|
CA2374391C
(fr)
|
1999-06-01 |
2014-10-28 |
Schering Corporation |
Proteines de recepteur mammaliennes, reactifs et procedes y relatifs
|
US7534605B2
(en)
|
1999-06-08 |
2009-05-19 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem |
CD44 polypeptides, polynucleotides encoding same, antibodies directed thereagainst and method of using same for diagnosing and treating inflammatory diseases
|
GB9914210D0
(en)
|
1999-06-17 |
1999-08-18 |
Danisco |
Promoter
|
US6262265B1
(en)
|
1999-06-18 |
2001-07-17 |
Microgenics Corporation |
Non-hydrolyzable analogs of heroin metabolites suitable for use in immunoassay
|
CN1420933A
(zh)
*
|
1999-06-25 |
2003-05-28 |
耶路撒冷希伯来大学伊森姆研究发展公司 |
应用微器官诱导血管生成的方法
|
US6818395B1
(en)
|
1999-06-28 |
2004-11-16 |
California Institute Of Technology |
Methods and apparatus for analyzing polynucleotide sequences
|
EP1196398A4
(fr)
|
1999-07-06 |
2002-11-06 |
Surromed Inc |
Colorants fluorescents pontes, leur preparation et leur utilisation dans des dosages
|
DE60042827D1
(de)
|
1999-07-30 |
2009-10-08 |
Schering Corp |
Cytokine aus säugetieren und dazugehörende reagenzien
|
US6875582B1
(en)
|
1999-08-19 |
2005-04-05 |
Omniscience Pharmaceuticals, Inc. |
Methods and targets of antibiotic resistance
|
US7811981B2
(en)
*
|
1999-08-30 |
2010-10-12 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem |
Methods of and compositions for inhibiting the proliferation of mammalian cells
|
US7101839B1
(en)
|
1999-08-30 |
2006-09-05 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem |
Methods of and compositions for inhibiting the proliferation of mammalian cells
|
EP3184637A1
(fr)
|
1999-09-09 |
2017-06-28 |
Merck Sharp & Dohme Corp. |
Utilisations de complexes d'interleukine-12 p40 et d'interleukine b30 mammaliennes, anticorps, dans des compositions pharmaceutiques
|
US6998232B1
(en)
|
1999-09-27 |
2006-02-14 |
Quark Biotech, Inc. |
Methods of diagnosing bladder cancer
|
US7668658B2
(en)
|
1999-10-13 |
2010-02-23 |
Sequenom, Inc. |
Methods for generating databases and databases for identifying polymorphic genetic markers
|
US7030228B1
(en)
*
|
1999-11-15 |
2006-04-18 |
Miltenyi Biotec Gmbh |
Antigen-binding fragments specific for dendritic cells, compositions and methods of use thereof antigens recognized thereby and cells obtained thereby
|
AU784258B2
(en)
*
|
1999-11-19 |
2006-03-02 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem |
Aspegillus niger beta-glucosidase gene, protein and uses thereof
|
EP2275447A1
(fr)
|
1999-11-24 |
2011-01-19 |
Schering Corporation |
Procedes d'inhibition de metastases
|
EP2336775A3
(fr)
|
1999-12-06 |
2013-03-20 |
Board Of Trustees Of The University Of Illinois |
Protéines TCR haute affinité et procédés
|
US6544792B1
(en)
|
1999-12-21 |
2003-04-08 |
Genencor International, Inc. |
Production of secreted polypeptides
|
ATE356874T1
(de)
|
1999-12-22 |
2007-04-15 |
Dade Behring Marburg Gmbh |
Lösungen von humanem procalcitonin
|
DE50015156D1
(de)
|
1999-12-22 |
2008-06-26 |
Dade Behring Marburg Gmbh |
Gegen Procalcitonin gerichtete Antikörper, ihre Herstellung und Verwendung
|
US6544506B2
(en)
*
|
2000-01-05 |
2003-04-08 |
Yeda Research & Development Co. Ltd. |
Veto cells effective in preventing graft rejection and devoid of graft versus host potential
|
US7230088B2
(en)
*
|
2001-07-03 |
2007-06-12 |
Mallinckrodt, Inc. |
Compounds for dual photodiagnosis and therapy
|
EP1252292A4
(fr)
*
|
2000-01-24 |
2004-11-17 |
Univ Ramot |
Plantes tolerant le stress de l'environnement, procedes d'elaboration pour ce type de plante et sequence polynucleotidique utilisee a cet effet
|
DE10003734A1
(de)
*
|
2000-01-28 |
2001-08-02 |
Bosch Gmbh Robert |
Detektionsverfahren und -vorrichtung
|
JP4981229B2
(ja)
*
|
2000-02-25 |
2012-07-18 |
ルードヴィッヒ インスティテュート フォー キャンサー リサーチ |
ハイブリッド血管内皮成長因子DNAsおよびタンパク質に関与する物質および方法
|
EP1944310A3
(fr)
|
2000-03-01 |
2008-08-06 |
Epoch Biosciences, Inc. |
Oligonucléotides modifiées pour discrimination de désadaptation
|
WO2001064958A2
(fr)
|
2000-03-01 |
2001-09-07 |
Epoch Bioscienecs, Inc. |
Oligonucleotides modifies permettant de discriminer des mesappariements
|
US20040002068A1
(en)
|
2000-03-01 |
2004-01-01 |
Corixa Corporation |
Compositions and methods for the detection, diagnosis and therapy of hematological malignancies
|
JP4448642B2
(ja)
|
2000-03-06 |
2010-04-14 |
シーメンス・ヘルスケア・ダイアグノスティックス・プロダクツ・ゲーエムベーハー |
多糖で被覆された担体、その製造および使用
|
US8288128B2
(en)
*
|
2004-11-18 |
2012-10-16 |
Eppendorf Array Technologies S.A. |
Real-time quantification of multiple targets on a micro-array
|
US7875442B2
(en)
*
|
2000-03-24 |
2011-01-25 |
Eppendorf Array Technologies |
Identification and quantification of a plurality of biological (micro)organisms or their components
|
WO2006053769A1
(fr)
|
2004-11-18 |
2006-05-26 |
Eppendorf Array Technologies |
Quantification en temps reel de cibles multiples sur un microreseau
|
US7829313B2
(en)
*
|
2000-03-24 |
2010-11-09 |
Eppendorf Array Technologies |
Identification and quantification of a plurality of biological (micro)organisms or their components
|
CA2404489A1
(fr)
|
2000-03-27 |
2001-10-04 |
Technion Research And Development Foundation Ltd. |
Complexes majeurs d'histocompatibilite monocatenaires de classe 1, constructions les codant et leurs methodes de production
|
US20030108927A1
(en)
*
|
2000-04-03 |
2003-06-12 |
Kathryn Leishman |
Compositions and methods for the prevention, treatment and detection of tuberculosis and other diseases
|
SI1274450T1
(sl)
|
2000-04-18 |
2009-04-30 |
Schering Corp |
Medicinske uporabe agonistov in antagonistov IL-174
|
IL135884A
(en)
*
|
2000-04-30 |
2005-08-31 |
Yissum Res Dev Co |
Method for measuring non-transferrin bound iron
|
JP4796259B2
(ja)
|
2000-05-04 |
2011-10-19 |
シーメンス・ヘルスケア・ダイアグノスティックス・プロダクツ・ゲーエムベーハー |
複数のアナライトの検出において使用するための組成物
|
US7019129B1
(en)
|
2000-05-09 |
2006-03-28 |
Biosearch Technologies, Inc. |
Dark quenchers for donor-acceptor energy transfer
|
JP5073909B2
(ja)
|
2000-05-10 |
2012-11-14 |
メルク・シャープ・アンド・ドーム・コーポレーション |
哺乳動物レセプタータンパク質;関連する試薬および方法
|
US7422743B2
(en)
|
2000-05-10 |
2008-09-09 |
Schering Corporation |
Mammalian receptor protein DCRS5;methods of treatment
|
NZ522327A
(en)
|
2000-05-25 |
2004-09-24 |
Schering Corp |
Mammalian DNAX Toll-like receptor protein, DTLR 10, antibodies and medicaments made therefrom and use in treating immunological disorders
|
WO2005000087A2
(fr)
*
|
2003-06-03 |
2005-01-06 |
Chiron Corporation |
Produits genetiques exprimes de facon differentielle dans des cellules cancereuses du colon et leurs methodes d'utilisation ii
|
US6936702B2
(en)
*
|
2000-06-07 |
2005-08-30 |
Li-Cor, Inc. |
Charge-switch nucleotides
|
CA2412567A1
(fr)
|
2000-06-07 |
2001-12-13 |
Li-Cor, Inc. |
Nucleotides a commutation de charges
|
US7846733B2
(en)
|
2000-06-26 |
2010-12-07 |
Nugen Technologies, Inc. |
Methods and compositions for transcription-based nucleic acid amplification
|
GB0016841D0
(en)
|
2000-07-07 |
2000-08-30 |
Stanley Christopher J |
Optical device for measurement of analytes in tears
|
US6958214B2
(en)
*
|
2000-07-10 |
2005-10-25 |
Sequenom, Inc. |
Polymorphic kinase anchor proteins and nucleic acids encoding the same
|
HUP0300810A2
(hu)
|
2000-07-20 |
2003-08-28 |
M.G.V.S. Ltd. |
Mesterséges értranszplantátum, valamint ennek létrehozása és alkalmazása
|
US20040037828A1
(en)
|
2002-07-09 |
2004-02-26 |
Bar-Ilan University |
Methods and pharmaceutical compositions for healing wounds
|
PT1315519E
(pt)
|
2000-08-08 |
2011-03-17 |
Technion Res & Dev Foundation |
Composições farmacêuticas e métodos úteis para tratamento de cancro e fibrose hepática
|
US20030114410A1
(en)
|
2000-08-08 |
2003-06-19 |
Technion Research And Development Foundation Ltd. |
Pharmaceutical compositions and methods useful for modulating angiogenesis and inhibiting metastasis and tumor fibrosis
|
GB0020498D0
(en)
|
2000-08-18 |
2000-10-11 |
Sterix Ltd |
Compound
|
EP1683874A3
(fr)
|
2000-08-29 |
2006-10-11 |
YEDA RESEARCH AND DEVELOPMENT Co. LTD. |
Méthode pour l'isolement de gènes codant pour des protéines à fonction spécifique et pour le criblage d'agents pharmaceutiques actifs
|
PT1322755E
(pt)
|
2000-09-08 |
2010-11-19 |
Univ Texas |
Péptidos de direccionamento humanos e de murganho identificados por apresentação em fagos
|
EP1315743B1
(fr)
|
2000-09-08 |
2012-11-07 |
Merck Sharp & Dohme Corp. |
Genes mammaliens, reactifs et methodes associes
|
US6673623B1
(en)
|
2000-09-12 |
2004-01-06 |
Novocure, Inc. |
Methods and compositions that control lipid production
|
DK1356060T3
(da)
*
|
2000-09-18 |
2006-05-01 |
Genencor Int |
Dobbeltarginintranslokation i Bacillus
|
US20070281037A9
(en)
*
|
2000-09-28 |
2007-12-06 |
Nanocyte Inc. |
Sterile preparations and compositions including stinging capsules and methods of producing and using same
|
IL155097A0
(en)
*
|
2000-09-28 |
2003-10-31 |
Nanocyte Inc |
Methods, compositions and devices utilizing stinging cells/capsules for delivering a therapeutic or a cosmetic agent into a tissue
|
US7632522B2
(en)
*
|
2000-09-28 |
2009-12-15 |
Nanocyte Inc. |
Use of stinging cells/capsules for the delivery of active agents to keratinous substances
|
AU2002213096B2
(en)
|
2000-10-06 |
2007-03-29 |
Nugen Technologies, Inc. |
Methods and probes for detection and/or quantification of nucleic acid sequences
|
GB0025147D0
(en)
|
2000-10-13 |
2000-11-29 |
Torsana Diabetes Diagnostics A |
Optical sensor for in situ measurement of analytes
|
US7045283B2
(en)
|
2000-10-18 |
2006-05-16 |
The Regents Of The University Of California |
Methods of high-throughput screening for internalizing antibodies
|
AU2002246744B2
(en)
|
2000-10-19 |
2008-04-10 |
Target Discovery, Inc. |
Methods for determining protein and peptide terminal sequences
|
US6890734B2
(en)
|
2000-11-10 |
2005-05-10 |
Schering Corporation |
Nucleic acids encoding a cytokine receptor complex
|
US8071740B2
(en)
|
2000-11-17 |
2011-12-06 |
Vascular Biogenics Ltd. |
Promoters exhibiting endothelial cell specificity and methods of using same for regulation of angiogenesis
|
MXPA03004325A
(es)
|
2000-11-17 |
2004-01-26 |
Vascular Biogenics Ltd |
Promotores que muestran especificidad celular endotelial y metodos para su uso.
|
IL156015A0
(en)
|
2000-11-24 |
2003-12-23 |
Vascular Biogenics Ltd |
Methods employing and compositions containing defined oxidized phospholipids for prevention and treatment of atherosclerosis
|
US20030054446A1
(en)
*
|
2000-11-29 |
2003-03-20 |
Weber Bernard H. F. |
Novel retina-specific human proteins C7orf9, C12orf7, MPP4 and F379
|
KR20030067696A
(ko)
|
2000-11-30 |
2003-08-14 |
모렉큐랄 스킨케어 리미티드 |
질병의 진단 및 치료
|
EP1337152A4
(fr)
*
|
2000-11-30 |
2004-08-11 |
Yeda Res & Dev |
Methodes d'utilisation de lymphocytes t mis en culture et n'induisant pas de reaction du greffon contre l'hote (gvhd) pour traiter des maladies
|
WO2002044425A2
(fr)
|
2000-12-01 |
2002-06-06 |
Visigen Biotechnologies, Inc. |
Synthese d'acides nucleiques d'enzymes, et compositions et methodes modifiant la fidelite d'incorporation de monomeres
|
NO20006130D0
(no)
*
|
2000-12-01 |
2000-12-01 |
Erling Sundrehagen |
Reagens og analysemetode
|
US20020165149A1
(en)
*
|
2000-12-08 |
2002-11-07 |
Kranz David M. |
Mutated class II major histocompatibility proteins
|
EP1427847B1
(fr)
*
|
2000-12-13 |
2010-07-28 |
Nugen Technologies, Inc. |
Methodes et compositions de generation de copies multiples de sequences d'acides nucleiques et methodes de detection correspondantes
|
DE10064827A1
(de)
*
|
2000-12-22 |
2002-06-27 |
Dade Behring Marburg Gmbh |
Nachweisverfahren
|
EP1463811A2
(fr)
*
|
2001-01-17 |
2004-10-06 |
Ramot at Tel Aviv University Ltd. |
Chitinases derivees de sequences polynucleotidiques de plantes carnivores codant pour celles-ci, et procedes d'isolement et d'utilisation de celles-ci
|
GB0101762D0
(en)
*
|
2001-01-23 |
2001-03-07 |
Medical Res Council |
Method
|
US20050031618A1
(en)
*
|
2001-01-31 |
2005-02-10 |
Dror Mevorach |
Induction of tolerance by apoptotic and/or necrotic cells
|
US20050202098A1
(en)
*
|
2001-01-31 |
2005-09-15 |
Tolaren |
Disease therapy using dying or dead cells
|
KR20030082535A
(ko)
|
2001-03-09 |
2003-10-22 |
뉴젠 테크놀로지스 인코포레이티드 |
Rna 서열의 증폭을 위한 방법 및 조성물
|
EP1385829A4
(fr)
*
|
2001-03-12 |
2005-10-19 |
Affymetrix Inc |
Composes de marquage d'acide nucleique
|
CA2440754A1
(fr)
|
2001-03-12 |
2002-09-19 |
Stephen Quake |
Procedes et appareil d'analyse de sequences de polynucleotide par extension de base asynchrone
|
US20030104410A1
(en)
*
|
2001-03-16 |
2003-06-05 |
Affymetrix, Inc. |
Human microarray
|
US20030003454A1
(en)
|
2001-03-23 |
2003-01-02 |
Yeda Research And Development Co. Ltd. At The Weizmann Institute Of Science |
Methods and kits for determining a risk to develop cancer, for evaluating an effectiveness and dosage of cancer therapy and for correlating between an activity of a DNA repair enzyme and a cancer
|
US20030220475A1
(en)
*
|
2001-04-03 |
2003-11-27 |
Fields Howard A. |
Neutralizing immunogenic hev polypepetides
|
AU2002254524A1
(en)
*
|
2001-04-06 |
2002-10-21 |
The Government Of The United States Of America, Represented By The Secretary, Department Of Health A |
Use of semenogelin in the diagnosis, prognosis and treatment of cancer
|
NZ528260A
(en)
|
2001-05-18 |
2005-09-30 |
Danisco |
Method of improving dough and bread quality with the addition of an enzyme that hydrolyses a glycolipid and a phospholipid and incapable of hydrolysing a triglyceride or monoglyceride
|
DE60229846D1
(de)
|
2001-05-22 |
2008-12-24 |
Merck & Co Inc |
Beta-secretase-substrat und seine verwendung
|
US7118907B2
(en)
*
|
2001-06-06 |
2006-10-10 |
Li-Cor, Inc. |
Single molecule detection systems and methods
|
US6770622B2
(en)
|
2001-06-08 |
2004-08-03 |
Gary A. Jarvis |
N-terminally truncated galectin-3 for use in treating cancer
|
US20070190534A1
(en)
*
|
2001-06-11 |
2007-08-16 |
Genesis Genomics Inc. |
Mitochondrial sites and genes associated with prostate cancer
|
WO2003002975A2
(fr)
*
|
2001-06-27 |
2003-01-09 |
The Uab Research Foundation |
Detecteurs biophotoniques et procedes d'utilisation de ces derniers
|
WO2003003015A2
(fr)
*
|
2001-06-28 |
2003-01-09 |
Advanced Research And Technology Institute, Inc. |
Procedes de preparation de billes marquees par des points quantiques multicolores et conjugues de ces billes
|
GB0116853D0
(en)
|
2001-07-10 |
2001-09-05 |
Torsana Diabetes Diagnostics A |
Optical sensor containing particles for in SITU measurement of analytes
|
MXPA04000397A
(es)
*
|
2001-07-19 |
2004-03-18 |
Yissum Res Dev Co |
Polipeptidos que tienen actividad catalitica de isomerasa de carotenoides, acidos nucleicos que los codifican y usos de los mismos.
|
US20030031627A1
(en)
*
|
2001-07-31 |
2003-02-13 |
Mallinckrodt Inc. |
Internal image antibodies for optical imaging and therapy
|
US6833441B2
(en)
|
2001-08-01 |
2004-12-21 |
Abmaxis, Inc. |
Compositions and methods for generating chimeric heteromultimers
|
WO2003012030A2
(fr)
*
|
2001-08-01 |
2003-02-13 |
University Of Utah, Technology Transfer Office |
Inhibiteurs et activateurs selectifs d'isoformes de phosphodiesterases nucleotidiques cycliques pde3
|
US20030082596A1
(en)
*
|
2001-08-08 |
2003-05-01 |
Michael Mittmann |
Methods of genetic analysis of probes: test3
|
US20060073530A1
(en)
*
|
2001-08-15 |
2006-04-06 |
Olaf Schneewind |
Methods and compositions involving sortase B
|
US7442781B2
(en)
|
2001-08-16 |
2008-10-28 |
Urifer Ltd. |
Diagnosis, prevention and treatment of cancer
|
US20040136972A1
(en)
|
2001-09-07 |
2004-07-15 |
Yeda Research And Development Co. Ltd. |
Methods of treating disease by transplantation of developing allogeneic or xenogeneic organs or tissues
|
ATE443259T1
(de)
|
2001-09-20 |
2009-10-15 |
Univ Texas |
Bestimmung der zirkulierenden therapeutischen antikörper, antigene sowie antigen-antikörper- komplexe mit elisa-tests
|
WO2003028582A2
(fr)
*
|
2001-09-28 |
2003-04-10 |
Aspenbio, Inc. |
Test de grossesse pour bovins
|
GB0212544D0
(en)
*
|
2002-05-30 |
2002-07-10 |
Microsens Biophage Ltd |
Methods for detection of target molecules and molecular interactions
|
US7521053B2
(en)
|
2001-10-11 |
2009-04-21 |
Amgen Inc. |
Angiopoietin-2 specific binding agents
|
US7138370B2
(en)
|
2001-10-11 |
2006-11-21 |
Amgen Inc. |
Specific binding agents of human angiopoietin-2
|
US8323903B2
(en)
*
|
2001-10-12 |
2012-12-04 |
Life Technologies Corporation |
Antibody complexes and methods for immunolabeling
|
US20050069962A1
(en)
*
|
2001-10-12 |
2005-03-31 |
Archer Robert M |
Antibody complexes and methods for immunolabeling
|
EP1439857B1
(fr)
|
2001-10-12 |
2009-02-25 |
Schering Corporation |
UTILISATION D'ANTICORPS BISPECIFIQUES RECONNAISSANT LE RECEPTEUR D'ACTIVATION FcEpsilon RI ET LE RECEPTEUR D'INHIBITION OX2Ra (CD200Ra) POUR REGULER DES REPONSES IMMUNITAIRES
|
DE60237777D1
(de)
|
2001-10-19 |
2010-11-04 |
Vascular Biogenics Ltd |
Etzungen und verfahren zur gezielten herunterregulierung von angiogenese und zur krebstherapie
|
US20040054162A1
(en)
*
|
2001-10-30 |
2004-03-18 |
Hanna Michelle M. |
Molecular detection systems utilizing reiterative oligonucleotide synthesis
|
US7045319B2
(en)
*
|
2001-10-30 |
2006-05-16 |
Ribomed Biotechnologies, Inc. |
Molecular detection systems utilizing reiterative oligonucleotide synthesis
|
US7175983B2
(en)
*
|
2001-11-02 |
2007-02-13 |
Abmaxis, Inc. |
Adapter-directed display systems
|
DE10153829A1
(de)
*
|
2001-11-05 |
2003-05-28 |
Bayer Ag |
Assay basierend auf dotierten Nanoteilchen
|
US20030124599A1
(en)
*
|
2001-11-14 |
2003-07-03 |
Shiping Chen |
Biochemical analysis system with combinatorial chemistry applications
|
CA2467904C
(fr)
|
2001-11-20 |
2009-04-07 |
The Curators Of The University Of Missouri |
Compositions et methodes pour le diagnostic precoce precis de la grossesse
|
US6952704B2
(en)
*
|
2001-11-26 |
2005-10-04 |
Microsoft Corporation |
Extending a directory schema independent of schema modification
|
US9575070B2
(en)
*
|
2001-12-04 |
2017-02-21 |
Wayne State University |
Neoepitope detection of disease using protein arrays
|
WO2003048298A2
(fr)
*
|
2001-12-05 |
2003-06-12 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem |
Nanoparticules contenant des homologues d'acides nucleiques polymeres, compositions pharmaceutiques et articles fabriques contenant ces nanoparticules, et procedes d'utilisation de celles-ci
|
US20050085432A1
(en)
*
|
2001-12-26 |
2005-04-21 |
Aviva Lapidot |
Methods of using conjugates of saccharides and acetamidino or guanidino compounds for treating bacterial infections
|
IL152904A0
(en)
|
2002-01-24 |
2003-06-24 |
Gamida Cell Ltd |
Utilization of retinoid and vitamin d receptor antagonists for expansion of renewable stem cell populations
|
WO2003062404A1
(fr)
|
2002-01-25 |
2003-07-31 |
Gamida-Cell Ltd. |
Methodes de developpement de cellules souches et de cellules precurseurs, populations de cellules multipliees obtenues a l'aide de ces methodes
|
US7781396B2
(en)
*
|
2002-01-31 |
2010-08-24 |
Tel Aviv University Future Technology Development L.P. |
Peptides directed for diagnosis and treatment of amyloid-associated disease
|
US20040052928A1
(en)
|
2002-09-06 |
2004-03-18 |
Ehud Gazit |
Peptides and methods using same for diagnosing and treating amyloid-associated diseases
|
EP2311869B2
(fr)
|
2002-02-01 |
2020-06-17 |
Merck Sharp & Dohme Corp. |
Utilisations d'une cytokine mammifère et réactifs associés
|
US6992176B2
(en)
|
2002-02-13 |
2006-01-31 |
Technion Research & Development Foundation Ltd. |
Antibody having a T-cell receptor-like specificity, yet higher affinity, and the use of same in the detection and treatment of cancer, viral infection and autoimmune disease
|
DK2508596T3
(en)
|
2002-02-21 |
2015-10-19 |
Inst Virology |
MN / CA IX-specific monoclonal antibodies generated from MN / CA IX-poor mice, as well as methods of use.
|
AU2003225589A1
(en)
|
2002-02-22 |
2003-09-09 |
The Government Of The United States Of America, As Represented By The Secretary, Dept. Of Health And |
Brother of the regulator of imprinted sites (boris)
|
US7053188B2
(en)
|
2002-02-22 |
2006-05-30 |
Purdue Research Foundation |
Monoclonal antibodies specific for neoplasia-specific NADH:disulfide reductase
|
AU2003214614B2
(en)
*
|
2002-03-18 |
2008-11-20 |
Gamida-Cell Ltd. |
Methods of inducing differentiation in ex vivo expanded stem cells
|
WO2003079967A2
(fr)
*
|
2002-03-26 |
2003-10-02 |
Nanocyte Inc. |
Cellules urticantes exprimant un polynucleotide exogene qui code pour un agent therapeutique, diagnostic ou cosmetique, et procedes, compositions et dispositifs faisant intervenir l'utilisation de ces cellules urticantes ou de capsules derivees de celles-ci pour administrer l'agent therapeutique, diagnostic ou cosmetique a
|
DE10214019A1
(de)
*
|
2002-03-30 |
2003-10-16 |
Detlef Mueller-Schulte |
Lumineszierende, sphärische, nicht autofluoreszierende Silicagel-Partikel mit veränderbaren Emissionsintensitäten und -frequenzen
|
US7332585B2
(en)
|
2002-04-05 |
2008-02-19 |
The Regents Of The California University |
Bispecific single chain Fv antibody molecules and methods of use thereof
|
EP1497304B1
(fr)
|
2002-04-12 |
2014-06-25 |
Catalyst Assets LLC |
Nucleotides a double marquage
|
CA2391438A1
(fr)
*
|
2002-05-01 |
2003-11-01 |
Procyon Biopharma Inc. |
Reactifs et methodes diagnostiques a base de psp94
|
US7534580B2
(en)
*
|
2002-05-01 |
2009-05-19 |
Ambrilia Biopharma Inc. |
PSP94 diagnostic reagents and assays
|
EP1546716A4
(fr)
*
|
2002-05-02 |
2007-04-11 |
Aspenbio Inc |
Detection de la gravidite
|
WO2003093296A2
(fr)
|
2002-05-03 |
2003-11-13 |
Sequenom, Inc. |
Muteines de proteines d'ancrage de kinase, leurs peptides, et procedes associes
|
US20040121442A1
(en)
*
|
2002-05-05 |
2004-06-24 |
Ilan Chet |
Fungal chitinase, polynucleotide sequences encoding same, promoters of same, and uses thereof
|
US20050221349A1
(en)
*
|
2002-05-30 |
2005-10-06 |
Stuart Wilson |
Methods of detecting target molecules and molecular interactions
|
CA2492631C
(fr)
*
|
2002-05-31 |
2013-03-12 |
Genetic Technologies Limited |
Anticorps maternels servant de marqueurs de cellules foetales permettant d'identifier et d'enrichir les cellules foetales du sang maternel
|
EP1509624A2
(fr)
*
|
2002-05-31 |
2005-03-02 |
Secretary, Department Of Atomic Energy |
Procede de detection d'un acide nucleique cible par une technique met/fret dans lequel le donneur et l'accepteur sont sur des brins complementaires
|
US7504215B2
(en)
|
2002-07-12 |
2009-03-17 |
Affymetrix, Inc. |
Nucleic acid labeling methods
|
JP2005533102A
(ja)
*
|
2002-07-12 |
2005-11-04 |
イッサム リサーチ ディベロップメント カンパニー オブ ザ ヘブリュー ユニバーシティー オブ エルサレム |
微小器官によって生物学的プロセスを誘発する方法と装置
|
CA2501188C
(fr)
|
2002-07-15 |
2012-05-15 |
Board Of Regents, The University Of Texas System |
Criblage combinatoire de banques de proteines par expression periplasmique
|
DK1537146T3
(da)
|
2002-07-15 |
2011-04-04 |
Univ Texas |
Antistoffer, der binder til anioniske phospholipider og aminophospholipider, og deres anvendelse til behandling af virusinfektioner
|
US7794716B2
(en)
|
2002-07-25 |
2010-09-14 |
Glenveigh Pharmaceuticals, Llc |
Antibody composition and passive immunization against pregnancy-induced hypertension
|
US7404951B2
(en)
|
2002-08-01 |
2008-07-29 |
Yeda Research And Development Co. Ltd. |
Method and composition for protecting neuronal tissue from damage induced by elevated glutamate levels
|
PT1534736E
(pt)
|
2002-08-10 |
2010-09-07 |
Univ Yale |
Antagonistas do receptor nogo
|
ATE418072T1
(de)
|
2002-09-09 |
2009-01-15 |
Arbor Vita Corp |
Verfahren zur diagnose von gebärmutterhalskrebs
|
AU2003278832A1
(en)
*
|
2002-09-13 |
2004-04-30 |
Carnegie Mellon University |
Optical biosensors and methods of use thereof
|
US20050042621A1
(en)
*
|
2002-09-27 |
2005-02-24 |
Affymetrix, Inc. |
Method for preparing a nucleic acid sample for hybridization to an array
|
US7267981B2
(en)
|
2002-10-07 |
2007-09-11 |
Technion Research & Development Foundation Ltd. |
Human foreskin fibroblasts for culturing ES cells
|
WO2004033101A1
(fr)
*
|
2002-10-11 |
2004-04-22 |
Zbx Corporation |
Dispositifs de diagnostic
|
JP2006503582A
(ja)
*
|
2002-10-21 |
2006-02-02 |
ディスカヴァーエックス インコーポレイテッド |
Ip3タンパク質結合測定法
|
MXPA05004434A
(es)
|
2002-10-24 |
2005-07-26 |
Sterix Ltd |
Inhibidores de 11-beta-hidroxi esteroide deshidrogenasa tipo 1 y tipo 2.
|
WO2004037204A2
(fr)
*
|
2002-10-25 |
2004-05-06 |
University Of South Florida |
Methodes et composes de perturbation de la signalisation cd40r/cd40l dans le traitement de la maladie d'alzheimer
|
EP2295980A1
(fr)
|
2002-10-30 |
2011-03-16 |
Yissum Research Development Company, of The Hebrew University of Jerusalem |
Molécules et leurs procédés d'utilisation pour la mesure de fer non lié par la transferrine
|
US20050054097A1
(en)
*
|
2002-11-17 |
2005-03-10 |
Tony Peled |
EX-VIVO expansion of hematopoietic system cell populations in mononuclear cell cultures
|
FI20022048A0
(fi)
*
|
2002-11-18 |
2002-11-18 |
Valtion Teknillinen |
Ei-kompetetiivinen immunomääritys pienille analyyteille
|
AU2002352938B8
(en)
*
|
2002-11-26 |
2009-10-08 |
The University Of Chicago |
Materials and methods for preventing and treating microbe-mediated epithelial disorders
|
US7947499B2
(en)
*
|
2002-11-29 |
2011-05-24 |
Technion Research & Development Foundation Ltd. |
Method of dynamically culturing embryonic stem cells
|
US8323897B2
(en)
|
2002-12-04 |
2012-12-04 |
Applied Biosystems, Llc |
Multiplex amplification of polynucleotides
|
US7491699B2
(en)
|
2002-12-09 |
2009-02-17 |
Ramot At Tel Aviv University Ltd. |
Peptide nanostructures and methods of generating and using the same
|
DE60334846D1
(de)
|
2002-12-12 |
2010-12-16 |
R B T Rakuto Bio Technologies |
VERWENDUNG von LIGNINPEROXIDASE ZUR HAUT- UND HAARAUFHELLUNG
|
ES2705683T3
(es)
|
2002-12-16 |
2019-03-26 |
Technion Res & Dev Foundation |
Medio de cultivo de células madre pluripotentes
|
JP2006512079A
(ja)
|
2003-01-02 |
2006-04-13 |
ラッパポート・ファミリー・インスティチュート・フォー・リサーチ・イン・ザ・メディカル・サイエンシズ |
高血糖性患者の心疾患を予防するための抗酸化治療の有効性を予測する方法
|
US20040229245A1
(en)
*
|
2003-01-06 |
2004-11-18 |
Anton Bittner |
Methods and algorithms for performing quality control during gene expression profiling on DNA microarray technology
|
EP1583713B1
(fr)
|
2003-01-07 |
2009-03-25 |
Ramot at Tel Aviv University Ltd. |
Nanostructures de peptides encapsulant une matiere etrangere ainsi que procede de fabrication correspondant
|
CA2512734C
(fr)
|
2003-01-17 |
2012-06-19 |
Danisco A/S |
Procede permettant de produire un ou plusieurs esters de glucide, un ester de proteine, un ester de sous-unite proteique et un ester d'hydroxy-acide
|
US20050196766A1
(en)
|
2003-12-24 |
2005-09-08 |
Soe Jorn B. |
Proteins
|
US7955814B2
(en)
|
2003-01-17 |
2011-06-07 |
Danisco A/S |
Method
|
MXPA05007654A
(es)
|
2003-01-17 |
2005-09-30 |
Danisco |
Metodo.
|
US20050014249A1
(en)
*
|
2003-02-21 |
2005-01-20 |
Norbert Staimer |
Chromatographic analysis on optical bio-discs and methods relating thereto
|
WO2004078991A2
(fr)
|
2003-03-04 |
2004-09-16 |
Yeda Research And Development Co. Ltd. |
Polypeptides pon, polynucleotides les codant et compositions et procedes utilisant ces derniers
|
AU2004217872B2
(en)
*
|
2003-03-05 |
2010-03-25 |
Genetic Technologies Limited |
Identification of fetal DNA and fetal cell markers in maternal plasma or serum
|
AU2004217699B2
(en)
*
|
2003-03-07 |
2008-07-03 |
Gamida-Cell Ltd. |
Expansion of renewable stem cell populations using modulators of PI 3-kinase
|
WO2004096157A2
(fr)
|
2003-03-07 |
2004-11-11 |
New England Medical Center Hospitals, Inc. |
Traitement de maladies a depot d'iga1
|
US8017113B2
(en)
|
2003-03-12 |
2011-09-13 |
Rappaport Family Institute For Research In The Medical Sciences |
Compositions and methods for diagnosing and treating an inflammation
|
US7294701B2
(en)
*
|
2003-04-02 |
2007-11-13 |
Technion Research & Development Foundation Ltd. |
Antibody fragment capable of modulating multidrug resistance and compositions and kits and methods using same
|
WO2004087042A2
(fr)
|
2003-04-04 |
2004-10-14 |
Yeda Research And Development Co. Ltd. |
Anticorps et compositions pharmaceutiques contenant ces derniers utiles pour inhiber l'activite de metalloproteines
|
US8252588B2
(en)
|
2003-04-08 |
2012-08-28 |
Yeda Research And Development Co. Ltd. |
Stem cells having increased sensitivity to SDF-1 and methods of generating and using same
|
FR2853551B1
(fr)
|
2003-04-09 |
2006-08-04 |
Lab Francais Du Fractionnement |
Formulation stabilisante pour compositions d'immunoglobulines g sous forme liquide et sous forme lyophilisee
|
US7402386B2
(en)
|
2003-04-14 |
2008-07-22 |
Nugen Technologies, Inc. |
Global amplification using random priming by a composite primer
|
MXPA05011100A
(es)
*
|
2003-04-16 |
2006-04-18 |
Univ Yale |
Antagonistas de receptor nogo para el tratamiento de condiciones que comprenden placas amiloideas.
|
US7917298B1
(en)
|
2003-04-17 |
2011-03-29 |
Nanosys, Inc. |
Nanocrystal taggants
|
US7321065B2
(en)
*
|
2003-04-18 |
2008-01-22 |
The Regents Of The University Of California |
Thyronamine derivatives and analogs and methods of use thereof
|
US7554007B2
(en)
*
|
2003-05-22 |
2009-06-30 |
Evogene Ltd. |
Methods of increasing abiotic stress tolerance and/or biomass in plants
|
CA2978152C
(fr)
|
2003-05-22 |
2021-01-26 |
Evogene Ltd. |
Procedes d'augmentation de la tolerance du stress abiotique des plantes et plantes ainsi produites
|
AU2005234725B2
(en)
|
2003-05-22 |
2012-02-23 |
Evogene Ltd. |
Methods of Increasing Abiotic Stress Tolerance and/or Biomass in Plants and Plants Generated Thereby
|
US7498428B2
(en)
*
|
2003-06-19 |
2009-03-03 |
Evogene Ltd. |
Nucleotide sequences for regulating gene expression in plant trichomes and constructs and methods utilizing same
|
US8129514B2
(en)
*
|
2003-06-19 |
2012-03-06 |
Evogene Ltd. |
Nucleotide sequences for regulating gene expression in plant trichomes and constructs and methods utilizing same
|
EP2719394B1
(fr)
|
2003-06-30 |
2015-07-29 |
Tel Aviv University Future Technology Development L.P. |
Peptides pour traiter des maladies associées aux amyloïdes
|
AU2004257645A1
(en)
*
|
2003-07-07 |
2005-01-27 |
David H. Wagner |
Methods for predicting development of auto-immune diseases and treatment of same
|
US20090088337A1
(en)
*
|
2003-07-10 |
2009-04-02 |
Ronald Gill |
RET-Based Analyte Detection
|
US8454566B2
(en)
*
|
2003-07-10 |
2013-06-04 |
Medtronic Minimed, Inc. |
Methods and compositions for the inhibition of biofilms on medical devices
|
EP1668111A4
(fr)
|
2003-08-08 |
2008-07-02 |
Genenews Inc |
Biomarqueurs d'osteoarthrite et leurs utilisations
|
US20050064479A1
(en)
*
|
2003-08-12 |
2005-03-24 |
Affymetrix, Inc. |
Compounds and methods for post incorporation labeling of nucleic acids
|
EP1654349A4
(fr)
|
2003-08-14 |
2008-08-20 |
Exelixis Inc |
Sulf utilises comme modificateurs de la voie beta-catenine et procedes associes
|
WO2005019417A2
(fr)
*
|
2003-08-14 |
2005-03-03 |
The Bio Balance Corporation |
Souches bacteriennes, compositions les comprenant et leur utilisation dans un traitement probiotique
|
JP4711963B2
(ja)
|
2003-09-15 |
2011-06-29 |
オクラホマ メディカル リサーチ ファウンデーション |
炎症性疾患および自己免疫疾患を診断、治療および評価するためにサイトカインアッセイを用いる方法
|
US7282339B2
(en)
*
|
2003-09-17 |
2007-10-16 |
Invitrogen Corporation |
Competitive immunoassay
|
US20050064435A1
(en)
*
|
2003-09-24 |
2005-03-24 |
Xing Su |
Programmable molecular barcodes
|
US7625707B2
(en)
|
2003-10-02 |
2009-12-01 |
Ramot At Tel Aviv University Ltd. |
Antibacterial agents and methods of identifying and utilizing same
|
ATE509034T1
(de)
|
2003-10-07 |
2011-05-15 |
Yeda Res & Dev |
Antikörper gegen nik, deren herstellung und verwendung
|
IL158287A0
(en)
|
2003-10-07 |
2004-05-12 |
Yeda Res & Dev |
Antibodies to nik, their preparation and use
|
US20050227251A1
(en)
|
2003-10-23 |
2005-10-13 |
Robert Darnell |
Method of purifying RNA binding protein-RNA complexes
|
CA2542221A1
(fr)
*
|
2003-10-23 |
2005-05-06 |
Pfizer Products Inc. |
Vaccin contre les parodontopathies
|
US20050214796A1
(en)
*
|
2003-10-29 |
2005-09-29 |
Hanna Michelle M |
Compositions, methods and detection technologies for reiterative oligonucleotide synthesis
|
WO2005047324A2
(fr)
|
2003-11-10 |
2005-05-26 |
Schering Corp |
Anticorps anti-interleukine-10
|
US7169560B2
(en)
|
2003-11-12 |
2007-01-30 |
Helicos Biosciences Corporation |
Short cycle methods for sequencing polynucleotides
|
JP3615752B1
(ja)
|
2003-11-18 |
2005-02-02 |
淳 高橋 |
細径樹脂捩じりブラシ
|
JP5039383B2
(ja)
|
2003-11-30 |
2012-10-03 |
イエダ リサーチ アンド ディベロップメント カンパニー リミテッド |
免疫モジュレーションのための方法および薬剤ならびに免疫モジュレーターの同定方法
|
CA2547351A1
(fr)
|
2003-12-01 |
2005-07-07 |
Dade Behring Marburg Gmbh |
Procede de detection homogene
|
US20050118727A1
(en)
*
|
2003-12-01 |
2005-06-02 |
Carsten Schelp |
Conjugates and their use in detection methods
|
US20050123935A1
(en)
*
|
2003-12-09 |
2005-06-09 |
Richard Haugland |
Pyrenyloxysulfonic acid fluorescent agents
|
US8039642B2
(en)
|
2003-12-09 |
2011-10-18 |
Life Technologies Corporation |
Pyrenyloxysulfonic acid fluorescent agents
|
WO2005059100A2
(fr)
*
|
2003-12-12 |
2005-06-30 |
New York University |
Procedes et compositions se rapportant a la cystatine c
|
US6991911B2
(en)
|
2003-12-15 |
2006-01-31 |
Dade Behring Inc. |
Assay for entactogens
|
US20100221233A1
(en)
*
|
2003-12-15 |
2010-09-02 |
University Of South Florida |
Compositions and methods for enhancing neuroprotection via administration of stem cells and blood brain barrier permeabilizers
|
US7022492B2
(en)
|
2003-12-15 |
2006-04-04 |
Dade Behring Inc. |
Ecstasy haptens and immunogens
|
EP1722834B1
(fr)
|
2003-12-22 |
2012-06-27 |
Regentis Biomaterials Ltd. |
Matrice comprenant un squelette proteique reticule naturel
|
CA2551560A1
(fr)
|
2003-12-23 |
2005-07-14 |
Arbor Vita Corporation |
Anticorps pour des souches oncogenes du hpv et leurs methodes d'utilisation
|
US7718408B2
(en)
*
|
2003-12-24 |
2010-05-18 |
Danisco A/S |
Method
|
GB0716126D0
(en)
*
|
2007-08-17 |
2007-09-26 |
Danisco |
Process
|
WO2005066347A1
(fr)
|
2003-12-24 |
2005-07-21 |
Danisco A/S |
Proteines
|
US8007847B2
(en)
|
2004-01-13 |
2011-08-30 |
Eytan Biderman |
Feeding formula appliance
|
US7423139B2
(en)
*
|
2004-01-20 |
2008-09-09 |
Insight Biopharmaceuticals Ltd. |
High level expression of recombinant human erythropoietin having a modified 5′-UTR
|
US20050186646A1
(en)
*
|
2004-01-26 |
2005-08-25 |
Cruz Miguel A. |
Rapid assay to detect ADAMTS-13 activity
|
WO2005071058A2
(fr)
*
|
2004-01-27 |
2005-08-04 |
Compugen Ltd. |
Procedes et systemes pour l'annotation de sequences de biomolecules
|
US20070178462A1
(en)
*
|
2004-02-18 |
2007-08-02 |
Uebele Victor N |
Nucleic acid molecules encoding novel murine low-voltage activated calcium channel proteins, designated-alpha1h, encoded proteins and methods of use thereof
|
US7981604B2
(en)
|
2004-02-19 |
2011-07-19 |
California Institute Of Technology |
Methods and kits for analyzing polynucleotide sequences
|
GB0403864D0
(en)
|
2004-02-20 |
2004-03-24 |
Ucl Ventures |
Modulator
|
EP2208797A3
(fr)
|
2004-03-01 |
2010-11-24 |
Applied Biosystems, LLC |
Techniques, compositions et kits d'amplification de polynucleotide
|
JP2007526337A
(ja)
|
2004-03-02 |
2007-09-13 |
アクセルロン ファーマ インコーポレーテッド |
Alk7およびミオスタチン阻害剤ならびにその使用
|
US8352031B2
(en)
|
2004-03-10 |
2013-01-08 |
Impulse Dynamics Nv |
Protein activity modification
|
GB0405637D0
(en)
|
2004-03-12 |
2004-04-21 |
Danisco |
Protein
|
BRPI0510004A
(pt)
*
|
2004-04-20 |
2007-09-18 |
Univ Chicago |
artigo de manufatura, métodos para administrar uma composição terapêutica a um epitélio de um indivìduo, para tratar uma condição mediada por micróbio de um epitélio de um indivìduo, para melhorar um sintoma de uma condição e para prevenir uma condição, e, uso de composto tipo peg pma
|
WO2006083269A2
(fr)
*
|
2004-05-14 |
2006-08-10 |
Florida Atlantic University |
Nanocapteurs luminescents
|
EP2400030B1
(fr)
|
2004-05-18 |
2016-01-20 |
The Board of Trustees of the Leland Stanford Junior University |
Détection de translocation de protéines par complémentation de fragment de rapporteur béta-galactosidase
|
US7635562B2
(en)
|
2004-05-25 |
2009-12-22 |
Helicos Biosciences Corporation |
Methods and devices for nucleic acid sequence determination
|
US7476734B2
(en)
|
2005-12-06 |
2009-01-13 |
Helicos Biosciences Corporation |
Nucleotide analogs
|
EP2583981A3
(fr)
|
2004-05-28 |
2013-07-31 |
Agensys, Inc. |
Anticorps et molécules correspondantes se liant aux protéines PSCA
|
US7812218B2
(en)
|
2004-06-14 |
2010-10-12 |
Evogene Ltd. |
Polynucleotides and polypeptides involved in plant fiber development and methods of using same
|
US8034553B2
(en)
|
2004-06-24 |
2011-10-11 |
Kimberly-Clark Worldwide, Inc. |
Biomarkers for wound healing
|
JP4796059B2
(ja)
*
|
2004-06-30 |
2011-10-19 |
ディスカヴァーエックス コーポレイション |
細胞内修飾の分析
|
US8680062B2
(en)
*
|
2004-07-06 |
2014-03-25 |
Deliversir Ltd. |
System for delivering therapeutic agents into living cells and cells nuclei
|
US7635598B2
(en)
*
|
2004-07-08 |
2009-12-22 |
Biosearch Technologies, Inc. |
Inducible fluorescence assay
|
WO2006006172A2
(fr)
*
|
2004-07-15 |
2006-01-19 |
Ramot At Tel Aviv University Ltd. |
Utilisation d'agents anti-amyloides pour traiter et determiner des infections pathogenes
|
WO2006008508A1
(fr)
|
2004-07-16 |
2006-01-26 |
Danisco A/S |
Procede de demucilagination enzymatique
|
WO2006015365A1
(fr)
*
|
2004-07-30 |
2006-02-09 |
Mount Sinai School Of Medicine Of New York University |
Inhibiteurs de npc1l1 et npc1l1 et procedes d'utilisation associes
|
US20060073168A1
(en)
*
|
2004-08-11 |
2006-04-06 |
Stephens David S |
Neisseria meningitidis serogroup a capsular polysaccharide acetyltransferase, methods and compositions
|
DE102005026163A1
(de)
*
|
2004-08-24 |
2006-03-02 |
Dade Behring Marburg Gmbh |
Gegen den Marburg I Polymorphismus der Faktor VII aktivierenden Protease (FSAP) gerichtete Antikörper, ihre Herstellung und Verwendung
|
ES2535235T3
(es)
|
2004-08-26 |
2015-05-07 |
Engeneic Molecular Delivery Pty Ltd |
Administración de ácidos nucleicos funcionales a células de mamífero a través de minicélulas intactas obtenidas a partir de bacterias
|
FI20050753A
(fi)
|
2004-09-03 |
2006-03-04 |
Licentia Oy |
Uudet peptidit
|
ES2345993T3
(es)
|
2004-09-14 |
2010-10-07 |
The Regents Of The University Of Colorado, A Body Corporate |
Metodo para el tratamiento con bucindolol basado en direccionamiento genetico.
|
EP1799812A4
(fr)
|
2004-09-16 |
2009-09-09 |
Gamida Cell Ltd |
Méthodes de culture ex vivo de cellules souches et de précurseur par co-culture avec des cellules mésenchymales
|
EP1799227B1
(fr)
|
2004-09-18 |
2010-11-10 |
University of Maryland, Baltimore |
Agents therapeutiques ciblant le canal nc ca-atp et procedes d'utilisation associes
|
CN101043891A
(zh)
|
2004-09-18 |
2007-09-26 |
巴尔的摩马里兰大学 |
靶向NCCa-ATP通道的治疗剂及其使用方法
|
EA011879B1
(ru)
|
2004-09-24 |
2009-06-30 |
Эмджин Инк. |
МОЛЕКУЛЫ С МОДИФИЦИРОВАННЫМ Fc ФРАГМЕНТОМ
|
US20060067889A1
(en)
*
|
2004-09-27 |
2006-03-30 |
Light Sciences Corporation |
Singlet oxygen photosensitizers activated by target binding enhancing the selectivity of targeted PDT agents
|
WO2006035442A2
(fr)
|
2004-09-29 |
2006-04-06 |
Collplant Ltd. |
Collagene de recombinaison produit dans une plante
|
EP1805319B1
(fr)
*
|
2004-09-29 |
2014-09-03 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Rnase t2 humaine recombinee et utilisations associees
|
GB0422052D0
(en)
|
2004-10-04 |
2004-11-03 |
Dansico As |
Enzymes
|
US7390489B2
(en)
*
|
2004-10-08 |
2008-06-24 |
Komed Co., Ltd. |
Monoclonal antibody selectively recognizing listeria monocytogenes, hybridoma producing the antibody, test kit comprising the antibody and detection method of listeria monocytogenes using the antibody
|
US7781402B2
(en)
*
|
2004-10-12 |
2010-08-24 |
Closed Loop Therapies Ltd. |
Methods and implantable devices for treating supraventricular arrhythmias
|
GB0423139D0
(en)
|
2004-10-18 |
2004-11-17 |
Danisco |
Enzymes
|
CA2589034C
(fr)
*
|
2004-11-02 |
2016-05-31 |
The Government Of The United States Of America, As Represented By The Secretary, Department Of Health & Human Services |
Compositions et procedes pour traiter des etats hyperproliferatifs
|
GB0424940D0
(en)
|
2004-11-11 |
2004-12-15 |
Danisco |
Transcription factors
|
US8809287B2
(en)
*
|
2004-11-15 |
2014-08-19 |
Icahn School Of Medicine At Mount Sinai |
Compositions and methods for altering Wnt autocrine signaling
|
IL165484A0
(en)
|
2004-11-30 |
2006-01-15 |
Applied Research Systems |
Production of proteins
|
JP2008521907A
(ja)
|
2004-12-03 |
2008-06-26 |
シェーリング コーポレイション |
抗igf1r治療について患者を予め選択するためのバイオマーカー
|
US7504769B2
(en)
*
|
2004-12-16 |
2009-03-17 |
E. I. Du Pont De Nemours + Company |
Aromatic chalcogen compounds and their use
|
US20060134680A1
(en)
*
|
2004-12-22 |
2006-06-22 |
Alexander Kotlyar |
Homogeneous populations of nucleic acids, methods of synthesyzing same and uses thereof
|
US7220549B2
(en)
*
|
2004-12-30 |
2007-05-22 |
Helicos Biosciences Corporation |
Stabilizing a nucleic acid for nucleic acid sequencing
|
WO2006075334A2
(fr)
|
2005-01-16 |
2006-07-20 |
Zlango Ltd. |
Communication iconique
|
US8019818B2
(en)
|
2005-01-18 |
2011-09-13 |
Zlango Ltd. |
Communications network system and methods for using same
|
US7482120B2
(en)
|
2005-01-28 |
2009-01-27 |
Helicos Biosciences Corporation |
Methods and compositions for improving fidelity in a nucleic acid synthesis reaction
|
EP3028765B1
(fr)
|
2005-01-31 |
2020-01-08 |
Realbio Technologies Ltd. |
Méthode de transfert séquentiel de liquides à travers un dispositif capillaire a flux lateral
|
EP2520669A3
(fr)
|
2005-02-07 |
2013-02-27 |
GeneNews Inc. |
Biomarqueurs de l'ostéoarthrite douce et leurs utilisations
|
AU2006215300C9
(en)
|
2005-02-17 |
2010-05-06 |
Hadasit Medical Research Services And Development Ltd. |
Bisphosphonates for treating endometriosis
|
GB0503546D0
(en)
*
|
2005-02-21 |
2005-03-30 |
Hellenic Pasteur Inst |
Antibody
|
US8216801B2
(en)
|
2005-02-25 |
2012-07-10 |
The State Of Israel, Ministry Of Agriculture & Rural Development, Agricultural Research Organization, (A.R.O.), The Volcani Center |
Methods for treating inflammatory disorders
|
US7695927B2
(en)
*
|
2005-03-18 |
2010-04-13 |
Detroit R & D |
Detection of hypertension using glucuronidated metabolic products
|
EP1863848A4
(fr)
|
2005-03-31 |
2009-09-23 |
Agensys Inc |
Anticorps et molecules correspondantes qui se fixent aux proteines 161p2f10b
|
EP1872136B9
(fr)
|
2005-04-04 |
2023-02-08 |
Biogen MA Inc. |
Procedes et produits pour evaluer une reponse immunitaire a une proteine therapeutique
|
WO2006109312A2
(fr)
*
|
2005-04-15 |
2006-10-19 |
Vascular Biogenics Ltd. |
Compositions contenant des peptides derives de la glycoproteine i beta 2 pour la prevention et le traitement de maladie cardiovasculaire
|
EP2339032B1
(fr)
|
2005-04-18 |
2016-12-28 |
MDNA Life Sciences Inc. |
Mutations mitochondriales et réagencements en tant qu'outil de diagnostic pour la détection de l'exposition au soleil, cancer de la prostate et autres cancers
|
US20130022979A1
(en)
|
2005-04-18 |
2013-01-24 |
Genesis Genomics Inc. |
3.4kb MITOCHONDRIAL DNA DELETION FOR USE IN THE DETECTION OF CANCER
|
US8834862B2
(en)
*
|
2005-04-19 |
2014-09-16 |
Nanocyte Inc. |
Methods, compositions and devices utilizing stinging cells/capsules for conditioning a tissue prior to delivery of an active agent
|
US7189582B2
(en)
|
2005-04-27 |
2007-03-13 |
Dade Behring Inc. |
Compositions and methods for detection of sirolimus
|
DE102005022047A1
(de)
|
2005-05-09 |
2006-11-30 |
Dade Behring Marburg Gmbh |
Bindungspartner des Plazentalen Wachstumsfaktors insbesondere gegen den Plazentalen Wachstumsfaktor gerichtete Antikörper, ihre Herstellung und Verwendung
|
EP2279726A3
(fr)
|
2005-05-26 |
2012-06-20 |
Biorest Ltd. |
Compositions et méthodes d'utilisation desdites compositions dans l'administration d'agents dans un organe cible protégé par une barrière sanguine
|
US20070021433A1
(en)
|
2005-06-03 |
2007-01-25 |
Jian-Qiang Fan |
Pharmacological chaperones for treating obesity
|
WO2006134602A2
(fr)
|
2005-06-16 |
2006-12-21 |
Ramot At Tel Aviv University Ltd. |
Cellules isolees et populations comprenant ces cellules pour le traitement de maladies du snc
|
WO2007001986A2
(fr)
|
2005-06-20 |
2007-01-04 |
Yuling Luo |
Methodes de detection des acides nucleiques dans des cellules individuelles et d'identification de cellules rares a partir de grandes populations cellulaires heterogenes
|
US20070225242A1
(en)
*
|
2005-06-21 |
2007-09-27 |
The Board Of Trustees Of The Leland Stanford Junior University |
Method and composition for treating and preventing tumor metastasis in vivo
|
US7695975B2
(en)
|
2005-06-23 |
2010-04-13 |
Siemens Healthcare Diagnostics Inc. |
Detection of adulterated samples
|
JP5383186B2
(ja)
*
|
2005-07-07 |
2014-01-08 |
イッサム リサーチ ディベロプメント カンパニー オブ ザ ヘブリュー ユニバーシティ オブ エルサレム リミテッド |
H19をダウンレギュレートする核酸薬剤、及びそれを使用する方法
|
JP5086254B2
(ja)
|
2005-07-07 |
2012-11-28 |
フルクルム エスピー リミテッド |
Sp1ポリペプチド、変性sp1ポリペプチドおよびそれらの使用
|
CA2615218A1
(fr)
|
2005-07-18 |
2007-01-25 |
Protalix Ltd. |
Administration mucosale ou enterale de macromolecules biologiquement actives
|
AU2006278260B2
(en)
*
|
2005-08-08 |
2012-03-08 |
Onconon, Llc. |
Antibody compositions, methods for treating neoplastic disease and methods for regulating fertility
|
US8008453B2
(en)
|
2005-08-12 |
2011-08-30 |
Amgen Inc. |
Modified Fc molecules
|
EP2514315A3
(fr)
|
2005-08-24 |
2012-11-07 |
Yeda Research and Development Co. Ltd. |
Cellules tolerogeniques derivees de donneurs universels et destinees a induire une tolerance a la transplantation non syngenique
|
US7666593B2
(en)
|
2005-08-26 |
2010-02-23 |
Helicos Biosciences Corporation |
Single molecule sequencing of captured nucleic acids
|
EP1962719A4
(fr)
|
2005-08-29 |
2011-05-04 |
Technion Res And Dev Of Foundation Ltd |
Milieux de culture de cellules souches
|
ME02705B
(fr)
|
2005-08-31 |
2017-10-20 |
Merck Sharp & Dohme |
Anticorps anti-il-23 obtenus par genie genetique
|
EP1929046B1
(fr)
|
2005-09-07 |
2012-07-11 |
Nugen Technologies, Inc. |
Procedure d'amplication d'acide nucleique amelioree
|
US7608395B2
(en)
*
|
2005-09-15 |
2009-10-27 |
Baylor Research Institute |
Systemic lupus erythematosus diagnostic assay
|
WO2007034487A1
(fr)
|
2005-09-22 |
2007-03-29 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem |
Constructions d’acide nucléique, compositions pharmaceutiques et procédés utilisant ces dernières dans le cadre des traitements anticancéreux
|
WO2007038659A1
(fr)
|
2005-09-26 |
2007-04-05 |
Invitrogen Corporation |
Colorants excitables au laser violet et leur methode d'utilisation
|
WO2007041340A2
(fr)
*
|
2005-09-30 |
2007-04-12 |
The Trustees Of Columbia University In The City Of New York |
Cellules microfluidiques a arrangements paralleles de molecules d'adn individuelles
|
WO2007047408A2
(fr)
*
|
2005-10-12 |
2007-04-26 |
Pathologica, Llc. |
Application de signature promac
|
US20070087437A1
(en)
*
|
2005-10-14 |
2007-04-19 |
Jifan Hu |
Methods for rejuvenating cells in vitro and in vivo
|
EP2319941A3
(fr)
|
2005-10-21 |
2011-08-17 |
GeneNews Inc. |
Procédé et appareil pour corréler des niveaux de produits biomarqueurs avec une maladie
|
US20070105160A1
(en)
*
|
2005-10-24 |
2007-05-10 |
Discoverx |
Detection of intracellular enzyme complex
|
MX350551B
(es)
|
2005-10-24 |
2017-09-08 |
Evogene Ltd |
Polipeptidos aislados, polinucleotidos que los codifican, plantas transgenicas que expresan los mismos y metodos para usarlos.
|
US7842823B2
(en)
*
|
2005-10-27 |
2010-11-30 |
The Regents Of The University Of California |
Fluorogenic probes for reactive oxygen species
|
WO2007051303A1
(fr)
|
2005-11-02 |
2007-05-10 |
Protiva Biotherapeutics, Inc. |
Molecules d'arnsi modifiees et utilisations de celles-ci
|
BRPI0618338A2
(pt)
|
2005-11-07 |
2011-08-23 |
Scripps Resarch Inst |
uso de inibidor de sinalização de fator tecidual, método para identificar um agente que inibe a sinalização de tf/viia, composições farmacêuticas e kit
|
DE212006000071U1
(de)
|
2005-11-18 |
2008-07-24 |
Board of Regents, The University of Texas System, Austin |
Quantifizierung von Fusionsproteinen und ihrer Aktivität in Folge chromosomaler Translokation
|
WO2007063545A2
(fr)
|
2005-11-29 |
2007-06-07 |
Gamida-Cell Ltd. |
Methodes d'amelioration de prise de greffe et de nostocytose de cellules souches
|
US8846393B2
(en)
|
2005-11-29 |
2014-09-30 |
Gamida-Cell Ltd. |
Methods of improving stem cell homing and engraftment
|
WO2008002462A2
(fr)
*
|
2006-06-23 |
2008-01-03 |
Micronics, Inc. |
Procédés et dispositifs destinés à des dosages immunologiques microfluidiques pratiqués au point de service
|
US7763453B2
(en)
|
2005-11-30 |
2010-07-27 |
Micronics, Inc. |
Microfluidic mixing and analytic apparatus
|
US9056291B2
(en)
|
2005-11-30 |
2015-06-16 |
Micronics, Inc. |
Microfluidic reactor system
|
RU2008127252A
(ru)
|
2005-12-08 |
2010-01-20 |
Новартис АГ (CH) |
Эффекты ингибиторов fgfr3 на транскрипцию генов
|
US20070134814A1
(en)
*
|
2005-12-09 |
2007-06-14 |
Kajander E O |
Methods and compositions for the detection of calcifying nano-particles, identification and quantification of associated proteins thereon, and correlation to disease
|
EP2674440B1
(fr)
|
2005-12-16 |
2019-07-03 |
IBC Pharmaceuticals, Inc. |
Ensembles bioactifs à base d'immunoglobuline multivalent
|
EP2172210A1
(fr)
|
2005-12-23 |
2010-04-07 |
Partnership&Corp. Technology Transfer |
Peptide synthétique et utilisation comme inhibiteur de la sécrétion de neurotransmitteur
|
US7465544B2
(en)
*
|
2006-01-11 |
2008-12-16 |
Wisconsin Alumni Research Foundation |
Synthetic cofactor analogs of S-adenosylmethionine as ligatable probes of biological methylation and methods for their use
|
US8775526B2
(en)
|
2006-01-16 |
2014-07-08 |
Zlango Ltd. |
Iconic communication
|
BRPI0707276B1
(pt)
|
2006-01-27 |
2021-08-31 |
Biogen Ma Inc |
Polipeptídeo de fusão antagonista de receptor nogo
|
DOP2007000020A
(es)
|
2006-01-31 |
2007-09-15 |
Bayer Schering Pharma Ag |
Modulación de la actividad de mdl-1 para el tratamiento de enfermedades inflamatorias
|
US7553941B2
(en)
*
|
2006-02-03 |
2009-06-30 |
Modigene Inc |
Long-acting polypeptides and methods of producing same
|
US10351615B2
(en)
|
2006-02-03 |
2019-07-16 |
Opko Biologics Ltd. |
Methods of treatment with long-acting growth hormone
|
US9458444B2
(en)
|
2006-02-03 |
2016-10-04 |
Opko Biologics Ltd. |
Long-acting coagulation factors and methods of producing same
|
US20140113860A1
(en)
|
2006-02-03 |
2014-04-24 |
Prolor Biotech Ltd. |
Long-acting polypeptides and methods of producing and administering same
|
US8450269B2
(en)
|
2006-02-03 |
2013-05-28 |
Prolor Biotech Ltd. |
Long-acting growth hormone and methods of producing same
|
US8759292B2
(en)
|
2006-02-03 |
2014-06-24 |
Prolor Biotech, Llc |
Long-acting coagulation factors and methods of producing same
|
US8048849B2
(en)
|
2006-02-03 |
2011-11-01 |
Modigene, Inc. |
Long-acting polypeptides and methods of producing same
|
US10221228B2
(en)
|
2006-02-03 |
2019-03-05 |
Opko Biologics Ltd. |
Long-acting polypeptides and methods of producing and administering same
|
US8476234B2
(en)
|
2006-02-03 |
2013-07-02 |
Prolor Biotech Inc. |
Long-acting coagulation factors and methods of producing same
|
US9249407B2
(en)
|
2006-02-03 |
2016-02-02 |
Opko Biologics Ltd. |
Long-acting coagulation factors and methods of producing same
|
US8048848B2
(en)
|
2006-02-03 |
2011-11-01 |
Prolor Biotech Ltd. |
Long-acting interferons and derivatives thereof and methods thereof
|
US8946155B2
(en)
|
2006-02-03 |
2015-02-03 |
Opko Biologics Ltd. |
Long-acting polypeptides and methods of producing and administering same
|
US20150038413A1
(en)
|
2006-02-03 |
2015-02-05 |
Opko Biologics Ltd. |
Long-acting polypeptides and methods of producing and administering same
|
BRPI0706967A2
(pt)
|
2006-02-06 |
2011-04-12 |
Rappaport Family Inst For Res |
método e kit para diagnosticar dmt1
|
LT1986661T
(lt)
|
2006-02-08 |
2018-12-10 |
Genzyme Corporation |
Nimano-piko a tipo ligos genų terapija
|
LT2676967T
(lt)
|
2006-02-28 |
2019-09-10 |
Biogen Ma Inc. |
Uždegiminių ir autoimuninių ligų gydymo būdai su natalizumabu
|
BRPI0708392A2
(pt)
|
2006-03-03 |
2011-05-24 |
Elan Pharm Inc |
métodos de tratamento de um paciente com uma doença inflamatória ou autoimune com natalizumab e de uso de natalizumab para tratar um paciente com uma doença inflamatória ou autoimune
|
EP1991852B1
(fr)
|
2006-03-06 |
2015-07-01 |
Zetiq Technologies Ltd. |
Procédés pour identifier un phénotype cellulaire
|
US7397546B2
(en)
|
2006-03-08 |
2008-07-08 |
Helicos Biosciences Corporation |
Systems and methods for reducing detected intensity non-uniformity in a laser beam
|
WO2007109733A2
(fr)
|
2006-03-21 |
2007-09-27 |
The Johns Hopkins University |
Marqueurs de diagnostic et de pronostic et strategies de traitement de la sclerose en plaques
|
EP2548951B1
(fr)
|
2006-03-23 |
2016-05-04 |
Pluristem Ltd. |
Procédés de développement cellulaire et utilisations thérapeutiques des cellules et des milieux conditionnés produits de cette manière
|
EP2004858A4
(fr)
|
2006-03-28 |
2009-12-09 |
Tel Hashomer Medical Res Infrastructure & Services Ltd |
Procedes et kits pour determiner la predisposition a la resistance a la warfarine
|
US20070232556A1
(en)
*
|
2006-03-31 |
2007-10-04 |
Montine Thomas J |
Methods and compositions for the treatment of neurological diseases and disorders
|
KR20090029184A
(ko)
*
|
2006-04-07 |
2009-03-20 |
더 가브먼트 오브 더 유나이티드 스테이츠 오브 아메리카, 리프리젠티드 바이 더 세크러테리, 디파트먼트 오브 헬쓰 앤드 휴먼 서비씨즈 |
항체 조성물 및 신생물성 질병의 치료 방법
|
US8841134B2
(en)
*
|
2006-04-10 |
2014-09-23 |
Bruker Biospin Corporation |
Fluorescence resonance energy transfer detection with nanoparticles for in vitro and in vivo applications
|
US20070281363A1
(en)
*
|
2006-04-13 |
2007-12-06 |
Ewald Terpetschnig |
Luminescent compounds
|
FR2900341B1
(fr)
|
2006-04-27 |
2012-09-14 |
Centre Nat Rech Scient |
Utilisation de ligands synthetiques multivalents de la nucleoline de surface pour le traitement du cancer
|
US7799534B2
(en)
*
|
2006-05-09 |
2010-09-21 |
Beckman Coulter, Inc. |
Nonseparation assay methods
|
BRPI0712084A2
(pt)
*
|
2006-05-09 |
2012-01-03 |
Musc Found For Res Dev |
detecÇço de insuficiÊncia cardÍaca diastàlica por identificaÇço do perfil plasmÁtico de protease e de inibidor de protease
|
US7732153B2
(en)
|
2006-05-09 |
2010-06-08 |
Beckman Coulter, Inc. |
Nonseparation assay methods
|
US20100196336A1
(en)
|
2006-05-23 |
2010-08-05 |
Dongsu Park |
Modified dendritic cells having enhanced survival and immunogenicity and related compositions and methods
|
US20080076188A1
(en)
*
|
2006-06-19 |
2008-03-27 |
Patsenker Leonid D |
Luminescent compounds
|
US20090092967A1
(en)
*
|
2006-06-26 |
2009-04-09 |
Epoch Biosciences, Inc. |
Method for generating target nucleic acid sequences
|
CN101505795B
(zh)
|
2006-07-03 |
2013-02-13 |
查尔斯·戴维·阿代尔 |
用于调节细胞粘附分子表达的组合物
|
CA2659251C
(fr)
|
2006-07-10 |
2016-06-14 |
The Regents Of The University Of California |
Chelate luminescent de 1-hydroxy-2-pyridinone et de lanthanides
|
US20080026394A1
(en)
*
|
2006-07-11 |
2008-01-31 |
Antara Biosciences Inc. |
Methods of detecting one or more cancer markers
|
JP2009544013A
(ja)
*
|
2006-07-11 |
2009-12-10 |
エムユーエスシー ファウンデーション フォー リサーチ ディベロップメント |
プロテアーゼおよびプロテアーゼ阻害因子のプロファイリングによる心筋梗塞後の心不全の予測
|
WO2008010934A2
(fr)
|
2006-07-14 |
2008-01-24 |
Chemocentryx, Inc. |
Triazolyle phényle benzènesulfonamides
|
WO2008010228A2
(fr)
|
2006-07-20 |
2008-01-24 |
Yeda Research And Development Co. Ltd. |
Organismes photosynthétiques, compositions et procédés de génération desdits organismes
|
US20110184747A1
(en)
*
|
2006-08-09 |
2011-07-28 |
Carmen Bozic |
Method for distribution of a drug
|
AU2007321881B2
(en)
|
2006-08-15 |
2012-11-01 |
The Regents Of The University Of California |
Luminescent macrocyclic lanthanide complexes
|
JP2008043332A
(ja)
|
2006-08-17 |
2008-02-28 |
Panomics Inc |
組織スライドからの核酸定量
|
EP2423332A1
(fr)
|
2006-08-25 |
2012-02-29 |
Oncotherapy Science, Inc. |
Marqueurs de pronostic et cibles thérapeutiques pour le cancer des poumons
|
US8809052B2
(en)
|
2006-08-28 |
2014-08-19 |
Yeda Research And Development Co. Ltd. |
Methods of generating mature oligodendrocytes
|
US7951776B2
(en)
|
2006-09-01 |
2011-05-31 |
American Type Culture Collection |
Methods for treatment of type 1 diabetes
|
JP2008111824A
(ja)
*
|
2006-09-01 |
2008-05-15 |
Nox Technologies Inc |
腫瘍特異的tNOXアイソフォーム及び方法
|
US7985542B2
(en)
*
|
2006-09-07 |
2011-07-26 |
Institut Pasteur |
Genomic morse code
|
US7569396B1
(en)
|
2006-09-08 |
2009-08-04 |
Purplecow Llc |
Caffeine detection using internally referenced competitive assays
|
ES2457243T3
(es)
*
|
2006-09-08 |
2014-04-25 |
The Chancellor, Masters And Scholars Of The University Of Oxford |
Diagnóstico clínico de una fibrosis hepática utilizando APOL1 de suero humano como biomarcador
|
US8050516B2
(en)
*
|
2006-09-13 |
2011-11-01 |
Fluidigm Corporation |
Methods and systems for determining a baseline during image processing
|
US8055034B2
(en)
|
2006-09-13 |
2011-11-08 |
Fluidigm Corporation |
Methods and systems for image processing of microfluidic devices
|
US7888059B2
(en)
*
|
2006-10-05 |
2011-02-15 |
Yeda Research And Development Co. Ltd. |
Highly purified and stabilized Na,K-ATPase isoforms and methods of producing same
|
WO2008041183A2
(fr)
|
2006-10-05 |
2008-04-10 |
Technion Research & Development Foundation Ltd. |
Microtubes et leurs procédés de fabrication
|
WO2008043566A2
(fr)
|
2006-10-11 |
2008-04-17 |
Janssen Pharmaceutica N.V. |
Compositions et procédés pour le traitement et le diagnostic du syndrome du côlon irritable
|
EP1912067A1
(fr)
*
|
2006-10-12 |
2008-04-16 |
Eppendorf Array Technologies S.A. |
Procédé de quantification d'un composé cible issu d'un échantillon biologique à l'aide de puces à microreseau
|
EP2426199A3
(fr)
|
2006-10-20 |
2012-08-22 |
Danisco US Inc. |
Oxydases de polyol
|
JP5057402B2
(ja)
*
|
2006-10-26 |
2012-10-24 |
アボット・ラボラトリーズ |
内在性の抗分析物抗体を含有する試料中の分析物の免疫アッセイ
|
US7776605B2
(en)
|
2006-10-26 |
2010-08-17 |
Abbott Laboratories |
Assay for cardiac troponin autoantibodies
|
US20080305512A1
(en)
*
|
2006-10-26 |
2008-12-11 |
Mattingly Phillip G |
Assay for cardiac troponin autoantibodies
|
JP2010507384A
(ja)
|
2006-10-27 |
2010-03-11 |
ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ |
キナーゼ阻害剤のプロファイリング方法
|
WO2008066655A2
(fr)
|
2006-11-02 |
2008-06-05 |
Yale University |
Estimation de la compétence d'ovocytes
|
US8293684B2
(en)
*
|
2006-11-29 |
2012-10-23 |
Exiqon |
Locked nucleic acid reagents for labelling nucleic acids
|
US8473216B2
(en)
*
|
2006-11-30 |
2013-06-25 |
Fluidigm Corporation |
Method and program for performing baseline correction of amplification curves in a PCR experiment
|
CA2671264C
(fr)
|
2006-11-30 |
2015-11-24 |
Research Development Foundation |
Bibliotheques d'immunoglobulines ameliorees
|
BRPI0720271A2
(pt)
|
2006-12-14 |
2014-01-28 |
Schering Corp |
Anticorpo anti-tslp projetado
|
CA2672756C
(fr)
*
|
2006-12-20 |
2018-11-20 |
Evogene Ltd. |
Polynucleotides et polypeptides impliques dans le developpement de fibres vegetales et procedes d'utilisation
|
US8506499B2
(en)
*
|
2007-01-04 |
2013-08-13 |
Musc Foundation For Research Development |
Predicting atrial fibrillation recurrence by protease and protease inhibitor profiling
|
US8642295B2
(en)
*
|
2007-01-11 |
2014-02-04 |
Erasmus University Medical Center |
Circular chromosome conformation capture (4C)
|
CA2674949A1
(fr)
|
2007-01-12 |
2008-07-24 |
J. Marc Simard |
Ciblage de canal ncca-atp destine a proteger les organes apres un episode ischemique
|
US20100086526A1
(en)
*
|
2007-01-16 |
2010-04-08 |
Abraham Hochberg |
Nucleic acid constructs and methods for specific silencing of h19
|
CA2673954C
(fr)
|
2007-01-25 |
2015-09-15 |
Danisco A/S |
Production d'une lipide acyltransferase a partir de cellules transformees de bacillus licheniformis
|
AU2008207746B2
(en)
|
2007-01-26 |
2013-09-05 |
University Of Louisville Research Foundation, Inc. |
Methods of detecting autoantibodies for diagnosing and characterizing disorders
|
WO2008093331A1
(fr)
*
|
2007-01-29 |
2008-08-07 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem |
Conjugues d'anticorps pour vaincre la multiresistances aux medicaments
|
US8911996B2
(en)
|
2007-01-31 |
2014-12-16 |
Technion Research & Development Foundation Limited |
Electrospun scaffolds and methods of generating and using same
|
EP2125050B1
(fr)
|
2007-02-01 |
2014-07-30 |
Technion Research & Development Foundation Ltd. |
Fibres et tissus d'albumine et leurs procédés de génération et d'utilisation
|
EP2111412A2
(fr)
|
2007-02-02 |
2009-10-28 |
Amgen, Inc |
Hepcidine, antagonistes de l'hepcidine, et procédés d'utilisation
|
US7751863B2
(en)
|
2007-02-06 |
2010-07-06 |
Glumetrics, Inc. |
Optical determination of ph and glucose
|
EP2120680A2
(fr)
|
2007-02-06 |
2009-11-25 |
Glumetrics, Inc. |
Systèmes et procédés optiques pour la mesure ratiométrique de la concentration en glucose dans le sang
|
US8088097B2
(en)
|
2007-11-21 |
2012-01-03 |
Glumetrics, Inc. |
Use of an equilibrium intravascular sensor to achieve tight glycemic control
|
US8143046B2
(en)
|
2007-02-07 |
2012-03-27 |
Danisco Us Inc., Genencor Division |
Variant Buttiauxella sp. phytases having altered properties
|
KR100855299B1
(ko)
*
|
2007-02-16 |
2008-08-29 |
건국대학교 산학협력단 |
인간 il-32 특이 항원결정기를 갖는 단일클론항체,특이항체분비 융합 세포주 및 항체들을 이용한 il-32측정법
|
AR065420A1
(es)
|
2007-02-23 |
2009-06-03 |
Schering Corp |
Anticuerpos anti-il-23 p19 de ingenieria
|
EP2426145B1
(fr)
|
2007-02-23 |
2017-01-18 |
Merck Sharp & Dohme Corp. |
Anticorps anti-23p19 de synthèse
|
CN101675076B
(zh)
|
2007-02-28 |
2013-09-18 |
默沙东公司 |
工程化的抗il-23r抗体
|
ES2662036T3
(es)
|
2007-02-28 |
2018-04-05 |
Yeda Research And Development Company Limited |
Secuencias que se dirigen al núcleo
|
US20100216654A1
(en)
|
2007-03-12 |
2010-08-26 |
Miraculins, Inc. |
Biomarkers of prostate cancer and uses thereof
|
EP2514766A3
(fr)
|
2007-03-29 |
2013-06-05 |
Technion Research & Development Foundation Ltd. |
Anticorps, procédés et kits pour diagnostiquer et traiter un mélanome
|
CA2933978C
(fr)
|
2007-03-30 |
2018-08-21 |
Engeneic Molecular Delivery Pty. Ltd. |
Minicellules intactes d'origine bacterienne englobant un acide nucleique fonctionnel exempt de plasmide pour administration in vivo a des cellules de mammifere
|
KR20100015774A
(ko)
|
2007-04-02 |
2010-02-12 |
라모트 앳 텔-아비브 유니버시티 리미티드 |
암세포 검출 방법 및 그 질병의 진단 및 그 질병의 치료의 모니터링을 위한 상기 방법의 용도
|
CA2682299C
(fr)
|
2007-04-06 |
2015-12-22 |
Becton, Dickinson And Company |
Compositions et procedes pour l'identification d'un gene de carbapenemase
|
CA2683143C
(fr)
|
2007-04-09 |
2018-06-12 |
Evogene Ltd. |
Polynucleotides, polypeptides et procedes permettant d'augmenter la teneur en huile, la vitesse de croissance et la biomasse de plantes
|
EP2076289B1
(fr)
|
2007-04-13 |
2014-11-12 |
Dana-Farber Cancer Institute, Inc. |
Méthodes de traitement d'un cancer résistant à des agents thérapeutiques anti-erbb
|
US8003314B2
(en)
|
2007-04-16 |
2011-08-23 |
Diagnostic Hybrids, Inc. |
Methods for direct fluorescent antibody virus detection in liquids
|
PL2144633T4
(pl)
*
|
2007-04-23 |
2015-02-27 |
Sabag Rfa Ltd |
Układ do transportu czynników terapeutycznych do żywych komórek i jąder komórkowych
|
US9156865B2
(en)
|
2007-04-23 |
2015-10-13 |
Deliversir Ltd |
System for delivering therapeutic agents into living cells and cells nuclei
|
US9556210B2
(en)
|
2007-04-23 |
2017-01-31 |
Sabag-Rfa Ltd. |
System for delivering therapeutic agents into living cells and cells nuclei
|
AU2008247819B2
(en)
|
2007-05-01 |
2013-02-14 |
Research Development Foundation |
Immunoglobulin Fc libraries
|
ES2564312T3
(es)
|
2007-05-01 |
2016-03-21 |
Tel Hashomer Medical Research Infrastructure And Services Ltd. |
Métodos y kits para detectar células fetales en la sangre materna
|
WO2009009215A2
(fr)
*
|
2007-05-02 |
2009-01-15 |
Emory University |
Amélioration d'incorporation de glycoprotéine dans des particules de type viral
|
CN107098970B
(zh)
|
2007-05-03 |
2021-11-23 |
新加坡科技研究局 |
结合细胞内prl-1多肽或prl-3多肽的抗体
|
SI2150608T1
(en)
|
2007-05-07 |
2018-04-30 |
Protalix Ltd. |
An extensive disposable bioreactor
|
EP2162057A1
(fr)
*
|
2007-05-10 |
2010-03-17 |
Glumetrics, Inc. |
Capteur de fluorescence d'équilibre de non consommation permettant de mesurer le taux de glucose intravasculaire en temps réel
|
US20090081639A1
(en)
*
|
2007-05-31 |
2009-03-26 |
Phil Hill |
Assay for sensitivity to chemotherapeutic agents
|
US7776877B2
(en)
|
2007-06-22 |
2010-08-17 |
Chemocentryx, Inc. |
N-(2-(hetaryl)aryl) arylsulfonamides and N-(2-(hetaryl) hetaryl arylsulfonamides
|
WO2009000089A1
(fr)
*
|
2007-06-28 |
2008-12-31 |
University Of Saskatchewan |
Compositions immunomodulantes et procédés de traitement d'une maladie par des peptides de défense modifiés de l'hôte
|
US20100197767A1
(en)
|
2007-07-11 |
2010-08-05 |
Lior Nissim |
Nucleic acid construct systems capable of daignosing or treating a cell state
|
DK2175859T3
(da)
|
2007-07-12 |
2012-06-18 |
Chemocentryx Inc |
Kondenserede heteroarylpyridyl- og phenylbenzen-sulfonamider som ccr2-modulatorer til behandling af inflammation
|
AU2008277257B2
(en)
|
2007-07-15 |
2014-03-06 |
Hillman, Yitzchak Mr |
Disease treatment via antimicrobial peptides or their inhibitors
|
IL184627A0
(en)
|
2007-07-15 |
2008-12-29 |
Technion Res & Dev Foundation |
Agents for diagnosing and modulating metastasis and fibrosis as well as inflammation in a mammalian tissue
|
ES2547305T3
(es)
|
2007-07-24 |
2015-10-05 |
Evogene Ltd. |
Polinucleótidos, polipéptidos codificados por los mismos, y métodos de uso de los mismos para aumentar la tolerancia al estrés abiótico y/o la biomasa y/o el rendimiento en plantas que los expresan
|
US8293685B2
(en)
|
2007-07-26 |
2012-10-23 |
The Regents Of The University Of California |
Methods for enhancing bacterial cell display of proteins and peptides
|
JP5659014B2
(ja)
*
|
2007-08-02 |
2015-01-28 |
ジリード バイオロジクス,インク. |
線維症、腫瘍浸潤、血管新生及び転移の治療及び診断のための方法及び組成物
|
US8715743B2
(en)
|
2007-08-03 |
2014-05-06 |
Musc Foundation For Research Development |
Human monoclonal antibodies and methods for producing the same
|
EP2185726B1
(fr)
|
2007-08-06 |
2014-01-08 |
Orion Genomics, LLC |
Nouveaux polymorphismes nucléotidiques uniques et combinaisons de nouveaux polymorphismes connus permettant de déterminer l'expression spécifique d'allèle du gène igf2
|
US7790401B2
(en)
|
2007-08-06 |
2010-09-07 |
Siemens Healthcare Diagnostics |
Methods for detection of immunosuppressant drugs
|
RU2488592C2
(ru)
|
2007-08-08 |
2013-07-27 |
Дзе Борд Оф Риджентс Оф Дзе Юниверсити Оф Техас Систем |
Пептиды направленного действия на vegfr-1/nrp-1
|
WO2009023676A1
(fr)
|
2007-08-12 |
2009-02-19 |
Integrated Dna Technologies, Inc. |
Système de microréseau avec spécificité de séquence améliorée
|
US20090136916A1
(en)
*
|
2007-08-13 |
2009-05-28 |
Trustees Of Tufts College |
Methods and microarrays for detecting enteric viruses
|
ES2406105T3
(es)
|
2007-08-15 |
2013-06-05 |
Yeda Research And Development Co. Ltd. |
Reguladores de la MMP-9 y usos de los mismos
|
WO2009034574A2
(fr)
|
2007-09-12 |
2009-03-19 |
Yeda Research And Development Co. Ltd. |
Procédés de traitement de tumeurs dans des sites privilégiés immunitairement
|
EP2200622B2
(fr)
|
2007-09-19 |
2015-07-29 |
Pluristem Ltd. |
Cellules adhérentes provenant de tissus adipeux ou placentaires et leur utilisation thérapeutique
|
EP2203749B1
(fr)
|
2007-10-05 |
2012-08-29 |
Affymetrix, Inc. |
Dosages à base de particules hautement multiplexées
|
CA2702582C
(fr)
*
|
2007-10-15 |
2013-12-24 |
Idexx Laboratories, Inc. |
Lipase pancreatique feline
|
ES2620487T3
(es)
|
2007-10-19 |
2017-06-28 |
Rappaport Family Institute For Research In The Medical Sciences |
Composiciones que comprenden semaforinas para uso en el tratamiento del cáncer
|
WO2009062027A1
(fr)
*
|
2007-11-07 |
2009-05-14 |
Beckman Coulter, Inc. |
Procédés de dosage sans fractionnement utilisant des enzymes génératrices de péroxyde
|
US8097712B2
(en)
|
2007-11-07 |
2012-01-17 |
Beelogics Inc. |
Compositions for conferring tolerance to viral disease in social insects, and the use thereof
|
JP5264421B2
(ja)
*
|
2007-11-22 |
2013-08-14 |
富士フイルム株式会社 |
被験物測定用担体およびその製造方法
|
WO2009069123A2
(fr)
|
2007-11-26 |
2009-06-04 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem |
Compositions renfermant des polypeptides fibreux et des polysaccharides
|
US7910378B2
(en)
|
2007-12-14 |
2011-03-22 |
Siemens Healthcare Diagnostics Inc. |
Methods for detection of hydrophobic drugs
|
CA2709517C
(fr)
|
2007-12-27 |
2019-02-26 |
Evogene Ltd. |
Polypeptides isoles, polynucleotides utiles pour modifier l'efficacite de l'utilisation de l'eau, l'efficacite de l'utilisation de fertilisant, la tolerance au stress biotique/abiotique, le rendement et la biomasse chez les plantes
|
CA2710713C
(fr)
|
2007-12-27 |
2017-09-19 |
Protiva Biotherapeutics, Inc. |
Silencage de l'expression de la polo-like kinase a l'aide d'un arn interferent
|
EP2944649A1
(fr)
|
2008-01-10 |
2015-11-18 |
Research Development Foundation |
Vaccins et diagnostics pour les ehrlichioses
|
WO2009094551A1
(fr)
|
2008-01-25 |
2009-07-30 |
Amgen Inc. |
Anticorps anti-ferroportine et procédés d'utilisation
|
CA2713667A1
(fr)
*
|
2008-01-31 |
2009-08-06 |
Compugen Ltd. |
Isoforme cd55 et ses utilisations pour la detection du cancer, la surveillance du cancer et la therapie contre le cancer
|
EP2712620A1
(fr)
|
2008-02-07 |
2014-04-02 |
Cornell University |
Procédés de prévention ou de traitement de la résistance à l'insuline
|
US20090203531A1
(en)
|
2008-02-12 |
2009-08-13 |
Nurith Kurn |
Method for Archiving and Clonal Expansion
|
JO2913B1
(en)
|
2008-02-20 |
2015-09-15 |
امجين إنك, |
Antibodies directed towards angiopoietin-1 and angiopoietin-2 proteins and their uses
|
WO2009104174A2
(fr)
|
2008-02-21 |
2009-08-27 |
Technion Research & Development Foundation Ltd . |
Procédé pour fixer sur un microtube une cellule étudiée
|
US20090311695A1
(en)
*
|
2008-03-12 |
2009-12-17 |
Talat Nasim |
Method
|
GB2470672B
(en)
|
2008-03-21 |
2012-09-12 |
Nugen Technologies Inc |
Methods of RNA amplification in the presence of DNA
|
NZ602175A
(en)
*
|
2008-03-28 |
2014-03-28 |
Mitomics Inc |
Aberrant mitochondrial dna, associated fusion transcripts and hybridization probes therefor
|
EP2107125A1
(fr)
|
2008-03-31 |
2009-10-07 |
Eppendorf Array Technologies SA (EAT) |
PCR en temps réel de cibles sur un micro-réseau
|
WO2009124150A2
(fr)
|
2008-04-01 |
2009-10-08 |
Biosearch Technologies, Inc. |
Sondes de désactiveur-fluorophore sombres d’acide nucléique stabilisé
|
CA2721333C
(fr)
|
2008-04-15 |
2020-12-01 |
Protiva Biotherapeutics, Inc. |
Nouvelles formulations lipidiques pour l'administration d'acides nucleiques
|
AU2009236219B8
(en)
|
2008-04-15 |
2015-06-25 |
Arbutus Biopharma Corporation |
Silencing of CSN5 gene expression using interfering RNA
|
WO2009129186A2
(fr)
|
2008-04-17 |
2009-10-22 |
Glumetrics, Inc. |
Capteur pour déploiement intra-vasculaire percutané sans canule à demeure
|
EP3020410A1
(fr)
|
2008-04-18 |
2016-05-18 |
Collplant Ltd. |
Procédés de génération et d'utilisation de procollagène
|
WO2009130695A2
(fr)
|
2008-04-21 |
2009-10-29 |
Danziger Innovation Ltd. |
Vecteurs d'expression de virus végétaux et leur utilisation pour générer des variations génotypiques dans des génomes de plantes
|
JP2011519034A
(ja)
*
|
2008-04-23 |
2011-06-30 |
ルミネックス コーポレーション |
生物学的起原の出発材料中に見出される複数の検体のスタンダードを作成する方法
|
JP2012500620A
(ja)
|
2008-04-24 |
2012-01-12 |
ザ トラスティーズ オブ コロンビア ユニバーシティー イン ザ シティー オブ ニューヨーク |
Dna分子組織化のための幾何学的パターンおよび脂質二重層、ならびにその使用
|
EP2281034B1
(fr)
|
2008-04-30 |
2015-10-21 |
DuPont Nutrition Biosciences ApS |
Procédé d'utilisation de l'alcool déshydrogénase de la Pseudoglucanobacter saccharoketogenes
|
JP2011519279A
(ja)
|
2008-05-01 |
2011-07-07 |
アムジエン・インコーポレーテツド |
抗ヘプシジン抗体及び使用の方法
|
JP2010043063A
(ja)
|
2008-05-09 |
2010-02-25 |
Agency For Science Technology & Research |
川崎病の診断及び治療
|
US8242243B2
(en)
|
2008-05-15 |
2012-08-14 |
Ribomed Biotechnologies, Inc. |
Methods and reagents for detecting CpG methylation with a methyl CpG binding protein (MBP)
|
WO2009141687A1
(fr)
*
|
2008-05-22 |
2009-11-26 |
Centre National De La Recherche Scientifique (Cnrs) |
Nouveaux composés optiquement purs pour une efficacité thérapeutique améliorée
|
BR122020021867B1
(pt)
|
2008-05-22 |
2021-05-11 |
Evogene Ltd |
método de aumento do rendimento, da taxa de crescimento, da biomassa, do vigor, da tolerância ao estresse abiótico e/ou da eficiência no uso do nitrogênio de uma planta, e, construção de ácido nucléico
|
WO2009144720A1
(fr)
|
2008-05-27 |
2009-12-03 |
Pluristem Ltd. |
Procédés de traitement de maladies inflammatoires du côlon
|
EP3514229A1
(fr)
|
2008-05-28 |
2019-07-24 |
Ramot at Tel-Aviv University Ltd. |
Cellules souches mésenchymateuses destinées au traitement de troubles du snc
|
US8791258B2
(en)
*
|
2008-06-10 |
2014-07-29 |
The Regents Of The University Of California |
Pro-fluorescent probes
|
FI20085579A0
(fi)
*
|
2008-06-12 |
2008-06-12 |
Valtion Teknillinen |
Kannabiskäytön toteaminen
|
US9952211B2
(en)
|
2008-06-29 |
2018-04-24 |
Realbio Technologies Ltd. |
Liquid-transfer device particularly useful as a capturing device in a biological assay process
|
WO2010009060A2
(fr)
*
|
2008-07-13 |
2010-01-21 |
Ribomed Biotechnologies, Inc. |
Procédés par balise moléculaire pour la détection de cibles utilisant l'abscription
|
EP2657342B1
(fr)
|
2008-08-08 |
2015-11-18 |
Genisphere, LLC |
Dendrimères d'ADN protégés contre la dégradation par les nucléases
|
WO2010016806A1
(fr)
|
2008-08-08 |
2010-02-11 |
Agency For Science, Technology And Research (A*Star) |
Vhz pour le diagnostic et le traitement de cancers
|
US20120034155A1
(en)
*
|
2010-08-03 |
2012-02-09 |
Searete Llc, A Limited Liability Corporation Of The State Of Delaware |
Artificial cells
|
BRPI0912898B1
(pt)
|
2008-08-18 |
2022-04-12 |
Evogene Ltd |
Método para aumentar a eficiência de uso do nitrogênio e/ou tolerância à deficiência de nitrogênio de uma planta
|
RU2539786C2
(ru)
|
2008-09-02 |
2015-01-27 |
Плуристем Лтд. |
Выращенные в прикрепленной к субстрату культуре клетки из ткани плаценты и их использование при лечении
|
US8583380B2
(en)
|
2008-09-05 |
2013-11-12 |
Aueon, Inc. |
Methods for stratifying and annotating cancer drug treatment options
|
US8367392B2
(en)
*
|
2008-09-05 |
2013-02-05 |
Transalgae Ltd. |
Genetic transformation of algal and cyanobacteria cells by microporation
|
EP2326340A4
(fr)
|
2008-09-11 |
2013-01-23 |
Univ Ben Gurion |
Compositions et procédés destinés à traiter une infection par s. pneumoniae
|
CN107595889A
(zh)
|
2008-09-12 |
2018-01-19 |
克里奥普拉斯低温生物有限公司 |
缺血性组织的细胞疗法
|
EP3670524A1
(fr)
|
2008-09-24 |
2020-06-24 |
Tel HaShomer Medical Research Infrastructure and Services Ltd. |
Peptides et compositions pour la prévention de l'adhésion cellulaire et leurs procédés d'utilisation
|
WO2010036323A1
(fr)
|
2008-09-25 |
2010-04-01 |
University Of Massachusetts Medical School |
Procédé d'identification des interactions entre des loci génomiques
|
CA2736729A1
(fr)
|
2008-09-29 |
2010-04-01 |
Ben Gurion University Of The Negev Research And Development Authority |
Beta-peptides amyloides et procedes d'utilisation associes
|
DE102008049601A1
(de)
|
2008-09-30 |
2010-04-01 |
Siemens Healthcare Diagnostics Products Gmbh |
Antikörper zur Bestimmung des Prothrombin-Fragments F2/F1+2 in einem homogenen Immunoassay
|
US8921658B2
(en)
*
|
2008-10-30 |
2014-12-30 |
Evogene Ltd. |
Isolated polynucleotides encoding a MAP65 polypeptide and methods of using same for increasing plant yield
|
JP5805538B2
(ja)
|
2008-11-07 |
2015-11-04 |
リサーチ ディベロップメント ファウンデーション |
Cripto/GSP78複合体形成およびシグナル伝達を阻害するための組成物および方法
|
US20110229892A1
(en)
|
2008-11-17 |
2011-09-22 |
Yehuda G Assaraf |
Method for predicting a patient's responsiveness to anti-folate therapy
|
WO2010058396A1
(fr)
|
2008-11-19 |
2010-05-27 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Anticorps anti-cd44vra et procédés diagnostiques et thérapeutiques l'utilisant
|
WO2010061383A1
(fr)
|
2008-11-26 |
2010-06-03 |
Biodalia Microbiological Technologies Ltd. |
Procédé permettant d’enrichir in-situ des aliments avec des fructanes
|
WO2010064231A1
(fr)
|
2008-12-02 |
2010-06-10 |
Tel Hashomer Medical Research Infrastructure And Services Ltd. |
Procédés d’analyse d’édition d’arn a-i et constructions d’acide nucléique capables de ceux-ci
|
CA2745111A1
(fr)
|
2008-12-03 |
2010-06-10 |
Research Development Foundation |
Modulation de l'angiogenese a mediation par olfml-3
|
WO2010064247A1
(fr)
|
2008-12-03 |
2010-06-10 |
Tel Hashomer Medical Research Infrastructure And Services Ltd. |
Procédés et trousses pour déterminer une prédisposition au cancer
|
EP3059247B1
(fr)
|
2008-12-05 |
2017-09-20 |
Abraxis BioScience, LLC |
Peptides de liaison à sparc et leurs utilisations
|
US8734759B2
(en)
|
2008-12-05 |
2014-05-27 |
Yeda Research And Development Co. Ltd. |
Methods of diagnosing and treating motor neuron diseases
|
EP2373997A1
(fr)
|
2008-12-09 |
2011-10-12 |
Dako Denmark A/S |
Procédé d'évaluation de prétraitement
|
WO2010068757A1
(fr)
|
2008-12-12 |
2010-06-17 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Compositions et procédés utiles pour détecter et traiter des maladies associées à des ruptures du chromosome 16p
|
WO2010071610A1
(fr)
|
2008-12-19 |
2010-06-24 |
Agency For Science, Technology And Research (A*Star) |
Marqueurs biologiques de chikungunya sévère
|
AU2009334452B2
(en)
|
2008-12-29 |
2015-06-11 |
Tel Hashomer Medical Research, Infrastructure And Services Ltd |
Peptides and compositions for prevention of cell adhesion and methods of using same
|
WO2010076788A2
(fr)
|
2008-12-29 |
2010-07-08 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Méthodes de prédiction de la réponse au traitement par un interféron et traitement d'une infection par l'hépatite c
|
WO2010076756A2
(fr)
|
2008-12-29 |
2010-07-08 |
Evogene Ltd. |
Polynucleotides, polypeptides codes par ceux-ci, et leurs procedes d'utilisation pour augmenter la tolerance au stress abiotique, la biomasse et/ou le rendement dans les plantes les exprimant
|
US8455263B2
(en)
|
2008-12-30 |
2013-06-04 |
Jin Po Lee |
Quantitative analyte assay device and method
|
WO2010076794A1
(fr)
|
2008-12-31 |
2010-07-08 |
Technion Research & Development Foundation Ltd. |
Procédé pour dénitrifier une saumure et systèmes aptes à une telle dénitrification
|
WO2010080769A2
(fr)
|
2009-01-06 |
2010-07-15 |
Arresto Biosciences, Inc. |
Procédés et compositions chimiothérapeutiques
|
IL196820A0
(en)
|
2009-02-01 |
2009-11-18 |
Yissum Res Dev Co |
Devitalized, acellular scaffold matrices derived from micro-organs seeded with various cells
|
WO2010086867A2
(fr)
|
2009-02-02 |
2010-08-05 |
Ramot At Tel Aviv University Ltd. |
Peptides, compositions pharmaceutiques en contenant et leurs utilisations
|
WO2010089707A1
(fr)
|
2009-02-04 |
2010-08-12 |
Yeda Research And Development Co. Ltd. |
Procédé et trousses pour déterminer la sensibilité ou la résistance d'un cancer prostatique à une radiothérapie
|
IL313131A
(en)
|
2009-02-11 |
2024-07-01 |
Caris Mpi Inc |
Molecular characterization of tumors
|
ES2544265T3
(es)
|
2009-02-11 |
2015-08-28 |
Orion Genomics, Llc |
Combinaciones de polimorfismos para determinar la expresión específica de alelo de IGF2
|
WO2010096658A1
(fr)
|
2009-02-19 |
2010-08-26 |
The Cleveland Clinic Foundation |
Corine en tant que marqueur pour une insuffisance cardiaque
|
EP2401362B1
(fr)
|
2009-02-26 |
2017-04-12 |
Tel HaShomer Medical Research Infrastructure and Services Ltd. |
Populations isolées de cellules souches rénales et leurs procédés d'isolement et d'utilisation
|
AR075773A1
(es)
|
2009-03-02 |
2011-04-27 |
Evogene Ltd |
Polipetidos y polinucleotidos aislados y metodos para su uso en el aumento del rendimiento de plantas y las caracteristicas agricolas
|
WO2010101931A2
(fr)
|
2009-03-03 |
2010-09-10 |
Access Medical System Co., Ltd. |
Système et procédé de détection pour dosages fluorescents à haute sensibilité
|
WO2010103515A2
(fr)
|
2009-03-09 |
2010-09-16 |
Ramot At Tel Aviv University Ltd. |
Compositions et procédés pour la prévention et le traitement de maladies neurodégénératives
|
US9347947B2
(en)
*
|
2009-03-12 |
2016-05-24 |
Siemens Healthcare Diagnostics Inc. |
Immunoassays employing non-particulate chemiluminescent reagent
|
WO2010103517A1
(fr)
|
2009-03-12 |
2010-09-16 |
Rappaport Family Institute For Research In The Medical Sciences |
Compositions solubles pour le traitement de maladies associées aux ligands cxcr3
|
CN102421914A
(zh)
|
2009-03-15 |
2012-04-18 |
里伯米德生物技术公司 |
基于流产转录的分子检测
|
US20100240065A1
(en)
*
|
2009-03-18 |
2010-09-23 |
Boehringer Ingelheim International Gmbh |
Prolyl Hydroxylase Compositions and Methods of Use Thereof
|
US8481698B2
(en)
*
|
2009-03-19 |
2013-07-09 |
The President And Fellows Of Harvard College |
Parallel proximity ligation event analysis
|
US9464319B2
(en)
|
2009-03-24 |
2016-10-11 |
California Institute Of Technology |
Multivolume devices, kits and related methods for quantification of nucleic acids and other analytes
|
US10196700B2
(en)
|
2009-03-24 |
2019-02-05 |
University Of Chicago |
Multivolume devices, kits and related methods for quantification and detection of nucleic acids and other analytes
|
CN104722342B
(zh)
|
2009-03-24 |
2017-01-11 |
芝加哥大学 |
滑动式芯片装置和方法
|
US9447461B2
(en)
|
2009-03-24 |
2016-09-20 |
California Institute Of Technology |
Analysis devices, kits, and related methods for digital quantification of nucleic acids and other analytes
|
AU2010241947B2
(en)
|
2009-03-27 |
2014-01-16 |
Gojo Industries, Inc. |
Compositions and methods for screening and using compounds antagonizing spore-surface interactions
|
EP3272871B1
(fr)
|
2009-03-27 |
2020-01-15 |
MDNA Life Sciences Inc. |
Adn mitochondrial aberrant, transcription de fusion associées, produits de translation et sondes d'hybridation associées
|
EP2414542B1
(fr)
|
2009-03-30 |
2017-08-30 |
Tel HaShomer Medical Research Infrastructure and Services Ltd. |
Méthodes pour prévoir l'évolution clinique de la sclérose en plaque et la traiter
|
EP2344179A1
(fr)
|
2009-04-01 |
2011-07-20 |
The Medical Research, Infrastructure, And Health Services Fund Of The Tel Aviv Medical Center |
Procédé de régulation de la prolifération et de la différenciation des kératinocytes
|
WO2010116375A1
(fr)
|
2009-04-08 |
2010-10-14 |
Yeda Research And Development Co. Ltd. |
Peptides isolés pour réguler l'apoptose
|
AU2010239131A1
(en)
|
2009-04-21 |
2011-11-17 |
Genetic Technologies Limited |
Methods for obtaining fetal genetic material
|
GB0908770D0
(en)
|
2009-04-24 |
2009-07-01 |
Danisco |
Method
|
LT2990421T
(lt)
|
2009-04-30 |
2018-04-25 |
Tel Hashomer Medical Research Infrastructure And Services Ltd. |
Anti-ceacam1 antikūnai ir jų panaudojimo būdai
|
EP2425253B1
(fr)
|
2009-05-01 |
2017-03-22 |
Dako Denmark A/S |
Nouveau cocktail d'anticorps
|
CA2761692A1
(fr)
*
|
2009-05-14 |
2010-11-25 |
Raymond A. Dwek |
Diagnostic clinique d'une fibrose hepatique a l'aide d'un nouveau panel de biomarqueurs proteiques plasmatiques humains a faible abondance
|
AU2010250810B2
(en)
|
2009-05-19 |
2014-03-20 |
Dupont Nutrition Biosciences Aps |
Use
|
US9182403B2
(en)
|
2009-05-19 |
2015-11-10 |
Zetiq Technologies Ltd. |
Kits for and methods of differential staining of cervical cancer cells and/or tissues
|
WO2011019423A2
(fr)
|
2009-05-20 |
2011-02-17 |
Schering Corporation |
Modulation de récepteurs pilr pour traiter les infections microbiennes
|
WO2010137013A1
(fr)
|
2009-05-27 |
2010-12-02 |
Ramot At Tel Aviv University Ltd. |
Unités cristallisées de photosystème i dérivées du pois et leur utilisation dans des dispositifs solides
|
EP2435072A2
(fr)
|
2009-05-27 |
2012-04-04 |
Yeda Research and Development Co. Ltd. |
Inhibiteurs des protéasomes et leurs utilisations
|
US20120078163A1
(en)
|
2009-05-27 |
2012-03-29 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Method of generating connective tissue
|
US20120070449A1
(en)
|
2009-05-28 |
2012-03-22 |
Yeda Research And Development Co. Ltd. |
Methods of treating inflammation
|
CN102439451B
(zh)
|
2009-06-02 |
2014-12-03 |
德克萨斯大学系统董事会 |
患神经退行性疾病的对象中抗体所识别的小分子的鉴定
|
EP3238534B1
(fr)
|
2009-06-10 |
2019-11-13 |
Evogene Ltd. |
Polynucléotides et polypeptides isolés et leurs procédés d'utilisation pour augmenter l'efficacité d'utilisation, le rendement, la vitesse de croissance, la vigueur, la biomasse, la teneur en huile et/ou la tolérance au stress abiotique de l'azote
|
CA2765779A1
(fr)
|
2009-06-24 |
2010-12-29 |
Fund For Medical Research Development Of Infrastructure And Health Servi Ces - At Rambam Medical Center |
Methodes et kits d'isolement de microparticules placentaires et utilisation dans le diagnostic des affections placentaires
|
CA2766009A1
(fr)
|
2009-06-25 |
2010-12-29 |
Danisco A/S |
Enzymes lipolytiques variantes avec expression, fonctionnalite ou activite amelioree
|
JP5766188B2
(ja)
|
2009-07-01 |
2015-08-19 |
プロチバ バイオセラピューティクス インコーポレイティッド |
固形腫瘍に治療剤を送達するための脂質製剤
|
US9663778B2
(en)
|
2009-07-09 |
2017-05-30 |
OPKO Biologies Ltd. |
Long-acting coagulation factors and methods of producing same
|
WO2011004379A1
(fr)
|
2009-07-10 |
2011-01-13 |
Tel Hashomer Medical Research Infrastructure And Services Ltd. |
Compositions et méthodes de traitement du cancer
|
MY160472A
(en)
|
2009-07-17 |
2017-03-15 |
Bioatla Llc |
Simultaneous, integrated selection and evolution of antibody/protein performance and expression in production hosts
|
US8716464B2
(en)
|
2009-07-20 |
2014-05-06 |
Thomas W. Geisbert |
Compositions and methods for silencing Ebola virus gene expression
|
WO2011010309A1
(fr)
|
2009-07-21 |
2011-01-27 |
Tel Hashomer Medical Research Infrastructure And Services Ltd. |
Méthode de diagnostic du cancer
|
GB0913442D0
(en)
|
2009-07-31 |
2009-09-16 |
Univ Ramot |
Cell-targeting nanoparticles comprising polynucleotide agents and uses thereof
|
EP2462164A2
(fr)
|
2009-08-04 |
2012-06-13 |
Biosystems International SAS |
Biomarqueurs du cancer du poumon
|
EP2467470A2
(fr)
|
2009-08-17 |
2012-06-27 |
Technion Research & Development Foundation Ltd. |
Cellules progénitrices de péricyte et leurs procédés de génération et d'utilisation
|
BR112012008054A2
(pt)
|
2009-08-21 |
2017-05-23 |
Gilead Biologics Inc |
domínios catalíticos de lisil oxidase e loxl2
|
EP2467146A1
(fr)
|
2009-08-21 |
2012-06-27 |
Beeologics Inc. |
Prévention et traitement de maladies des insectes bénéfiques par l intermédiaire de molécules transcrites végétales
|
EP2470513B1
(fr)
|
2009-08-24 |
2014-10-08 |
Lumiphore, Inc. |
Chélateurs hopo macrocycliques
|
WO2011024172A2
(fr)
|
2009-08-27 |
2011-03-03 |
Technion Research & Development Foundation Ltd. |
Compositions liposomales et leurs utilisations
|
RU2595409C2
(ru)
|
2009-09-03 |
2016-08-27 |
Мерк Шарп И Доум Корп., |
Анти-gitr-антитела
|
WO2011027966A2
(fr)
|
2009-09-03 |
2011-03-10 |
Seegene, Inc. |
Sonde td et ses utilisations
|
US9610331B2
(en)
|
2009-09-08 |
2017-04-04 |
Yeda Research And Development Co. Ltd. |
Methods for hematopoietic precursor mobilization
|
EP2475784A1
(fr)
|
2009-09-08 |
2012-07-18 |
Ramot at Tel-Aviv University Ltd. |
Procédés de diagnostic de la sclérose latérale amyotrophique (sla)
|
WO2011030329A1
(fr)
|
2009-09-10 |
2011-03-17 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Méthode de traitement de tumeurs
|
EP2477652B1
(fr)
|
2009-09-16 |
2015-04-15 |
Vaxart, Inc. |
Stratégie d'immunisation pour empêcher une infection par le h1n1
|
WO2011033506A2
(fr)
|
2009-09-17 |
2011-03-24 |
Yeda Research And Development Co. Ltd. |
Polypeptides pon1 isolés, polynucléotides codant pour ceux-ci et utilisations de ceux-ci dans le traitement ou la prévention des dommages associés à l'exposition à un organophosphate
|
US8735124B2
(en)
|
2009-09-17 |
2014-05-27 |
Yeda Research And Development Co. Ltd. |
Isolated PON1 polypeptides, polynucleotides encoding same and uses thereof in treating or preventing organophosphate exposure associated damage
|
CA2773935C
(fr)
|
2009-09-17 |
2018-06-19 |
Ramot At Tel Aviv University Ltd. |
Peptides pour le traitement de troubles lies au stress oxydatif
|
EP2480668A2
(fr)
|
2009-09-23 |
2012-08-01 |
Protiva Biotherapeutics Inc. |
Compositions et procédés pour réduire au silence des gènes exprimés dans le cancer
|
US20130023433A1
(en)
|
2009-09-28 |
2013-01-24 |
Yuling Luo |
Methods of detecting nucleic acid sequences with high specificity
|
WO2011041546A1
(fr)
|
2009-09-30 |
2011-04-07 |
Glumetrics, Inc. |
Capteurs dotés de revêtements thromborésistants
|
US20110081706A1
(en)
*
|
2009-10-02 |
2011-04-07 |
TransAlgae Ltd |
Method and system for efficient harvesting of microalgae and cyanobacteria
|
WO2011044186A1
(fr)
|
2009-10-06 |
2011-04-14 |
The Board Of Trustees Of The University Of Illinois |
Récepteurs de lymphocytes t à chaîne unique humains
|
ES2666372T3
(es)
|
2009-10-11 |
2018-05-04 |
Biogen Ma Inc. |
Ensayos relacionados con anti-VLA-4
|
US8962584B2
(en)
|
2009-10-14 |
2015-02-24 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem, Ltd. |
Compositions for controlling Varroa mites in bees
|
EP3272869B1
(fr)
|
2009-10-14 |
2020-06-24 |
Yissum Research Development Company of The Hebrew University of Jerusalem Ltd. |
Compositions pour commander les mites varroas dans les abeilles
|
ES2609006T3
(es)
|
2009-10-16 |
2017-04-18 |
Rutgers, The State University Of New Jersey |
Procedimeinto de tratamiento de lesión crónica de tejido nervioso usando una estrategia de terapia celular
|
WO2011048600A1
(fr)
|
2009-10-21 |
2011-04-28 |
Danziger Innovations Ltd. |
Génération de variations génotypiques dans des génomes de plantes par infection d'un gamète
|
WO2011056688A2
(fr)
|
2009-10-27 |
2011-05-12 |
Caris Life Sciences, Inc. |
Profilage moléculaire pour médecine personnalisée
|
US8467843B2
(en)
|
2009-11-04 |
2013-06-18 |
Glumetrics, Inc. |
Optical sensor configuration for ratiometric correction of blood glucose measurement
|
KR20110050327A
(ko)
|
2009-11-07 |
2011-05-13 |
주식회사 씨젠 |
Thd 프라이머 타겟 검출
|
IL201999A
(en)
|
2009-11-08 |
2017-10-31 |
Medical Res & Development Fund For Health Services Bnai Zion Medical Center The State Of Israel |
A knockout mouse of the 1 – mo gene, a gene associated with morbidly extreme obesity
|
EP2498806B1
(fr)
|
2009-11-12 |
2014-12-31 |
Ramot at Tel-Aviv University Ltd. |
Compositions contenant du pedf et leurs utilisations dans le traitement et la prévention de syndromes liés aux ovaires
|
EP4166652A1
(fr)
|
2009-11-12 |
2023-04-19 |
Technion Research & Development Foundation Ltd. |
Milieux de culture, cultures cellulaires et procédés de culture de cellules souches pluripotentes dans un état indifférencié
|
WO2011058555A1
(fr)
|
2009-11-12 |
2011-05-19 |
Yeda Research And Development Co. Ltd. |
Procédé d'édition de l'adn dans une cellule et constructions ayant cette capacité
|
US8592151B2
(en)
*
|
2009-11-17 |
2013-11-26 |
Musc Foundation For Research Development |
Assessing left ventricular remodeling via temporal detection and measurement of microRNA in body fluids
|
EP2501800A4
(fr)
|
2009-11-17 |
2013-05-22 |
Musc Found For Res Dev |
Anticorps monoclonaux humains pour nucléoline humaine
|
WO2011061736A1
(fr)
|
2009-11-17 |
2011-05-26 |
Protalix Ltd. |
Alpha galactosidase alcaline pour le traitement de la maladie de fabry
|
GB0920089D0
(en)
|
2009-11-17 |
2009-12-30 |
Danisco |
Method
|
US9733242B2
(en)
|
2012-10-07 |
2017-08-15 |
Sevident, Inc. |
Devices for capturing analyte
|
US20120273993A1
(en)
|
2009-11-24 |
2012-11-01 |
Collplant Ltd. |
Method of generating collagen fibers
|
US9910040B2
(en)
|
2012-07-09 |
2018-03-06 |
Sevident, Inc. |
Molecular nets comprising capture agents and linking agents
|
WO2011064669A2
(fr)
|
2009-11-30 |
2011-06-03 |
Pluristem Ltd. |
Cellules adhérentes du placenta et leur utilisation dans le traitement de pathologies
|
US8652788B2
(en)
|
2009-12-02 |
2014-02-18 |
Abbott Laboratories |
Assay for diagnosis of cardiac myocyte damage
|
US8835120B2
(en)
|
2009-12-02 |
2014-09-16 |
Abbott Laboratories |
Assay for cardiac troponin-T (cTnT)
|
US20110136141A1
(en)
*
|
2009-12-03 |
2011-06-09 |
Abbott Laboratories |
Peptide reagents and method for inhibiting autoantibody antigen binding
|
US8183002B2
(en)
|
2009-12-03 |
2012-05-22 |
Abbott Laboratories |
Autoantibody enhanced immunoassays and kits
|
WO2011067745A2
(fr)
|
2009-12-06 |
2011-06-09 |
Rosetta Green Ltd. |
Compositions et procédés d'amélioration de résistance de plantes au stress abiotique
|
US8778904B2
(en)
|
2009-12-09 |
2014-07-15 |
Quark Pharmaceuticals, Inc. |
Methods and compositions for treating diseases, disorders or injury of the CNS
|
US8691227B2
(en)
|
2009-12-17 |
2014-04-08 |
Merck Sharp & Dohme Corp. |
Methods of treating multiple sclerosis, rheumatoid arthritis and inflammatory bowel disease using agonists antibodies to PILR-α
|
CA2784344C
(fr)
|
2009-12-21 |
2018-01-02 |
Seegene, Inc. |
Detection de cible par amorce tsg
|
WO2011087707A1
(fr)
|
2009-12-22 |
2011-07-21 |
Elitech Holding B.V. |
Sonde de substrat de l'endonucléase iv hyperthermostable
|
GB0922377D0
(en)
|
2009-12-22 |
2010-02-03 |
Arab Gulf University The |
Mutant LDL receptor
|
US9493785B2
(en)
|
2009-12-28 |
2016-11-15 |
Evogene Ltd. |
Isolated polynucleotides and polypeptides and methods of using same for increasing plant yield, biomass, growth rate, vigor, oil content, abiotic stress tolerance of plants and nitrogen use efficiency
|
AU2010337829B2
(en)
|
2009-12-29 |
2015-03-19 |
Gamida-Cell Ltd. |
Methods for enhancing natural killer cell proliferation and activity
|
CA2786374C
(fr)
|
2010-01-05 |
2019-01-22 |
Vascular Biogenics Ltd. |
Procedes pour l'utilisation d'un agent adenoviral antiangiogenese specifique
|
PL2524060T3
(pl)
|
2010-01-11 |
2018-05-30 |
Biogen Ma Inc. |
Test wykrywający przeciwciała przeciwko wirusowi jc
|
US11287423B2
(en)
|
2010-01-11 |
2022-03-29 |
Biogen Ma Inc. |
Assay for JC virus antibodies
|
SG182490A1
(en)
|
2010-01-12 |
2012-08-30 |
Vascular Biogenics Ltd |
Methods of producing adenovirus vectors and viral preparations generated thereby
|
EA201270701A1
(ru)
|
2010-01-27 |
2013-01-30 |
Йеда Рисеч Энд Девелопмент Ко. Лтд. |
Ингибирующие металлопротеины антитела
|
KR101851117B1
(ko)
|
2010-01-29 |
2018-04-23 |
마이크로닉스 인코포레이티드. |
샘플-투-앤서 마이크로유체 카트리지
|
US20130171621A1
(en)
|
2010-01-29 |
2013-07-04 |
Advanced Cell Diagnostics Inc. |
Methods of in situ detection of nucleic acids
|
US8574832B2
(en)
|
2010-02-03 |
2013-11-05 |
Massachusetts Institute Of Technology |
Methods for preparing sequencing libraries
|
RU2549684C2
(ru)
|
2010-02-04 |
2015-04-27 |
Джилид Байолоджикс, Инк. |
Антитела, связывающиеся с лизилоксидазоподобным ферментом-2 (loxl2), и способы их применения
|
WO2011097627A1
(fr)
|
2010-02-08 |
2011-08-11 |
Agensys, Inc. |
Conjugués anticorps-médicaments (adc) qui se lient aux protéines 161p2f10b
|
US9410131B2
(en)
|
2010-02-11 |
2016-08-09 |
Yeda Research And Development Co. Ltd. |
Enzymatic systems for carbon fixation and methods of generating same
|
WO2011104708A2
(fr)
|
2010-02-24 |
2011-09-01 |
Ben Gurion University Of The Negev Research And Development Authority |
Méthodes d'inhibition de la nécrose
|
WO2011107939A1
(fr)
|
2010-03-01 |
2011-09-09 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Méthodes de prédiction de l'efficacité d'un traitement par anti-vegfa pour des tumeurs solides
|
WO2011107994A1
(fr)
|
2010-03-04 |
2011-09-09 |
Yeda Research And Development Co. Ltd. |
Procédés de mesure de la stabilité d'une protéine
|
WO2011111034A1
(fr)
|
2010-03-08 |
2011-09-15 |
Yeda Research And Development Co. Ltd. |
Production de protéines recombinantes dans des systèmes hétérologues
|
ES2809679T3
(es)
|
2010-03-08 |
2021-03-05 |
Monsanto Technology Llc |
Moléculas polinucleotídicas para la regulación génica en plantas
|
US20120329089A1
(en)
|
2010-03-11 |
2012-12-27 |
Jacob Edrei |
Methods of generating hydrogen
|
WO2011114251A1
(fr)
|
2010-03-18 |
2011-09-22 |
Danisco A/S |
Produits alimentaires
|
EP2556085A2
(fr)
|
2010-04-05 |
2013-02-13 |
Bar-Ilan University |
Polypeptides formant des pores pouvant être activés par une protéase
|
CN103168118A
(zh)
|
2010-04-06 |
2013-06-19 |
麻省理工学院 |
用减少数量的转录物测量进行的基因表达概况分析
|
US9125931B2
(en)
|
2010-04-06 |
2015-09-08 |
Massachusetts Institute Of Technology |
Post-transcriptional regulation of RNA-related processes using encoded protein-binding RNA aptamers
|
WO2011128895A2
(fr)
|
2010-04-12 |
2011-10-20 |
Ben Gurion University Of The Negev Research And Development Authority |
Sulfotransférase d'une microalgue rouge et utilisations de celle-ci
|
US8927274B2
(en)
|
2010-04-12 |
2015-01-06 |
Technion Research & Development Foundation Limited |
Populations of pancreatic progenitor cells and methods of isolating and using same
|
JP5786020B2
(ja)
|
2010-04-16 |
2015-09-30 |
アボットジャパン株式会社 |
関節リウマチを診断する方法および試薬
|
JP5858984B2
(ja)
|
2010-04-18 |
2016-02-10 |
イェダ リサーチ アンド デベロップメント カンパニー リミテッド |
ErbB/ErbBリガンドに関連する疾患を治療するための分子及びその分子を使用する方法
|
BR122021002337B1
(pt)
|
2010-04-28 |
2022-03-22 |
Evogene Ltd |
Método de aumento de produção, biomassa, taxa de crescimento, vigor, teor de óleo, produção de fibra qualidade de fibra, tolerância ao estresse abiótico e/ou eficiência de uso de nitrogênio de uma planta, e construto de ácido nucleico isolado
|
US20130053277A1
(en)
|
2010-05-04 |
2013-02-28 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Methods of identifying inhibitors of polypeptides-of-interest
|
WO2011138785A2
(fr)
|
2010-05-05 |
2011-11-10 |
Rappaport Family Institute For Research In The Medical Sciences |
Utilisation thérapeutique de ccl1
|
IL208820A0
(en)
|
2010-10-19 |
2011-01-31 |
Rachel Teitelbaum |
Biologic female contraceptives
|
US20120190563A1
(en)
|
2010-05-07 |
2012-07-26 |
Abbott Laboratories |
Methods for predicting sensitivity to treatment with a targeted tyrosine kinase inhibitor
|
MX2012012986A
(es)
|
2010-05-07 |
2013-03-05 |
Abbvie Inc |
Metodos para predecir la sensibilidad al tratamiento con un inhibidor de cinasa de tirosina dirigido.
|
WO2011141914A1
(fr)
|
2010-05-13 |
2011-11-17 |
Tel Hashomer Medical Research Infrastructure And Services Ltd. |
Populations isolées de cellules rénales adultes et procédés d'isolement et d'utilisation desdites populations
|
US20110287458A1
(en)
|
2010-05-18 |
2011-11-24 |
The Texas A&M University System |
Method and composition for the diagnosis and monitoring of inflammatory diseases
|
US9624285B2
(en)
|
2010-06-03 |
2017-04-18 |
Ramot a Tel-Aviv University Ltd. |
Methods of treating diabetes and compositions capable of same
|
AU2011263306A1
(en)
|
2010-06-07 |
2013-01-10 |
Osnat Ashur-Fabian |
Methods and kits for diagnosing conditions related to hypoxia
|
EP2395354A1
(fr)
|
2010-06-10 |
2011-12-14 |
Siemens Healthcare Diagnostics Products GmbH |
Test d'activité homogène destiné à la détermination de réactions enzymatiques
|
WO2011158243A2
(fr)
|
2010-06-16 |
2011-12-22 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Procédé de diagnostic et de traitement du cancer
|
BR112012032126A2
(pt)
|
2010-06-16 |
2017-10-17 |
Futuragene Israel Ltd Empresa Isralense |
polinucleotídeo isolado, estrutura de ácido nucléico, sistema de estrutura de ácido nucléico, polipeptídeo isolado, planta, composição inseticida, e método para controlar ou exterminar um inseto
|
US8329424B2
(en)
|
2010-06-25 |
2012-12-11 |
Siemens Healthcare Diagnostics |
Reduction in false results in assay measurements
|
US20130316338A1
(en)
|
2010-06-29 |
2013-11-28 |
The United States Government As Represented By The Department Of Veterans Affairs |
CCR6 As A Biomarker of Alzheimer's Disease
|
GB201011513D0
(en)
|
2010-07-08 |
2010-08-25 |
Danisco |
Method
|
ES2817780T3
(es)
|
2010-07-12 |
2021-04-08 |
The State Of Israel Ministry Of Agriculture And Rural Development Agricultural Res Organization A R |
Polinucleótidos aislados y métodos y plantas que usan los mismos para regular la acidez de las plantas
|
EP2407242A1
(fr)
|
2010-07-13 |
2012-01-18 |
Dublin City University |
Analyse de clone directe et technologie de sélection
|
EP2593554A2
(fr)
|
2010-07-15 |
2013-05-22 |
Technion Research And Development Foundation Ltd. |
Construction d'acide nucléique destinée à accroître la tolérance au stress abiotique dans des végétaux
|
BR112013000985A2
(pt)
|
2010-07-15 |
2017-09-05 |
Technion Res & Dev Foundation |
Entidades isoladas de alta afinidade com especificidade semelhante à do receptor de célula t em relação a complexos nativos de mhc classe ii e peptídeos autoantigênicos de descarboxilase do ácido glutâmico (gad)
|
EP2593480A2
(fr)
|
2010-07-15 |
2013-05-22 |
Technion Research & Development Foundation Ltd. |
Entités de haute affinité isolées présentant une spécificité de type récepteur des lymphocytes t pour les complexes natifs du mhc de classe ii et les peptides auto-antigéniques associés au diabète
|
WO2012009627A2
(fr)
|
2010-07-16 |
2012-01-19 |
Vanderbilt University |
Processeur à faible ressource utilisant des valves de tension superficielle pour extraire, concentrer et détecter des espèces moléculaires
|
SG187033A1
(en)
|
2010-07-16 |
2013-02-28 |
Bioatla Llc |
Novel methods of protein evolution
|
US9624469B2
(en)
|
2010-07-22 |
2017-04-18 |
Cellect Biotherapeutics Ltd. |
Regulatory immune cells with enhanced targeted cell death effect
|
CN103026230B
(zh)
|
2010-07-23 |
2015-01-14 |
卢米耐克斯公司 |
共偶联以控制免疫测定中试剂的反应性
|
US9120862B2
(en)
|
2010-07-26 |
2015-09-01 |
Abbott Laboratories |
Antibodies relating to PIVKA-II and uses thereof
|
US9144585B2
(en)
|
2010-07-27 |
2015-09-29 |
Technion Research & Development Foundation Limited |
Isolated mesenchymal progenitor cells and extracellular matrix produced thereby
|
US20130130387A1
(en)
|
2010-07-27 |
2013-05-23 |
Technion Research & Development Foundation Limited |
Method for generating induced pluripotent stem cells from keratinocytes derived from plucked hair follicles
|
US20130130311A1
(en)
|
2010-07-27 |
2013-05-23 |
Yeda Research And Development Co., Ltd. |
Methods and systems for assessing clonality of cell cultures
|
US8901074B2
(en)
|
2010-08-04 |
2014-12-02 |
Ramot At Tel-Aviv University |
Methods of treating autoimmune diseases of the central nervous system (CNS) and neurodegenerative diseases
|
CA2807240A1
(fr)
|
2010-08-04 |
2012-02-09 |
Idexx Laboratories, Inc. |
Detection des produits de degradation du nt-probnp canin
|
US10088490B2
(en)
|
2010-08-20 |
2018-10-02 |
Siemens Healthcare Diagnostics Inc. |
Assay for analytes using multiple receptors
|
US9394523B2
(en)
|
2010-08-22 |
2016-07-19 |
Ramot At Tel-Aviv University Ltd. |
Induced pluripotent stem cells derived from human pancreatic beta cells
|
WO2012025925A1
(fr)
|
2010-08-24 |
2012-03-01 |
Rappaport Family Institute For Research In The Medical Sciences |
Procédés d'amélioration de la transplantation en utilisant des sdf-1alpha
|
BR122019017037B1
(pt)
|
2010-08-30 |
2022-05-31 |
Evogene Ltd |
Método de aumento de eficiência do uso de nitrogênio, rendimento, biomassa, taxa de crescimento, vigor e/ou tolerância ao estresse à deficiência de nitrogênio de uma planta
|
SG188411A1
(en)
|
2010-09-07 |
2013-04-30 |
Technion Res & Dev Foundation |
Novel methods and culture media for culturing pluripotent stem cells
|
EP2613799A1
(fr)
|
2010-09-07 |
2013-07-17 |
Yissum Research Development Company of the Hebrew University of Jerusalem Ltd. |
Translecture d'acétylcholinestérase (ache-r) pour le traitement ou la prévention de la maladie de parkinson
|
WO2012032510A1
(fr)
|
2010-09-07 |
2012-03-15 |
Yeda Research And Development Co. Ltd. |
Amorces pour l'amplification d'adn et procédés de sélection de ces dernières
|
WO2012032519A2
(fr)
|
2010-09-07 |
2012-03-15 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Méthodes de diagnostic de la maladie de parkinson
|
MX2013002667A
(es)
|
2010-09-08 |
2013-08-01 |
Yeda Res & Dev |
Una combinacion de farmacos inmunosupresores para un injerto estable y a largo plazo.
|
PT2613801T
(pt)
|
2010-09-08 |
2016-09-12 |
Yeda Res & Dev |
Utilização de células t de memória central anti-terceiros no tratamento anti-leucemia/linfoma
|
WO2012035539A1
(fr)
|
2010-09-15 |
2012-03-22 |
Ramot At Tel-Aviv University Ltd. |
Procédés d'expansion et de redifférenciation de cellules bêta des îlots
|
EP2619321B1
(fr)
|
2010-09-20 |
2018-08-01 |
Advanced Cell Diagnostics, Inc. |
Marqueurs biologiques permettant de différencier un mélanome d'un nævus bénin sur la peau
|
US20130210901A1
(en)
|
2010-09-20 |
2013-08-15 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Method of treating neurodegenerative diseases
|
CA2810931C
(fr)
|
2010-09-24 |
2018-04-17 |
The Board Of Trustees Of The Leland Stanford Junior University |
Capture directe, amplification et sequencage d'adn cible a l'aide d'amorces immobilisees
|
IL290591B2
(en)
|
2010-09-29 |
2024-08-01 |
Seagen Inc |
Antibody drug preparations (ADC) that bind to 191P4D12 proteins
|
BR112013008026A2
(pt)
|
2010-10-04 |
2016-06-21 |
Centre Nat Rech Scient |
composições que compreendem ligantes sintéticos multivalentes de nucleolina de superfície e glicosaminaglicanos
|
EP2441520A1
(fr)
|
2010-10-12 |
2012-04-18 |
Eppendorf AG |
Application en temps réel et détection basée sur un micro-réseau de cibles d'acides nucléiques dans un dosage sur puce de flux
|
EP2627766B1
(fr)
|
2010-10-17 |
2016-05-25 |
Yeda Research and Development Co. Ltd. |
Procédés et compositions utilisables en vue du traitement de pathologies médicales associées à l'insuline
|
WO2012052878A1
(fr)
|
2010-10-19 |
2012-04-26 |
Vascular Biogenics Ltd. |
Polynucléotides isolés et constructions d'acide nucléique pour diriger l'expression d'un gène d'intérêt dans des cellules
|
EP3034625B1
(fr)
|
2010-10-21 |
2017-10-04 |
Advanced Cell Diagnostics, Inc. |
Procédé ultrasensible de détection in situ d'acides nucléiques
|
KR20120042100A
(ko)
|
2010-10-22 |
2012-05-03 |
주식회사 씨젠 |
이중표지 고정화 프로브를 이용한 고상에서의 타겟 핵산서열 검출
|
WO2012056452A2
(fr)
|
2010-10-27 |
2012-05-03 |
Nanocyte (Israel) Ltd. |
Compositions pharmaceutiques et dispositifs d'administration comprenant des cellules ou capsules urticantes
|
WO2012056455A1
(fr)
|
2010-10-28 |
2012-05-03 |
Yeda Research And Development Co. Ltd. |
Procédés de génération d'anticorps anti-métalloenzymes
|
US20130227724A1
(en)
|
2010-11-03 |
2013-08-29 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Transgenic plants with improved saccharification yields and methods of generating same
|
US9410132B2
(en)
|
2010-11-04 |
2016-08-09 |
Ben-Gurion University Of The Negev Research And Development Authority |
Acyl-CoA: diacylglycerol acyltransferase 1-like gene (PtDGAT1) and uses thereof
|
WO2012066549A1
(fr)
|
2010-11-15 |
2012-05-24 |
Ramot At Tel-Aviv University Ltd. |
Analogues dipeptidiques pour le traitement d'états pathologiques associé à la formation de fibrilles amyloïdes
|
EP2640404B1
(fr)
|
2010-11-17 |
2017-02-22 |
Ben Gurion University of The Negev Research and Development Authority |
Thérapie à base de cellules t pour les maladies neurodégénératives
|
WO2012073238A1
(fr)
|
2010-12-02 |
2012-06-07 |
Technion Research & Development Foundation Ltd. |
Procédé de génération de cellules cornéennes et populations de cellules les comprenant
|
EP2463382A1
(fr)
|
2010-12-07 |
2012-06-13 |
Enterologics, Inc. |
Procédé d'identification de E. Coli M-17
|
EP2652125B1
(fr)
|
2010-12-15 |
2017-04-26 |
Kadimastem Ltd. |
Cellules produisant de l'insuline dérivées de cellules souches pluripotentes
|
US9551006B2
(en)
|
2010-12-22 |
2017-01-24 |
Evogene Ltd. |
Isolated polynucleotides and polypeptides, and methods of using same for improving plant properties
|
AR084358A1
(es)
|
2010-12-27 |
2013-05-08 |
Lilly Co Eli |
Composiciones y metodos para identificar y diferenciar componentes virales de vacunas multivalentes de la “fiebre de embarque” (complejo de enfermedad respiratoria bovina (brdc))
|
EP2658562B1
(fr)
|
2010-12-28 |
2017-07-26 |
Kamedis Ltd. |
Extraits de plantes pour le traitement et prévention d'infections
|
EP2471945A1
(fr)
|
2010-12-30 |
2012-07-04 |
Siemens Healthcare Diagnostics Products GmbH |
Procédé de détermination d'inhibiteurs de coagulation
|
WO2012092376A2
(fr)
|
2010-12-31 |
2012-07-05 |
Short Jay M |
Génération d'anticorps monoclonaux entiers
|
MX2017015093A
(es)
|
2011-01-11 |
2023-03-10 |
Seegene Inc |
Detección de secuencias de ácido nucleico objetivo mediante ensayo de escisión y extensión del pto.
|
EP3567121B1
(fr)
|
2011-01-17 |
2023-08-30 |
Life Technologies Corporation |
Workflow pour la détection de ligands à l'aide d'acides nucléiques
|
PT3272861T
(pt)
|
2011-01-20 |
2020-03-26 |
Protalix Ltd |
Construção de ácido nucleico para expressão de alfα-galactosidase em plantas e células de plantas
|
WO2012103414A2
(fr)
|
2011-01-28 |
2012-08-02 |
Advanced Cell Diagnostics, Inc. |
Dosage pvh rnascope® pour la détermination du statut pvh dans les cancers de la tête et du cou et les lésions cervicales
|
US20130316358A1
(en)
|
2011-01-31 |
2013-11-28 |
Yeda Research And Development Co. Ltd. |
Methods of diagnosing disease using overlap extension pcr
|
CA2826467C
(fr)
|
2011-02-07 |
2019-11-12 |
Research Development Foundation |
Polypeptides fc modifies d'immunoglobuline
|
WO2012116073A2
(fr)
|
2011-02-23 |
2012-08-30 |
The Board Of Trustees Of The University Of Illinois |
Dendron-hélices amphiphiles, micelles de ceux-ci et utilisations
|
US20130330349A1
(en)
|
2011-02-23 |
2013-12-12 |
Rappaport Family Institute For Research In The Medical Sciences |
High affinity molecules capable of binding a type a plexin receptor and uses of same
|
WO2012117406A2
(fr)
|
2011-03-02 |
2012-09-07 |
Futuragene Israel Ltd. |
Plantes transgéniques résistantes aux bactéries
|
EP2680864B1
(fr)
|
2011-03-03 |
2019-05-08 |
Ramot at Tel-Aviv University Ltd. |
Cellules musculaires génétiquement modifiées qui expriment des facteurs neurotrophiques
|
CA2829110C
(fr)
|
2011-03-06 |
2019-01-15 |
Merck Serono S.A. |
Lignees cellulaires a basse teneur de fucose et leurs utilisations
|
AU2012226530B2
(en)
|
2011-03-08 |
2016-12-01 |
King Abdullah University Of Science And Technology |
Molecular biomarker set for early detection of ovarian cancer
|
US9061006B2
(en)
|
2011-03-08 |
2015-06-23 |
Ramot At Tel-Aviv University Ltd. |
Compositions and methods for diagnosing and treating phenylketonuria (PKU)
|
EP2684048B1
(fr)
|
2011-03-11 |
2018-10-03 |
Board of Regents of the University of Nebraska |
Biomarqueur pour la maladie coronarienne
|
CN103533934B
(zh)
|
2011-03-17 |
2016-03-30 |
特尔汗什莫尔医学基础设施研究和服务公司 |
用于治疗自身免疫性疾病的喹诺酮类似物
|
BR112013023653A2
(pt)
|
2011-03-17 |
2016-12-13 |
Univ Ramot |
anticorpo biespecífico, método de preparação do anticorpo, e composição farmacêutica
|
KR101903339B1
(ko)
|
2011-03-22 |
2018-10-01 |
플루리스템 리미티드 |
방사선 또는 화학적 손상을 치료하는 방법
|
US8969003B2
(en)
|
2011-03-23 |
2015-03-03 |
Elitech Holding B.V. |
Functionalized 3-alkynyl pyrazolopyrimidine analogues as universal bases and methods of use
|
WO2012129547A1
(fr)
|
2011-03-23 |
2012-09-27 |
Elitech Holding B.V. |
Analogues de 3-alcynyl pyrazolopyrimidines fonctionnalisées comme bases universelles et procédés d'utilisation
|
JP5960793B2
(ja)
|
2011-03-24 |
2016-08-02 |
ニューリム ファーマシューティカルズ(1991)リミテッド |
神経保護ペプチド
|
WO2012131680A2
(fr)
|
2011-03-28 |
2012-10-04 |
Yeda Research And Development Co. Ltd. |
Compositions et procédés pour le traitement de l'inflammation
|
JP2014510533A
(ja)
|
2011-03-28 |
2014-05-01 |
ノバルティス アーゲー |
サイクリン依存性キナーゼ阻害剤に関連するマーカー
|
WO2012134195A2
(fr)
|
2011-03-29 |
2012-10-04 |
Seegene, Inc. |
Détection de séquence d'acide nucléique cible par clivage de pto et clivage dépendant de l'extension
|
KR102489185B1
(ko)
|
2011-04-01 |
2023-01-17 |
이뮤노젠 아이엔씨 |
Folr1 암 치료의 효능을 증가시키기 위한 방법
|
EP2694095B1
(fr)
|
2011-04-05 |
2018-03-07 |
Longevity Biotech, Inc. |
Compositions comprenant des analogues du glucagon et leurs procédés de fabrication et d'utilisation
|
WO2012137202A1
(fr)
|
2011-04-05 |
2012-10-11 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Composition comprenant un indicateur de fer attaché à une microparticule et utilisations de celle-ci pour quantifier du fer non lié à la transferrine (ntbi) et du fer labile cellulaire (lci)
|
KR102010600B1
(ko)
|
2011-04-06 |
2019-08-13 |
라모트 앳 텔-아비브 유니버시티 리미티드 |
대사 활성 프로필을 모니터링 및 분석하는 방법 및 그의 진단 및 치료학적 용도
|
US20140031272A1
(en)
|
2011-04-08 |
2014-01-30 |
Danisco Us Inc. |
Compositions
|
WO2012142164A1
(fr)
|
2011-04-12 |
2012-10-18 |
The United States Of America, As Represented By The Secretary, Department Of Health & Human Services |
Anticorps monoclonaux humains qui se lient aux facteurs de croissance insulinomimétique (igf) de type i et ii
|
CA2832812C
(fr)
|
2011-04-15 |
2017-12-05 |
Pluristem Ltd. |
Procedes et systemes de recolte de cellules
|
EP2699906B1
(fr)
|
2011-04-20 |
2017-11-29 |
Access Medical Systems, Ltd. |
Amplification cyclique de polymère luminescent
|
CA3137817A1
(fr)
|
2011-05-03 |
2012-11-08 |
Evogene Ltd. |
Polynucleotides et polypeptides isoles et leurs procedes d'utilisation pour augmenter le rendement de plantes, la biomasse, la vitesse de croissance, la vigueur, la teneur en huile, la tolerance au stress abiotique de plantes et l'efficacite d'utilisation de l'azote
|
EP2704793B1
(fr)
|
2011-05-04 |
2019-07-17 |
Ramot at Tel Aviv University, Ltd. |
Régulation de la composition moléculaire des bêta amyloïdes pour le traitement de la maladie d'azheimer
|
MX342067B
(es)
|
2011-05-04 |
2016-09-09 |
Seegene Inc |
Detección de secuencias de ácido nucleico objetivo por desdoblamiento e hibridización de oligonucleótido de sonda.
|
WO2012154876A1
(fr)
|
2011-05-09 |
2012-11-15 |
Fluidigm Corporation |
Détection d'acide nucléique à l'aide d'une sonde
|
WO2012153333A1
(fr)
|
2011-05-09 |
2012-11-15 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Régénération et réparation de tissu mésenchymateux par utilisation d'amélogénine
|
WO2012153336A2
(fr)
|
2011-05-12 |
2012-11-15 |
Rakuto Bio Technologies Ltd. |
Procédés et dispositifs pour éclaircir la carnation de la peau
|
WO2012156976A1
(fr)
|
2011-05-16 |
2012-11-22 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Procédés de préparation d'artémisinine dans des plantes non-hôtes et vecteurs destinés à une utilisation dans celles-ci
|
US9506051B2
(en)
|
2011-05-20 |
2016-11-29 |
Oligomerix, Inc. |
Tau protease compositions and methods of use
|
CN107102135A
(zh)
|
2011-05-20 |
2017-08-29 |
阿波特日本有限公司 |
用于减少非特异性结合的免疫检验方法和试剂
|
WO2012160526A2
(fr)
|
2011-05-23 |
2012-11-29 |
Ofir Menashe |
Formulations à base de particules contenant des micro-organismes et leurs utilisations
|
WO2012160563A2
(fr)
|
2011-05-23 |
2012-11-29 |
Yeda Research And Development Co. Ltd. |
Utilisation de la phosphorylation d'akt en tant que biomarqueur pour le pronostic et le traitement de maladies neurodégénératives
|
ES2537189T3
(es)
|
2011-05-24 |
2015-06-03 |
Elitech Holding B.V. |
Detección de estafilococos áureos resistentes a la meticilina
|
US8481333B2
(en)
|
2011-05-31 |
2013-07-09 |
Idexx Laboratories, Inc. |
Detection of degradation products of feline NT-proBNP
|
EP2714719B1
(fr)
|
2011-05-31 |
2018-12-12 |
Hutchison Biofilm Medical Solutions Limited |
Dispersion et détachement d'agrégats cellulaires
|
KR102292563B1
(ko)
|
2011-05-31 |
2021-08-24 |
바이오젠 엠에이 인코포레이티드 |
Pml의 위험을 판단하는 방법
|
US20140113376A1
(en)
|
2011-06-01 |
2014-04-24 |
Rotem Sorek |
Compositions and methods for downregulating prokaryotic genes
|
US10166295B2
(en)
|
2011-06-02 |
2019-01-01 |
Opko Biologics Ltd. |
Pegylated OXM variants
|
EP2720720B1
(fr)
|
2011-06-14 |
2018-02-28 |
Yeda Research and Development Co. Ltd. |
Plurithérapie destinée à empêcher la formation de dcis et l'évolution en un cancer du sein
|
WO2012176203A1
(fr)
|
2011-06-23 |
2012-12-27 |
Kaiima Bio Agritech Ltd. |
Blé commun, plantes ou parties de celles-ci ayant un génome partiellement ou complètement multiplié, hybrides et produits de ceux-ci, et procédés de génération et d'utilisation
|
US9835621B2
(en)
|
2011-07-14 |
2017-12-05 |
University Of Kentucky Research Foundation |
Process for detection of alzheimer's disease from a serum sample
|
GB201112091D0
(en)
|
2011-07-14 |
2011-08-31 |
Gt Biolog Ltd |
Bacterial strains isolated from pigs
|
JP2014523914A
(ja)
|
2011-07-18 |
2014-09-18 |
プレジデント・アンド・フェロウズ・オブ・ハーバード・カレッジ |
操作された微生物標的化分子およびその使用
|
RU2014106125A
(ru)
|
2011-07-20 |
2015-08-27 |
Каиима Био Агритех Лтд. |
Растения кукурузы с частично или полностью умноженным геномом и их применения
|
EP2550982A1
(fr)
|
2011-07-27 |
2013-01-30 |
Technion Research & Development Foundation Ltd. |
Dispositifs pour applications chirurgicales
|
CA2844012C
(fr)
|
2011-08-04 |
2021-03-16 |
Yeda Research And Development Co. Ltd. |
Micro-arn et compositions les comprenant pour le traitement et le diagnostic de troubles medicaux associes a la serotonine, a l'adrenaline, a la noradrenaline, au glutamate et a l'hormone de liberation de la corticotropine
|
AU2012294814A1
(en)
|
2011-08-05 |
2014-02-27 |
Research Development Foundation |
Improved methods and compositions for modulation of Olfml3 mediated angiogenesis
|
WO2013021389A2
(fr)
|
2011-08-09 |
2013-02-14 |
Yeda Research And Development Co.Ltd. |
Régulation à la baisse de mir-7 pour favoriser la différenciation des cellules bêta et la production d'insuline
|
ES2671238T3
(es)
|
2011-08-12 |
2018-06-05 |
Siemens Healthcare Diagnostics Inc. |
Detección de esteroides sexuales
|
AU2012296138A1
(en)
|
2011-08-14 |
2014-03-06 |
Kaiima Bio Agritech Ltd. |
Durum wheat plants having a partially or fully multiplied genome and uses thereof
|
EP2744517B1
(fr)
|
2011-08-15 |
2019-03-13 |
The University of Chicago |
Compositions et procédés liés aux anticorps anti-protéine a du staphylocoque
|
EP3348575A1
(fr)
|
2011-08-16 |
2018-07-18 |
Emory University |
Agents spécifiques de liaison à jaml, anticorps, et leurs utilisations associées
|
WO2013035070A1
(fr)
|
2011-09-07 |
2013-03-14 |
Yeda Research And Development Co. Ltd. |
Signature olfactive et mélange odorant la contenant
|
AU2012305931B2
(en)
|
2011-09-08 |
2017-09-07 |
Yeda Research And Development Co. Ltd |
Anti third party central memory T cells, methods of producing same and use of same in transplantation and disease treatment
|
CN103890195A
(zh)
|
2011-09-08 |
2014-06-25 |
耶达研究及发展有限公司 |
用于肺癌的新型风险生物标志物
|
EP2755466A4
(fr)
|
2011-09-13 |
2015-04-15 |
Monsanto Technology Llc |
Procédés et compositions de lutte contre les mauvaises herbes
|
US10829828B2
(en)
|
2011-09-13 |
2020-11-10 |
Monsanto Technology Llc |
Methods and compositions for weed control
|
EP3296402B1
(fr)
|
2011-09-13 |
2020-04-15 |
Monsanto Technology LLC |
Procédés et compositions pour lutter contre les mauvaises herbes
|
US10806146B2
(en)
|
2011-09-13 |
2020-10-20 |
Monsanto Technology Llc |
Methods and compositions for weed control
|
CA2848680C
(fr)
|
2011-09-13 |
2020-05-19 |
Monsanto Technology Llc |
Procedes et compositions de lutte contre les mauvaises herbes
|
US10760086B2
(en)
|
2011-09-13 |
2020-09-01 |
Monsanto Technology Llc |
Methods and compositions for weed control
|
BR112014005979A8
(pt)
|
2011-09-13 |
2017-09-12 |
Monsanto Technology Llc |
Métodos e composições quimicas agricolas para controle de planta, método de redução de expressão de um gene ppg oxidase em uma planta, cassete de expressão microbiana, método para fazer um polinucleotídeo, método de identificação de polinucleotídeos úteis na modulação de expressão do gene ppg oxidase e mistura herbicida
|
GB201117313D0
(en)
|
2011-10-07 |
2011-11-16 |
Gt Biolog Ltd |
Bacterium for use in medicine
|
WO2013054320A1
(fr)
|
2011-10-11 |
2013-04-18 |
Tel Hashomer Medical Research Infrastructure And Services Ltd. |
Anticorps dirigés contre la molécule d'adhésion cellulaire associée à l'antigène carcino-embryonnaire (ceacam)
|
BR112014009536A2
(pt)
|
2011-10-21 |
2017-04-18 |
Augurex Life Sciences Corp |
antígenos derivados de 14-3-3 xitrulinada e usos dos mesmos no diagnóstico de artrite reumatoide
|
WO2013061328A2
(fr)
|
2011-10-27 |
2013-05-02 |
Yeda Research And Development Co. Ltd. |
Procédé de traitement du cancer
|
EP2773758B1
(fr)
|
2011-11-03 |
2017-06-07 |
Quark Pharmaceuticals, Inc. |
Compositions pour la neuroprotection
|
EP2776565A1
(fr)
|
2011-11-08 |
2014-09-17 |
Quark Pharmaceuticals, Inc. |
Méthodes et compositions destinées à traiter des maladies, des troubles ou une lésion du système nerveux
|
US9736998B2
(en)
|
2011-11-23 |
2017-08-22 |
Danziger Dan Flower Farm |
Otomeria plants
|
WO2013076730A1
(fr)
|
2011-11-27 |
2013-05-30 |
Yeda Research And Development Co. Ltd. |
Méthodes de régulation de l'angiogenèse et compositions capables de réguler l'angiogenèse
|
SG11201402902VA
(en)
|
2011-12-08 |
2014-07-30 |
Yeda Res & Dev |
Mammalian fetal pulmonary cells and therapeutic use of same
|
WO2013093921A1
(fr)
|
2011-12-20 |
2013-06-27 |
Collplant Ltd. |
Fibres de polymère synthétique enrobées de collagène
|
RU2648354C2
(ru)
|
2011-12-22 |
2018-03-23 |
Иеда Рисеч Энд Девелопмент Ко. Лтд. |
Комбинированная терапия для стабильного и долговременного приживления трансплантата с использованием конкретных протоколов для т/в-клеточной деплеции
|
US9035039B2
(en)
|
2011-12-22 |
2015-05-19 |
Protiva Biotherapeutics, Inc. |
Compositions and methods for silencing SMAD4
|
CN105833925B
(zh)
|
2011-12-22 |
2018-11-13 |
瑞尔比奥技术有限公司 |
用于分析物测定的序贯侧向流动毛细管装置
|
CN104270939A
(zh)
|
2011-12-28 |
2015-01-07 |
凯伊玛生物农业科技有限公司 |
具有部分加倍或完全加倍的基因组的栽培高粱植物及其应用
|
KR20140108718A
(ko)
|
2011-12-29 |
2014-09-12 |
베일러 리서치 인스티튜트 |
가와사키 질환용 바이오마커
|
CN104080480A
(zh)
|
2012-01-01 |
2014-10-01 |
奇比艾企业有限公司 |
用于选择性递送治疗剂和诊断剂的endo180靶向微粒
|
WO2013106458A2
(fr)
|
2012-01-09 |
2013-07-18 |
Micronics, Inc. |
Filière de réacteur microfluidique
|
EP3418397B1
(fr)
|
2012-01-24 |
2020-10-07 |
CD Diagnostics, Inc. |
Système de détection d'une infection dans le liquide synovial
|
WO2013114363A2
(fr)
|
2012-01-30 |
2013-08-08 |
Yeda Research And Development Co.Ltd. |
Agents antimicrobiens
|
US20150010527A1
(en)
|
2012-02-01 |
2015-01-08 |
Protalix Ltd. |
Dnase i polypeptides, polynucleotides encoding same, methods of producing dnase i and uses thereof in therapy
|
US8771964B2
(en)
|
2012-02-02 |
2014-07-08 |
Siemens Healthcare Diagnostics Inc. |
Compositions and methods for detection of methadone metabolite
|
WO2013118120A2
(fr)
|
2012-02-06 |
2013-08-15 |
Rosetta Green Ltd. |
Polynucléotides isolés exprimant ou modulant des microarn ou des cibles de ceux-ci, plantes transgéniques comprenant ceux-ci et leurs utilisations dans l'amélioration de l'efficacité d'utilisation de l'azote, de la tolérance au stress abiotique, de la biomasse, de la vigueur ou du rendement d'une plante
|
BR112014020119A2
(pt)
|
2012-02-13 |
2020-10-27 |
Gamida-Cell Ltd |
cultura de células-tronco mesenquimais
|
EP2822576B1
(fr)
|
2012-02-14 |
2018-01-10 |
OPKO Biologics Ltd. |
Facteurs de coagulation à action prolongée et leurs procédés de production
|
SG11201404892UA
(en)
|
2012-02-17 |
2014-09-26 |
Nvs Technologies Inc |
Polymer scaffolds for assay applications
|
KR20140130495A
(ko)
|
2012-02-19 |
2014-11-10 |
프로탈릭스 리미티드 |
고셰병 치료용 경구형 단위 투약 형태 및 이의 용도
|
EP3401393B1
(fr)
|
2012-02-22 |
2020-02-19 |
Exostem Biotec Ltd |
Microarn pour la génération d'astrocytes
|
EP2844745A2
(fr)
|
2012-02-22 |
2015-03-11 |
Brainstem Biotec Ltd. |
Génération de cellules souches neuronales et de motoneurones
|
KR102075810B1
(ko)
|
2012-02-24 |
2020-02-10 |
아뷰터스 바이오파마 코포레이션 |
트리알킬 양이온성 지질 및 그의 사용 방법
|
SG11201405241VA
(en)
|
2012-02-29 |
2014-09-26 |
Chemocentryx Inc |
Pyrazol-1-yl benzene sulfonamides as ccr9 antagonists
|
EP2833714A1
(fr)
|
2012-03-01 |
2015-02-11 |
The State of Israel - Ministry of Agriculture & Rural Development, Agricultural Research Organization (ARO) (Volcani Center) |
Plantes d'ail stérile mâle, descendance hybride de celles-ci et procédés de génération et d'utilisation de celles-ci
|
KR101794981B1
(ko)
|
2012-03-05 |
2017-11-09 |
주식회사 씨젠 |
Pto 절단 및 연장 어세이에 의한 타겟 핵산서열에서의 뉴클레오타이드 변이 검출
|
ES2691931T3
(es)
|
2012-03-07 |
2018-11-29 |
Yeda Research And Development Co. Ltd. |
Composiciones para inhibición de quiescina sulfhidrilo oxidasa (QSOX1) y usos de las mismas
|
RS58910B1
(sr)
|
2012-03-20 |
2019-08-30 |
Biogen Ma Inc |
Antitela koja neutrališu virus jcv
|
EP2828280B1
(fr)
|
2012-03-22 |
2018-05-02 |
Ramot at Tel-Aviv University Ltd. |
Peptides multimères plif et utilisations de ceux-ci
|
US20140178869A1
(en)
|
2012-04-05 |
2014-06-26 |
Advanced Cell Diagnostics, Inc. |
Detection of immunoglobulin light chain restriction by rna in situ hybridization
|
US9568431B2
(en)
|
2012-04-16 |
2017-02-14 |
Access Medical Systems, Ltd. |
Luminescent immunoassays for quantitating analytes having a wide concentration range
|
AU2013250767A1
(en)
|
2012-04-18 |
2014-10-09 |
Quiet Therapeutics Ltd. |
Lipidated glycosaminoglycan particles for the delivery of nucleic acids
|
EP2838552A4
(fr)
|
2012-04-19 |
2016-05-18 |
Opko Biolog Ltd |
Variants d'oxyntomoduline à action prolongée et procédés pour les produire
|
US20130280696A1
(en)
|
2012-04-23 |
2013-10-24 |
Elliott Millenson |
Devices and methods for detecting analyte in bodily fluid
|
EP2841084B1
(fr)
|
2012-04-24 |
2018-05-30 |
Biokine Therapeutics Ltd. |
Peptide antagoniste de cxcr4 et son utilisation pour le traitment de tumeurs pulmonaires
|
CN104703622B
(zh)
|
2012-04-26 |
2017-05-24 |
芝加哥大学 |
与金黄色葡萄球菌疾病期间抵消凝固酶活性的抗体相关的组合物和方法
|
US10202642B2
(en)
|
2012-05-02 |
2019-02-12 |
Ibis Biosciences, Inc. |
DNA sequencing
|
US10584377B2
(en)
|
2012-05-02 |
2020-03-10 |
Ibis Biosciences, Inc. |
DNA sequencing
|
JP6181158B2
(ja)
|
2012-05-09 |
2017-08-16 |
イェダ リサーチ アンド デベロップメント カンパニー リミテッド |
TNF−α阻害剤としてのTACEプロドメインの変異体およびその医学的使用
|
CN104583239B
(zh)
|
2012-05-10 |
2018-09-18 |
生物蛋白有限公司 |
多特异单克隆抗体
|
WO2013173844A1
(fr)
|
2012-05-18 |
2013-11-21 |
Pacific Biosciences Of California, Inc. |
Colorants hétéroarylcyanines
|
US8865158B2
(en)
|
2012-05-22 |
2014-10-21 |
Ramot At Tel-Aviv University Ltd. |
Bacteriophages for reducing toxicity of bacteria
|
JP5868549B2
(ja)
|
2012-05-24 |
2016-02-24 |
マウントゲイト グループ リミテッド |
狂犬病感染の予防および治療に関する組成物および方法
|
US10240162B2
(en)
|
2012-05-24 |
2019-03-26 |
A.B. Seeds Ltd. |
Compositions and methods for silencing gene expression
|
CA2874146C
(fr)
|
2012-06-01 |
2023-03-21 |
Icahn School Of Medicine At Mount Sinai |
Niveaux de ceramide dans le traitement et la prevention d'infections
|
US9731048B2
(en)
|
2012-06-03 |
2017-08-15 |
Ben-Gurion University Of The Negev Research And Development Authority |
Functionalized titanium binding peptides and implants coated with same
|
PE20150181A1
(es)
|
2012-06-04 |
2015-02-28 |
Opko Biolog Ltd |
Variantes de oxm pegilada
|
CN104603291B
(zh)
|
2012-06-22 |
2018-04-06 |
Htg分子诊断有限公司 |
黑素细胞病变中的分子恶性肿瘤
|
WO2014004444A1
(fr)
|
2012-06-27 |
2014-01-03 |
Siemens Healthcare Diagnostics Inc. |
Compositions et procédés pour évaluer le mélange de liquides
|
EP2870110A1
(fr)
|
2012-07-03 |
2015-05-13 |
Nanospun Technologies Ltd. |
Procédés et dispositifs pour l'adsorption et la biodégradation de pétrole
|
EP3309263B1
(fr)
|
2012-07-09 |
2019-12-25 |
Novartis AG |
Biomarqueurs associés à des inhibiteurs de cdk
|
US20150173883A1
(en)
|
2012-07-18 |
2015-06-25 |
President And Fellows Of Harvard College |
Modification of surfaces for simultaneous repellency and targeted binding of desired moieties
|
US9175266B2
(en)
|
2012-07-23 |
2015-11-03 |
Gamida Cell Ltd. |
Enhancement of natural killer (NK) cell proliferation and activity
|
US9567569B2
(en)
|
2012-07-23 |
2017-02-14 |
Gamida Cell Ltd. |
Methods of culturing and expanding mesenchymal stem cells
|
WO2014018375A1
(fr)
|
2012-07-23 |
2014-01-30 |
Xenon Pharmaceuticals Inc. |
Cyp8b1 et ses utilisations dans des méthodes thérapeutiques et diagnostiques
|
KR102250696B1
(ko)
|
2012-07-27 |
2021-05-12 |
더 보오드 오브 트러스티스 오브 더 유니버시티 오브 일리노이즈 |
T 세포 수용체 조작
|
EP2880155B1
(fr)
|
2012-07-29 |
2019-04-17 |
Yeda Research and Development Co., Ltd. |
Utilisation de la voie de la glycine réductrice en vue de la génération de microorganismes formatotrophes et autotrophes
|
JP6340366B2
(ja)
|
2012-07-31 |
2018-06-06 |
イェダ リサーチ アンド デベロップメント カンパニー リミテッド |
運動ニューロン疾患を診断および処置する方法
|
CN104520714A
(zh)
|
2012-07-31 |
2015-04-15 |
诺华股份有限公司 |
与对人双微体2(mdm2)抑制剂的敏感性相关的标志物
|
ES2813407T3
(es)
|
2012-08-06 |
2021-03-23 |
Brainstorm Cell Therapeutics Ltd |
Métodos para generar células madre mesenquimales que secretan factores neurotróficos
|
US8968742B2
(en)
|
2012-08-23 |
2015-03-03 |
Agensys, Inc. |
Antibody drug conjugates (ADC) that bind to 158P1D7 proteins
|
WO2014035712A1
(fr)
|
2012-08-28 |
2014-03-06 |
Pierce Biotechnology, Inc. |
Composés de benzopyrylium
|
WO2014033723A1
(fr)
|
2012-09-03 |
2014-03-06 |
A.B. Seeds Ltd. |
Procédé d'amélioration de la tolérance au stress abiotique des plantes et plantes ainsi produites
|
US10543278B2
(en)
|
2012-09-12 |
2020-01-28 |
Ramot At Tel-Aviv University Ltd. |
Immunoparticles and methods of generating and using same
|
EP2906954B1
(fr)
|
2012-10-09 |
2018-04-11 |
Ramot at Tel-Aviv University Ltd. |
Procédés et trousses utilisant la mortaline soluble dans le sang pour prédire un pronostic de cancer
|
KR20150083859A
(ko)
|
2012-10-12 |
2015-07-20 |
엔브이에스 테크놀로지스 인코포레이티드 |
직교 반응성 기를 갖는 중합체 및 그의 용도
|
US9650436B2
(en)
|
2012-10-12 |
2017-05-16 |
Arizona Board Of Regents On Behalf Of Arizona State University |
Antibody based reagents that specifically recognize toxic oligomeric forms of tau
|
WO2014072832A2
(fr)
|
2012-10-18 |
2014-05-15 |
Oslo Universitetstssykehus Hf |
Biomarqueurs pour le cancer du col de l'utérus
|
WO2014063097A1
(fr)
|
2012-10-19 |
2014-04-24 |
Danisco Us Inc. |
Stabilisation de membranes biomimétiques
|
US9395369B2
(en)
|
2012-10-19 |
2016-07-19 |
Regents Of The University Of Minnesota |
Guinea pig cytomegalovirus (CIDMTR strain)
|
US20150354006A1
(en)
|
2012-10-19 |
2015-12-10 |
Novartis Ag |
Markers for acute lymphoblastic leukemia
|
CN104918639B
(zh)
|
2012-10-22 |
2018-01-26 |
萨拜格Rfa公司 |
用于将治疗剂递送到活细胞和细胞核中的系统
|
CA2888345C
(fr)
|
2012-10-24 |
2020-04-21 |
Research Development Foundation |
Anticorps anti-jam-c et procedes pour le traitement du cancer
|
WO2014064682A1
(fr)
|
2012-10-24 |
2014-05-01 |
Yeda Research And Development Co. Ltd. |
Combinaisons d'anticorps ciblant les récepteurs du facteur de croissance épidermique pour traiter le cancer
|
EP2912181B1
(fr)
|
2012-10-29 |
2017-11-29 |
Yeda Research and Development Co., Ltd. |
Aptamères, aptamères multimères et leurs utilisations
|
EP2920148B1
(fr)
|
2012-11-16 |
2019-06-12 |
The Regents of the University of California |
Ligature pictet-spengler pour la modification chimique de protéines
|
WO2014080401A2
(fr)
|
2012-11-20 |
2014-05-30 |
Prolor Biotech Inc |
Procédé d'augmentation du volume hydrodynamique de polypeptides par la fixation à des peptides carboxy terminaux de gonadotrophine
|
WO2015079413A2
(fr)
|
2013-11-28 |
2015-06-04 |
Yeda Research And Development Co. Ltd. |
Inhibiteurs de synaptojanine-2 et leurs utilisations
|
BR112015002626A2
(pt)
|
2012-11-29 |
2017-09-26 |
Yeda Res & Dev |
métodos para prevenção de metástases tumorais, tratamento e prognostico do câncer e identificação dos agentes que são inibidores da metástase putativa
|
US9244083B2
(en)
|
2012-11-30 |
2016-01-26 |
Siemens Healthcare Diagnostics Inc. |
Compositions and methods for detecting vitamin D
|
US9121859B2
(en)
|
2012-12-04 |
2015-09-01 |
Siemens Healthcare Diagnostics Inc. |
Compounds and methods for determination of FKBP-binding immunosuppressant drugs
|
JP6935167B2
(ja)
|
2012-12-21 |
2021-09-15 |
ペルキネルマー ヘルス サイエンシーズ, インコーポレイテッド |
マイクロ流体使用のための低弾性フィルム
|
CN104919035B
(zh)
|
2012-12-21 |
2017-08-11 |
精密公司 |
便携式荧光检测系统和微测定盒
|
EP2935908B1
(fr)
|
2012-12-21 |
2019-08-14 |
PerkinElmer Health Sciences, Inc. |
Circuits fluidiques et procédés de fabrication associés
|
US10683505B2
(en)
|
2013-01-01 |
2020-06-16 |
Monsanto Technology Llc |
Methods of introducing dsRNA to plant seeds for modulating gene expression
|
CN105358695B
(zh)
|
2013-01-01 |
2019-07-12 |
A.B.种子有限公司 |
将dsRNA引入植物种子以调节基因表达的方法
|
WO2014108850A2
(fr)
|
2013-01-09 |
2014-07-17 |
Yeda Research And Development Co. Ltd. |
Analyse de transcriptome à haut débit
|
WO2014108854A1
(fr)
|
2013-01-09 |
2014-07-17 |
Fusimab Ltd. |
Anticorps anti-hgf et anti-ang2 monospécifiques, et anticorps anti-hgf/anti-ang2 bispécifiques
|
EP3431985A1
(fr)
|
2013-01-17 |
2019-01-23 |
Novellusdx Ltd. |
Procédés et systèmes pour identifier des mutations conductrices spécifiques à un patient
|
EP2945942B1
(fr)
|
2013-01-18 |
2018-05-09 |
ARK Diagnostics, Inc. |
Immunodosages de viroconazole
|
WO2014116721A1
(fr)
|
2013-01-22 |
2014-07-31 |
The Arizona Board Of Regents For And On Behalf Of Arizona State University |
Vecteur geminiviral pour l'expression du rituximab
|
CA2897474A1
(fr)
|
2013-01-24 |
2014-07-31 |
California Institute Of Technology |
Caracterisation a base de chromophore et procedes de detection
|
US10077475B2
(en)
|
2013-01-24 |
2018-09-18 |
California Institute Of Technology |
FRET-based analytes detection and related methods and systems
|
EP3885446A1
(fr)
|
2013-02-01 |
2021-09-29 |
The Regents of The University of California |
Procédés pour assemblage du génome et phasage d'haplotype
|
US9411930B2
(en)
|
2013-02-01 |
2016-08-09 |
The Regents Of The University Of California |
Methods for genome assembly and haplotype phasing
|
AU2014212230B2
(en)
|
2013-02-01 |
2019-07-04 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Method for generating retinal pigment epithelium (RPE) cells from induced pluripotent stem cells (iPSCs)
|
US10000737B2
(en)
|
2013-02-04 |
2018-06-19 |
Ramot At Tel-Aviv University Ltd. |
Generation of cytotoxic tumor specific cell lines and uses thereof
|
WO2014126861A1
(fr)
|
2013-02-13 |
2014-08-21 |
Ark Diagnostics, Inc. |
Dosages immunologiques du posaconazole
|
WO2014130846A1
(fr)
|
2013-02-22 |
2014-08-28 |
Seungpyo Hong |
Administration d'un médicament par voie transdermique faisant appel à des micelles amphiphiles « dendron-coil »
|
ES2662825T3
(es)
|
2013-02-25 |
2018-04-09 |
Seegene, Inc. |
Detección de variación de nucleótido en una secuencia de ácidos nucleicos diana
|
JP6454650B2
(ja)
|
2013-03-06 |
2019-01-23 |
プロタリクス リミテッド |
TNFαポリペプチド阻害剤を発現する植物細胞及び薬学的に許容される担体を含む医薬組成物
|
AU2014224174B2
(en)
|
2013-03-06 |
2018-08-30 |
Hadasit Medical Research Services And Development Ltd. |
Use of plant cells expressing a TNFalpha polypeptide inhibitor in therapy
|
TWI582239B
(zh)
|
2013-03-11 |
2017-05-11 |
諾華公司 |
與wnt抑制劑相關之標記
|
EP2971106B1
(fr)
|
2013-03-11 |
2020-02-26 |
ELITechGroup, Inc. |
Procédés d'amplification isotherme par déplacement de brin en temps réel
|
US10609930B2
(en)
|
2013-03-13 |
2020-04-07 |
Monsanto Technology Llc |
Methods and compositions for weed control
|
KR101943623B1
(ko)
|
2013-03-13 |
2019-01-30 |
주식회사 씨젠 |
멜팅 피크 분석을 이용한 타겟 핵산서열의 정량
|
KR102257912B1
(ko)
|
2013-03-13 |
2021-05-27 |
메소 스케일 테크놀러지즈, 엘엘시 |
개선된 분석 방법
|
US10612019B2
(en)
|
2013-03-13 |
2020-04-07 |
Monsanto Technology Llc |
Methods and compositions for weed control
|
US10114015B2
(en)
|
2013-03-13 |
2018-10-30 |
Meso Scale Technologies, Llc. |
Assay methods
|
CN105246916A
(zh)
|
2013-03-14 |
2016-01-13 |
诺华股份有限公司 |
针对notch 3的抗体
|
US20140287945A1
(en)
|
2013-03-14 |
2014-09-25 |
NVS Technologies, Inc. |
Surface oxidation for sequestering biomolecules and related methods
|
WO2014159063A1
(fr)
|
2013-03-14 |
2014-10-02 |
Elitech Holding B.V. |
Analogues de 3-alcynyl pyrazolopyrimidines fonctionnalisés utilisés en tant que bases universelles et procédés d'utilisation
|
US9273349B2
(en)
|
2013-03-14 |
2016-03-01 |
Affymetrix, Inc. |
Detection of nucleic acids
|
WO2014159242A1
(fr)
|
2013-03-14 |
2014-10-02 |
Novartis Ag |
Mutants de notch 3 et leurs utilisations
|
WO2014145718A2
(fr)
|
2013-03-15 |
2014-09-18 |
Longevity Biotech, Inc. |
Peptides comprenant des acides aminés non endogènes et procédés de fabrication et d'utilisation associés
|
US10568328B2
(en)
|
2013-03-15 |
2020-02-25 |
Monsanto Technology Llc |
Methods and compositions for weed control
|
US9944992B2
(en)
|
2013-03-15 |
2018-04-17 |
The University Of Chicago |
Methods and compositions related to T-cell activity
|
EP2971160B1
(fr)
|
2013-03-15 |
2018-05-30 |
Bio-Rad Laboratories, Inc. |
Tests numériques pour la détection de mutations
|
EP4174082A1
(fr)
|
2013-03-15 |
2023-05-03 |
GLAdiator Biosciences, Inc. |
Domaines gla en tant qu'agents de ciblage
|
KR101403507B1
(ko)
|
2013-03-21 |
2014-06-09 |
주식회사 현일바이오 |
결핵균 및 비결핵 마이코박테리아의 선택적 검출 방법, 그리고 이를 이용한 키트
|
CA2907680A1
(fr)
|
2013-03-21 |
2014-09-25 |
Collplant Ltd. |
Compositions comprenant du collagene et prp pour la regeneration tissulaire
|
CN105163749B
(zh)
|
2013-03-24 |
2018-03-27 |
拜欧肯治疗有限公司 |
治疗骨髓性白血病的方法
|
GB201306536D0
(en)
|
2013-04-10 |
2013-05-22 |
Gt Biolog Ltd |
Polypeptide and immune modulation
|
US20140308751A1
(en)
|
2013-04-12 |
2014-10-16 |
Siemens Healthcare Diagnostics Inc. |
Assays for Analyte Homologs
|
WO2014174511A1
(fr)
|
2013-04-21 |
2014-10-30 |
Yeda Research And Development Co. Ltd. |
Agents de régulation à la baisse de l'activité et/ou de la quantité de bcl-xl et/ou bcl-w
|
EP2989199B1
(fr)
|
2013-04-23 |
2020-08-12 |
Yeda Research and Development Co., Ltd. |
Cellules souches pluripotentes naïves isolées et leurs procédés de génération
|
US20160091485A1
(en)
|
2013-04-25 |
2016-03-31 |
The Broad Institute, Inc. |
Markers for ezh2 inhibitors
|
WO2014174520A1
(fr)
|
2013-04-25 |
2014-10-30 |
Yeda Research And Development Co. Ltd. |
Utilisation de peptides inhibiteurs pour le traitement de maladies inflammatoires
|
US10190153B2
(en)
|
2013-05-07 |
2019-01-29 |
Micronics, Inc. |
Methods for preparation of nucleic acid-containing samples using clay minerals and alkaline solutions
|
EP2994543B1
(fr)
|
2013-05-07 |
2018-08-15 |
Micronics, Inc. |
Dispositif pour la préparation et l'analyse d'acides nucléiques
|
WO2014182844A1
(fr)
|
2013-05-07 |
2014-11-13 |
Micronics, Inc. |
Dispositifs microfluidiques et méthodes de séparation du sérum et de compatibilité croisée du sang
|
US9328384B2
(en)
|
2013-05-13 |
2016-05-03 |
Elitechgroup B.V. |
Droplet digital PCR with short minor groove probes
|
US20160115231A1
(en)
|
2013-05-21 |
2016-04-28 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Treatment of mast cell related pathologies
|
EP3848044A1
(fr)
|
2013-05-21 |
2021-07-14 |
President and Fellows of Harvard College |
Compositions se liant à l'hème manipulées et leurs utilisations
|
KR102280377B1
(ko)
|
2013-05-27 |
2021-07-23 |
라쿠토 바이오 테크놀로지스 리미티드 |
효소 시스템-함유 화장료 조성물
|
EP3004334A4
(fr)
|
2013-05-28 |
2016-12-21 |
Biogen Ma Inc |
Méthodes d'évaluation de risque de développement d'une lemp
|
EP3008201B1
(fr)
|
2013-06-12 |
2019-08-07 |
The General Hospital Corporation |
Procédés pour détection multiplexe de molécules cibles et leurs utilisations
|
DK3010519T3
(en)
|
2013-06-18 |
2021-05-17 |
Dnatrix Inc |
Oncolytic adenovirus for use in a treatment of brain cancer
|
ES2938044T3
(es)
|
2013-06-24 |
2023-04-04 |
Univ Ramot |
Estructura a base de epiplón y sistema de suministro
|
AU2014302082B2
(en)
|
2013-06-28 |
2019-08-08 |
Baylor Research Institute |
Dendritic cell ASGPR targeting immunotherapeutics for multiple sclerosis
|
JP6050555B2
(ja)
|
2013-07-15 |
2016-12-21 |
シージーン アイエヌシー |
Ptoの切断及び延長−依存的固定化オリゴヌクレオチドハイブリダイゼーションを用いたターゲット核酸配列の検出
|
BR112016000555B1
(pt)
|
2013-07-19 |
2022-12-27 |
Monsanto Technology Llc |
Método para controlar uma infestação da espécie de leptinotarsa em uma planta, composição inseticida e construção de dna recombinante
|
US9850496B2
(en)
|
2013-07-19 |
2017-12-26 |
Monsanto Technology Llc |
Compositions and methods for controlling Leptinotarsa
|
WO2015015489A1
(fr)
|
2013-07-30 |
2015-02-05 |
Biolinerx Ltd. |
Anticorps convenant au traitement du diabète et de maladies autoimmunes
|
WO2015017552A1
(fr)
|
2013-08-01 |
2015-02-05 |
Agensys, Inc. |
Conjugués anticorps-médicament (adc) se liant à la protéine cd37
|
US9914775B2
(en)
|
2013-08-21 |
2018-03-13 |
The Board Of Regents Of The University Of Texas System |
Methods for treating inflammatory disorders or cancer metastasis by administering antibodies to connexin 43 (Cx43) hemichannels
|
ES2702674T3
(es)
|
2013-08-29 |
2019-03-04 |
Yeda Res & Dev |
Inhibidores selectivos de la isoforma alfa2 de Na,K-ATPasa y el uso para la reducción de la presión intraocular
|
SG10201907501QA
(en)
|
2013-08-30 |
2019-10-30 |
Immunogen Inc |
Antibodies and assays for detection of folate receptor 1
|
US20160251410A1
(en)
|
2013-09-03 |
2016-09-01 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Compositions and methods for expressing recombinant polypeptides
|
IL228284A
(en)
|
2013-09-03 |
2016-12-29 |
Technion Res & Dev Foundation |
Implants from cellular scaffolding and blood vessel stalk
|
WO2015033344A1
(fr)
|
2013-09-05 |
2015-03-12 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Procédés et nécessaires permettant d'inhiber la pathogénicité d'un streptocoque du groupe a (sga) ou d'un streptocoque du groupe g (sgg)
|
WO2015037009A1
(fr)
|
2013-09-16 |
2015-03-19 |
Plexicure Ltd. |
Protéines isolées capables de se lier à la plexine-a4, et procédés de production et d'utilisation
|
WO2015040609A1
(fr)
|
2013-09-17 |
2015-03-26 |
Yeda Research And Development Co. Ltd. |
Nouveaux peptides d'erk et leurs utilisations
|
AU2014330807B2
(en)
|
2013-10-01 |
2020-07-02 |
Kadimastem Ltd. |
Directed differentiation of astrocytes from human pluripotent stem cells for use in drug screening and the treatment of Amyotrophic Lateral Sclerosis (ALS)
|
EP3052193B1
(fr)
|
2013-10-03 |
2018-01-31 |
Oklahoma Medical Research Foundation |
Biomarqueurs d'activité, de l'intensité et de l'éruption de la maladie du lupus érythémateux disséminé
|
US9476884B2
(en)
|
2013-10-04 |
2016-10-25 |
University Of Massachusetts |
Hybridization- independent labeling of repetitive DNA sequence in human chromosomes
|
WO2015057008A2
(fr)
|
2013-10-18 |
2015-04-23 |
Seegene, Inc. |
Détection de séquence d'acide nucléique cible sur phase solide par clivage et extension de pto au moyen d'un dosage de hcto
|
US20150158926A1
(en)
|
2013-10-21 |
2015-06-11 |
Opko Biologics, Ltd. |
Long-acting polypeptides and methods of producing and administering same
|
PT3060239T
(pt)
|
2013-10-21 |
2020-08-26 |
Opko Biologics Ltd |
Polipéptidos de ação prolongada e métodos de produção e administração dos mesmos
|
EP3060917B1
(fr)
|
2013-10-24 |
2019-05-15 |
Siemens Healthcare Diagnostics Inc. |
Dosages pour analytes macromoléculaires
|
US10767156B2
(en)
|
2013-10-24 |
2020-09-08 |
Yeda Research And Development Co., Ltd. |
Polynucleotides encoding BREX system polypeptides and methods of using same
|
US20160243187A1
(en)
|
2013-10-31 |
2016-08-25 |
Biokine Therapeutics Ltd. |
Methods of treating acute myeloid leukemia with a flt3 mutation
|
RU2694950C2
(ru)
|
2013-11-04 |
2019-07-18 |
Монсанто Текнолоджи Ллс |
Композиции и способы для борьбы с членистоногими паразитами и заражениями вредителями
|
US20170002064A1
(en)
|
2013-11-08 |
2017-01-05 |
The Board Of Regents Of The University Of Texas System |
Vh4 antibodies against gray matter neuron and astrocyte
|
CA2930693A1
(fr)
|
2013-11-15 |
2015-05-21 |
The Board Of Trustees Of The Leland Stanford Junior Unversity |
Procedes de traitement d'une insuffisance cardiaque avec des agonistes de recepteur 2 d'hypocretine
|
US20170336395A1
(en)
|
2013-11-20 |
2017-11-23 |
University Of Iowa Research Foundation |
Methods and compositions for treating amyloid deposits
|
ES2729406T3
(es)
|
2013-11-22 |
2019-11-04 |
Univ Illinois |
Receptores de linfocitos T humanos de alta afinidad modificados
|
CA2925698C
(fr)
|
2013-11-28 |
2021-11-09 |
Tel Hashomer Medical Research Infrastructure And Services Ltd. |
Inhibiteurs de l'arn polymerase i et leurs utilisations
|
UA119253C2
(uk)
|
2013-12-10 |
2019-05-27 |
Біолоджикс, Інк. |
Спосіб боротьби із вірусом у кліща varroa та у бджіл
|
ES2697757T3
(es)
|
2013-12-10 |
2019-01-28 |
Yeda Res & Dev |
Uso de enzimas que catalizan la síntesis de piruvato a partir de formiato y acetil-CoA y bacterias que expresan la misma
|
WO2015089172A1
(fr)
|
2013-12-13 |
2015-06-18 |
Siemens Healthcare Diagnostics Inc. |
Agent de pré-traitement dans des dosages de non agglutination
|
WO2015095604A2
(fr)
|
2013-12-18 |
2015-06-25 |
President And Fellows Of Harvard College |
Méthodes et analyses associées à des cellules tumorales circulantes
|
EP3084437B1
(fr)
|
2013-12-18 |
2018-02-28 |
Siemens Healthcare Diagnostics Inc. |
Détection d'une maladie endothéliale
|
CA2934039A1
(fr)
|
2013-12-19 |
2015-06-25 |
Danisco Us Inc. |
Utilisation d'hydrophobines pour augmenter le transfert de gaz dans des processus de fermentation aerobie
|
US11293929B2
(en)
|
2014-01-07 |
2022-04-05 |
Bioatla, Inc. |
Proteins targeting orthologs
|
US10286058B2
(en)
|
2014-01-13 |
2019-05-14 |
Baylor Research Institute |
Vaccines against HPV and HPV-related diseases
|
BR112016016337A2
(pt)
|
2014-01-15 |
2017-10-03 |
Monsanto Technology Llc |
Composição e métodos para controlar crescimento, desenvolvimento ou a capacidade de reprodução de uma planta, e para sensibilizar uma planta para um herbicida inibidor de epsps
|
EP3099719B1
(fr)
|
2014-01-29 |
2020-04-01 |
Dana-Farber Cancer Institute, Inc. |
Anticorps contre le domaine extracellulaire de muc1-c (muc1-c/ecd)
|
WO2015114633A1
(fr)
|
2014-01-30 |
2015-08-06 |
Yissum Research And Development Company Of The Hebrew University Of Jerusalem Ltd. |
Peptides se liant à l'actine et compositions les contenant pour inhiber l'angiogenèse et traiter des affections médicales associées à celle-ci
|
CA2937992A1
(fr)
|
2014-02-03 |
2015-08-06 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Methode d'elimination de cellules souches
|
US10125365B2
(en)
|
2014-02-05 |
2018-11-13 |
Yeda Research And Development Co. Ltd. |
Micro-RNAs and compositions comprising same for the treatment and diagnosis of serotonin-, adrenalin-, noradrenalin-, glutamate-, and corticotropin-releasing hormone- associated medical conditions
|
US10066014B2
(en)
|
2014-02-06 |
2018-09-04 |
Yeda Research And Development Co. Ltd. |
Anti CD84 antibodies, compositions comprising same and uses thereof
|
WO2015120273A1
(fr)
|
2014-02-07 |
2015-08-13 |
The General Hospital Corporation |
Diagnostic différentiel de néoplasmes hépatiques
|
US20170101633A1
(en)
|
2014-02-10 |
2017-04-13 |
Protalix Ltd. |
Method of maintaining disease stability in a subject having gaucher's disease
|
US10564149B2
(en)
|
2014-02-11 |
2020-02-18 |
Brainstorm Cell Therapeutics Ltd. |
Populations of mesenchymal stem cells that secrete neurotrophic factors
|
WO2015123565A1
(fr)
|
2014-02-14 |
2015-08-20 |
The General Hospital Corporation |
Méthodes de diagnostic d'une maladie liée à l'igg4
|
US9540688B2
(en)
|
2014-02-19 |
2017-01-10 |
Personal Genomics, Inc. |
Real-time sequencing method for single molecule
|
US20150247205A1
(en)
|
2014-02-28 |
2015-09-03 |
The General Hospital Corporation |
Diagnosis of multiple myeloma and lymphoma
|
EP3114483A1
(fr)
|
2014-03-03 |
2017-01-11 |
Yissum Research and Development Company of the Hebrew University of Jerusalem Ltd. |
Procédé et dispositif de détection de pseudomonas aeruginosa
|
EP2923709A1
(fr)
|
2014-03-28 |
2015-09-30 |
Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. |
Vaccin contre la malaria multi-composants-multi-étapes
|
WO2015147370A1
(fr)
|
2014-03-28 |
2015-10-01 |
Seegene, Inc. |
Détection de séquences d'acide nucléique cible à l'aide de différentes températures de détection
|
US11091770B2
(en)
|
2014-04-01 |
2021-08-17 |
Monsanto Technology Llc |
Compositions and methods for controlling insect pests
|
WO2015155777A1
(fr)
|
2014-04-10 |
2015-10-15 |
Bonus Therapeutics Ltd. |
Compositions pour la réparation des os
|
CN106574296B
(zh)
|
2014-04-14 |
2021-03-02 |
耶路撒冷希伯来大学伊森姆研究发展公司 |
用于测定dna的组织或细胞来源的方法和试剂盒
|
ES2764504T3
(es)
|
2014-04-17 |
2020-06-03 |
Yeda Res & Dev |
Métodos y equipos para analizar restos de unión al ADN fijados al ADN
|
EA037613B1
(ru)
|
2014-04-27 |
2021-04-21 |
Фэймуэйв Лтд. |
Гуманизированные антитела против ceacam1
|
US11427647B2
(en)
|
2014-04-27 |
2022-08-30 |
Famewave Ltd. |
Polynucleotides encoding humanized antibodies against CEACAM1
|
ES2870658T3
(es)
|
2014-04-28 |
2021-10-27 |
Yeda Res & Dev |
Respuesta del microbioma a agentes
|
US20170071208A1
(en)
|
2014-05-04 |
2017-03-16 |
Forrest Innovations Ltd. |
Compositions for mosquito control and uses of same
|
EP3502698A1
(fr)
|
2014-05-05 |
2019-06-26 |
MicroBPlex, Inc. |
Milieux préparés avec des anticorps nouvellement synthétisés et leurs utilisations
|
KR20170007773A
(ko)
|
2014-05-07 |
2017-01-20 |
엔플렉스 피티와이 엘티디 |
합성 실 기초된 측방 유동 면역검정
|
EP3140653B1
(fr)
|
2014-05-08 |
2022-05-11 |
Novodiax, Inc. |
Analyse par immunohistochimie directe
|
SG11201609344VA
(en)
|
2014-05-09 |
2016-12-29 |
Biosearch Technologies Inc |
Cosmic quenchers
|
CN106796218B
(zh)
|
2014-05-15 |
2020-10-13 |
中尺度技术有限责任公司 |
改进的测定方法
|
WO2015179435A1
(fr)
|
2014-05-19 |
2015-11-26 |
Bayer Healthcare Llc |
Anticorps monoclonaux humanisés optimisés dirigés contre la protéine c activée et leurs utilisations
|
US10294482B2
(en)
|
2014-05-22 |
2019-05-21 |
Yeda Research And Development Co. Ltd. |
Recombinant microorganisms capable of carbon fixation
|
EP3149155B1
(fr)
|
2014-06-02 |
2020-09-23 |
Kadimastem Ltd. |
Procédés d'induction de la myélinisation et de maturation des oligodendrocytes
|
US20170253881A1
(en)
|
2014-06-02 |
2017-09-07 |
Technion Research & Development Foundation Limited |
Compositions and methods of selectively inhibiting irp1 and treating inflammation
|
EP2955517A1
(fr)
|
2014-06-10 |
2015-12-16 |
Siemens Healthcare Diagnostics Products GmbH |
Procédé de stabilisation d'échantillons de liquide corporel par administration de détergent
|
CN106795515B
(zh)
|
2014-06-23 |
2021-06-08 |
孟山都技术公司 |
用于经由rna干扰调控基因表达的组合物和方法
|
WO2015198320A1
(fr)
|
2014-06-24 |
2015-12-30 |
Insight Biopharmaceuticals Ltd. |
Procédés de purification d'anticorps
|
CA2953663A1
(fr)
|
2014-06-25 |
2015-12-30 |
Tel Hashomer Medical Research Infrastructure And Services Ltd. |
Identification de cellules souches cancereuses et utilisation de celles-ci pour des diagnostics et traitements
|
EP3161138A4
(fr)
|
2014-06-25 |
2017-12-06 |
Monsanto Technology LLC |
Procédés et compositions pour administrer des acides nucléiques à des cellules végétales et réguler l'expression génique
|
JP2017520549A
(ja)
|
2014-06-26 |
2017-07-27 |
ラモット アット テル アビブ ユニバーシティ, リミテッド |
核酸の送達のためのリポソーム製剤
|
CN106661114B
(zh)
|
2014-06-27 |
2019-01-29 |
西门子医疗保健诊断公司 |
维生素d测定法中对维生素d差向异构体特异性的结合配偶体
|
KR102309377B1
(ko)
|
2014-06-27 |
2021-10-05 |
지멘스 헬쓰케어 다이아그노스틱스 인크. |
비타민 d 에피머에 특이적인 결합 파트너
|
WO2016005985A2
(fr)
|
2014-07-09 |
2016-01-14 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Méthode pour reprogrammer des cellules
|
KR102569494B1
(ko)
|
2014-07-15 |
2023-08-21 |
이슘 리서치 디벨롭먼트 컴퍼니 오브 더 히브루 유니버시티 오브 예루살렘 엘티디. |
Cd44의 단리된 폴리펩타이드 및 이의 사용
|
WO2016013008A1
(fr)
|
2014-07-21 |
2016-01-28 |
Novellusdx Ltd. |
Procédés et systèmes pour déterminer un indice oncogénique de mutations spécifiques d'un patient
|
WO2016013007A1
(fr)
|
2014-07-21 |
2016-01-28 |
Novellusdx Ltd. |
Procédés de détermination d'une réponse à un médicament de mutations spécifiques à un patient
|
US10378012B2
(en)
|
2014-07-29 |
2019-08-13 |
Monsanto Technology Llc |
Compositions and methods for controlling insect pests
|
JP2017525351A
(ja)
|
2014-07-30 |
2017-09-07 |
イェダ リサーチ アンド ディベロップメント カンパニー リミテッドYeda Research And Development Co.Ltd. |
多能性幹細胞の培養用培地
|
AU2015296029B2
(en)
|
2014-08-01 |
2022-01-27 |
Dovetail Genomics, Llc |
Tagging nucleic acids for sequence assembly
|
WO2016024278A1
(fr)
|
2014-08-14 |
2016-02-18 |
Memed Diagnostics Ltd. |
Analyse computationnelle de données biologiques au moyen d'un collecteur et d'un hyperplan
|
WO2016030899A1
(fr)
|
2014-08-28 |
2016-03-03 |
Yeda Research And Development Co. Ltd. |
Méthodes de traitement de la sclérose latérale amyotrophique
|
WO2016038609A1
(fr)
|
2014-09-08 |
2016-03-17 |
Yeda Research And Development Co. Ltd. |
Anticorps anti-her3 et leurs utilisations
|
EP2992895A1
(fr)
|
2014-09-08 |
2016-03-09 |
Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. |
Vaccin contre la malaria multi-composants-multi-étapes
|
JP2017534574A
(ja)
|
2014-09-08 |
2017-11-24 |
イェダ リサーチ アンド ディベロップメント カンパニー リミテッドYeda Research And Development Co.Ltd. |
チロシンキナーゼ阻害薬(tki)に耐性のがんを処置するための組成物および方法
|
US20180010132A1
(en)
|
2014-09-11 |
2018-01-11 |
Novartis Ag |
Inhibition of prmt5 to treat mtap-deficiency-related diseases
|
IL234638A0
(en)
|
2014-09-14 |
2014-12-02 |
Yeda Res & Dev |
NMDA receptor antagonists for the treatment of Gaucher disease
|
ES2804826T3
(es)
|
2014-09-16 |
2021-02-09 |
Synermore Biologics Co Ltd |
Anticuerpo anti-EGFR y usos del mismo
|
CN106999608A
(zh)
|
2014-09-21 |
2017-08-01 |
耶路撒冷希伯来大学伊森姆研究发展公司 |
为了治疗脂质相关病症而下调mir‑132
|
RU2713653C2
(ru)
|
2014-10-06 |
2020-02-06 |
Кемосентрикс, Инк. |
КОМБИНИРОВАННАЯ ТЕРАПИЯ ИНГИБИТОРАМИ С-С ХЕМОКИНОВОГО РЕЦЕПТОРА 9 (CCR9) И АНТИТЕЛАМИ, БЛОКИРУЮЩИМИ α4β7-ИНТЕГРИН
|
US20170253921A1
(en)
|
2014-10-13 |
2017-09-07 |
Life Technologies Corporation |
Methods, kits & compositions for determining gene copy numbers
|
GB2555995B
(en)
|
2014-10-20 |
2019-06-26 |
Gen Probe Inc |
Red blood cell lysis solution
|
AU2015334890B2
(en)
|
2014-10-24 |
2021-12-23 |
Dupont Nutrition Biosciences Aps |
Proline tolerant tripeptidyl peptidases and uses thereof
|
EP3172329A1
(fr)
|
2014-10-24 |
2017-05-31 |
Danisco US Inc. |
Procédé de production d'alcool au moyen d'une tripeptidyl peptidase
|
CN107406825B
(zh)
|
2014-11-13 |
2022-04-08 |
恩祖迪克控股有限公司 |
甲壳纲十足目雌性动物的功能性别反转
|
WO2016079731A2
(fr)
|
2014-11-17 |
2016-05-26 |
Yeda Research And Development Co. Ltd. |
Procédé d'analyse de microbiome
|
WO2016079736A2
(fr)
|
2014-11-17 |
2016-05-26 |
Yeda Research And Development Co. Ltd. |
Procédés de traitement de maladies associées à une fonction mitochondriale
|
US11270782B2
(en)
|
2014-11-19 |
2022-03-08 |
Koninklijke Philips N.V. |
Diagnostic method employing HNL
|
WO2016079739A2
(fr)
|
2014-11-20 |
2016-05-26 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Compositions et procédés de production de polypeptides présentant un schéma de glycosylation modifié dans des cellules végétales
|
CN107208070B
(zh)
|
2014-11-26 |
2021-09-07 |
技术创新动力基金(以色列)有限合伙公司 |
细菌基因的靶向消除
|
WO2016084084A1
(fr)
|
2014-11-27 |
2016-06-02 |
Danziger Innovations Ltd. |
Construction d'acide nucléique pour l'édition de génome
|
EP3754027A1
(fr)
|
2014-12-01 |
2020-12-23 |
The Broad Institute, Inc. |
Procédé de détermination in situ de proximité d'acide nucléique
|
EP3227446A1
(fr)
|
2014-12-01 |
2017-10-11 |
Novartis AG |
Compositions et méthodes pour le diagnostic et le traitement du cancer de la prostate
|
SG10202012249YA
(en)
|
2014-12-08 |
2021-01-28 |
Berg Llc |
Use of markers including filamin a in the diagnosis and treatment of prostate cancer
|
WO2016092555A2
(fr)
|
2014-12-11 |
2016-06-16 |
Yeda Research And Development Co. Ltd. |
Polypeptides de phosphotriestérase isolés, polynucléotides codant pour ceux-ci et utilisations de ceux-ci dans le traitement ou la prévention des dommages associés à l'exposition aux organophosphates
|
EP3230468B1
(fr)
|
2014-12-12 |
2020-09-16 |
ELITechGroup, Inc. |
Procédés et kits pour la détection de bactéries résistantes aux antibiotiques
|
WO2016094162A1
(fr)
|
2014-12-12 |
2016-06-16 |
Elitechgroup B.V. |
Procédés et compositions pour la détection de bactéries résistant aux antibiotiques
|
EP3395351A1
(fr)
|
2014-12-23 |
2018-10-31 |
4D Pharma Research Limited |
Modulation immunitaire
|
WO2016103269A1
(fr)
|
2014-12-23 |
2016-06-30 |
Ramot At Tel-Aviv University Ltd. |
Populations de cellules progénitrices neuronales et leurs procédés de production et d'utilisation
|
JP6427278B2
(ja)
|
2014-12-23 |
2018-11-21 |
フォーディー ファーマ リサーチ リミテッド4D Pharma Research Limited |
pirinポリペプチド及び免疫モジュレーション
|
JP2018502575A
(ja)
|
2014-12-30 |
2018-02-01 |
セル キュア ニューロサイエンシズ リミテッド |
網膜色素上皮細胞集団の評価法
|
JP6882981B2
(ja)
|
2014-12-30 |
2021-06-02 |
セル キュア ニューロサイエンシズ リミテッド |
Rpe細胞集団およびそれを作製する方法
|
EP3240612B1
(fr)
|
2014-12-30 |
2020-12-23 |
Cell Cure Neurosciences Ltd. |
Procédés de traitement de maladies rétiniennes
|
RU2017125957A
(ru)
|
2015-01-04 |
2019-02-04 |
Проталикс Лтд. |
Модифицированная днказа и ее применения
|
WO2016116935A1
(fr)
|
2015-01-21 |
2016-07-28 |
Yeda Research And Development Co. Ltd. |
Utilisation de la rasa2 en tant que marqueur pronostique et thérapeutique pour un mélanome
|
CN108064288B
(zh)
|
2015-01-22 |
2021-11-26 |
孟山都技术公司 |
用于控制叶甲属的组合物和方法
|
EP3256490A1
(fr)
|
2015-02-09 |
2017-12-20 |
Research Development Foundation |
Polypeptides ayant un domaine fc d'immunoglobuline modifié manifestant une activation du complément améliorée
|
CN107533590B
(zh)
|
2015-02-17 |
2021-10-26 |
多弗泰尔基因组学有限责任公司 |
核酸序列装配
|
DK3262411T3
(da)
|
2015-02-25 |
2022-04-19 |
Univ Vanderbilt |
Antibody-mediated neutralization of marburg virus
|
WO2016135732A1
(fr)
|
2015-02-26 |
2016-09-01 |
Yeda Research And Development Co. Ltd. |
Procédé favorisant la pousse des cheveux
|
BR112017019062A2
(pt)
|
2015-03-09 |
2018-04-17 |
Agensys Inc |
conjugados de anticorpo-fármaco (adc) que se ligam a proteínas flt3
|
WO2016142948A1
(fr)
|
2015-03-11 |
2016-09-15 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Oligonucléotides leurres pour le traitement de maladies
|
CN107614700A
(zh)
|
2015-03-11 |
2018-01-19 |
布罗德研究所有限公司 |
基因型和表型偶联
|
IL237852A0
(en)
|
2015-03-19 |
2016-03-24 |
Yeda Res & Dev |
Antibodies against amphigoline, medical preparations containing them and their use
|
US10028659B2
(en)
|
2015-03-26 |
2018-07-24 |
Verily Life Sciences Llc |
Aptamer-based sensors, implantable devices and detection system
|
US11807896B2
(en)
|
2015-03-26 |
2023-11-07 |
Dovetail Genomics, Llc |
Physical linkage preservation in DNA storage
|
EP4218771A1
(fr)
|
2015-03-27 |
2023-08-02 |
Yeda Research and Development Co. Ltd |
Méthodes de traitement des maladies des motoneureones
|
AU2016243124A1
(en)
|
2015-03-27 |
2017-11-02 |
University Of Southern California |
CAR T-cell therapy directed to LHR for the treatment of solid tumors
|
US9612534B2
(en)
|
2015-03-31 |
2017-04-04 |
Tokyo Electron Limited |
Exposure dose homogenization through rotation, translation, and variable processing conditions
|
CA2979309A1
(fr)
|
2015-03-31 |
2016-10-06 |
Yeda Research And Development Co. Ltd. |
Glutamate oxaloacetate transaminase 1 (got1), preparations, procedes de generation des preparations et utilisations des preparations
|
EP3277260B1
(fr)
|
2015-04-01 |
2021-05-12 |
The State of Israel, Ministry of Agriculture & Rural Development, Agricultural Research Organization (ARO) (Volcani Center) |
Extraits végétaux de crassifolium erodium l'her et leurs utilisations
|
HUE057044T2
(hu)
|
2015-04-07 |
2022-04-28 |
Ela Pharma Ltd |
Sejt- vagy szövetnekrózis kezelésére és/vagy megelõzésére szolgáló, katepszin C-t és/vagy CELA1-et és/vagy CELA3A-t és/vagy szerkezetileg rokon enzimeket specifikusan targetáló készítmények
|
US11965216B2
(en)
|
2015-04-07 |
2024-04-23 |
Polyskope Labs |
Detection of one or more pathogens
|
EP3081575A1
(fr)
|
2015-04-12 |
2016-10-19 |
Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. |
Anticorps anti-plasmodium pour parasite
|
SG11201708480YA
(en)
|
2015-04-15 |
2017-12-28 |
Biosearch Tech Inc |
Dual quencher probes
|
AU2016255725B2
(en)
|
2015-04-27 |
2021-09-23 |
The Medical Research, Infrastructure and Health Services Fund of the Tel Aviv Medical Center |
EGR1 targeting molecules for the treatment of inflammatory and hyperproliferative conditions
|
EP3288386B1
(fr)
|
2015-04-29 |
2022-01-19 |
The State of Israel, Ministry of Agriculture & Rural Development, Agricultural Research Organization (ARO) (Volcani Center) |
Compositions anti-phytopathogènes
|
WO2016174652A1
(fr)
|
2015-04-30 |
2016-11-03 |
Technion Research & Development Foundation Limited |
Récepteurs antigéniques chimériques et méthodes d'utilisation correspondantes
|
WO2016178207A1
(fr)
|
2015-05-04 |
2016-11-10 |
Ramot At Tel-Aviv University Ltd. |
Procédés et kits pour fragmenter l'adn
|
WO2016182984A1
(fr)
|
2015-05-08 |
2016-11-17 |
Centrillion Technology Holdings Corporation |
Terminateurs réversibles à liaison disulfure
|
WO2016181393A1
(fr)
|
2015-05-11 |
2016-11-17 |
Yeda Research And Development Co. Ltd. |
Inhibiteurs de citrine pour le traitement du cancer
|
US11219636B2
(en)
|
2015-05-17 |
2022-01-11 |
The Medical Research, Infrastructure and Health Services Fund of the Tel Aviv Medical Center |
Compositions and methods for treating cancer
|
CN107636167B
(zh)
|
2015-05-18 |
2022-09-02 |
传奇诊断股份公司 |
靶核酸和变异体的检测
|
WO2016185457A1
(fr)
|
2015-05-19 |
2016-11-24 |
Yeda Research And Development Co. Ltd. |
Méthodes pour favoriser la lymphagiogenèse
|
US10849985B2
(en)
|
2015-05-20 |
2020-12-01 |
Yeda Research And Development Co. Ltd. |
Method of targeting senescent cells
|
CA2986203A1
(fr)
|
2015-05-21 |
2016-11-24 |
Yeda Research And Development Co. Ltd. |
Populations bacteriennes pour favoriser la sante
|
EP3302571B1
(fr)
|
2015-05-29 |
2020-11-18 |
OPKO Biologics Ltd. |
Variantes de l'oxyntomoduline pégylée
|
EP3302053B1
(fr)
|
2015-06-02 |
2021-03-17 |
Monsanto Technology LLC |
Compositions et procédés pour l'administration d'un polynucléotide dans une plante
|
WO2016196782A1
(fr)
|
2015-06-03 |
2016-12-08 |
Monsanto Technology Llc |
Procédés et compositions pour l'introduction d'acides nucléiques dans des plantes
|
EP3302559B1
(fr)
|
2015-06-04 |
2022-01-12 |
University of Southern California |
Immunothérapie des cellules car ciblées par lym-1 et lym-2
|
NL2014935B1
(en)
|
2015-06-08 |
2017-02-03 |
Applied Immune Tech Ltd |
T cell receptor like antibodies having fine specificity.
|
MA41060B1
(fr)
|
2015-06-15 |
2019-11-29 |
4D Pharma Res Ltd |
Compositions comprenant des souches bactériennes
|
BR112017025005A2
(pt)
|
2015-06-15 |
2018-08-07 |
4D Pharma Research Limited |
composições compreendendo cepas baterianas
|
MA41010B1
(fr)
|
2015-06-15 |
2020-01-31 |
4D Pharma Res Ltd |
Compositions comprenant des souches bactériennes
|
PT3650033T
(pt)
|
2015-06-15 |
2022-05-25 |
4D Pharma Res Ltd |
Composições compreendendo estirpes bacterianas
|
CN107847529B
(zh)
|
2015-06-15 |
2022-05-03 |
4D制药研究有限公司 |
包含细菌菌株的组合物
|
EP4026563A1
(fr)
|
2015-06-18 |
2022-07-13 |
Yeda Research and Development Co. Ltd |
Protocoles de conditionnement et utilisation de ceux-ci pour la régénération de tissu
|
WO2016203476A1
(fr)
|
2015-06-18 |
2016-12-22 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Procédés et compositions pour le diagnostic et le traitement d'un cancer urothélial
|
CN113289009A
(zh)
|
2015-06-19 |
2021-08-24 |
Opko生物科学有限公司 |
长效凝固因子及其产生方法
|
MX2017016501A
(es)
|
2015-06-26 |
2018-03-12 |
Dupont Nutrition Biosci Aps |
Aminopeptidasas para hidrolizados de proteinas.
|
AU2016291558A1
(en)
|
2015-07-10 |
2018-02-08 |
West Virginia University |
Markers of stroke and stroke severity
|
AU2016291817A1
(en)
|
2015-07-16 |
2018-02-22 |
Biolinerx Ltd. |
Compositions and methods for treating cancer
|
CN114457039A
(zh)
|
2015-07-16 |
2022-05-10 |
耶达研究及发展有限公司 |
基因修饰的抗第三方中央型记忆t细胞及其在免疫疗法中的用途
|
WO2017013648A1
(fr)
|
2015-07-19 |
2017-01-26 |
Yeda Research And Development Co. Ltd. |
Inhibiteurs sélectifs des isoformes contenant alpha2 de la na,k-atpase et leur utilisation pour réduire la pression intraoculaire
|
WO2017015334A1
(fr)
|
2015-07-21 |
2017-01-26 |
Saint Louis University |
Compositions et méthodes pour diagnostiquer et traiter l'infertilité associée à l'endométriose
|
MX2018000844A
(es)
|
2015-07-22 |
2018-07-06 |
Phytopharma Int Ltd |
Composiciones ingeribles por abejas, procedimientos para el uso de las mismas para producir miel y miel producida de esta manera.
|
WO2017017686A1
(fr)
|
2015-07-29 |
2017-02-02 |
Hadasit Medical Research Services And Development Ltd. |
Production à grande échelle de cellules de l'épithélium pigmentaire rétinien
|
ES2965461T3
(es)
|
2015-08-03 |
2024-04-15 |
Biokine Therapeutics Ltd |
Inhibidor de CXCR4 para el tratamiento del cáncer
|
EP3332009A1
(fr)
|
2015-08-04 |
2018-06-13 |
Yeda Research and Development Co., Ltd. |
Procédés de criblage pour riborégulateurs et atténuateurs
|
CA2994416A1
(fr)
|
2015-08-04 |
2017-02-09 |
Cd Diagnostics, Inc. |
Procedes de detection d'une necrose liee a une reaction locale indesirable sur les tissus (altr)
|
EP4155391A1
(fr)
|
2015-08-05 |
2023-03-29 |
Cell Cure Neurosciences Ltd. |
Préparation de cellules de l'épithélium pigmentaire rétinien
|
EP3331995A1
(fr)
|
2015-08-05 |
2018-06-13 |
Cell Cure Neurosciences Ltd. |
Préparation de photorécepteurs pour le traitement de maladies rétiniennes
|
EP3331549B1
(fr)
|
2015-08-06 |
2020-12-23 |
President and Fellows of Harvard College |
Molécules améliorées aptes à se lier à des microbes, et leurs utilisations
|
EP3334449B1
(fr)
|
2015-08-10 |
2021-09-29 |
The Medical Research, Infrastructure, And Health Services Fund Of The Tel Aviv Medical Center |
Méthodes et compositions pharmaceutiques permettant d'améliorer la cicatrisation des plaies par cd24
|
EP3334831A1
(fr)
|
2015-08-13 |
2018-06-20 |
Forrest Innovations Ltd. |
Formulations et compositions d'administration d'acides nucléiques à des cellules végétales
|
AU2016308339A1
(en)
|
2015-08-18 |
2018-04-12 |
Baylor College Of Medicine |
Methods and compositions for altering function and structure of chromatin loops and/or domains
|
WO2017033188A1
(fr)
|
2015-08-24 |
2017-03-02 |
Yeda Research And Development Co. Ltd. |
Huile et biocarburant d'origine algale et leurs procédés de production
|
WO2017033152A1
(fr)
|
2015-08-25 |
2017-03-02 |
Prothena Biosciences Limited |
Procédés de détection d'alpha-synucléine phosphorylée
|
US10526408B2
(en)
|
2015-08-28 |
2020-01-07 |
Research Development Foundation |
Engineered antibody FC variants
|
CA3035810A1
(fr)
|
2015-09-02 |
2017-03-09 |
University Of Massachusetts |
Detection de loci de genes comprenant des repetitions matricielles de crispr et/ou des acides ribonucleiques mono-guides polychromatiques
|
US10765706B2
(en)
|
2015-09-03 |
2020-09-08 |
University Of South Florida |
Method of stem cell delivery into the brain during chronic disease using blood brain barrier permeabilizers
|
CA3036409C
(fr)
|
2015-09-08 |
2023-07-11 |
Erik J. Sontheimer |
Activite dnase h de la proteine cas9 de neisseria meningitidis
|
WO2017042816A1
(fr)
|
2015-09-10 |
2017-03-16 |
Yeda Research And Development Co. Ltd. |
Ablation de cellules dendritiques dont le test est positif pour la perforine, dans le traitement du cancer
|
EP3353547A1
(fr)
|
2015-09-22 |
2018-08-01 |
Delta TM Technologies |
Conception de systèmes tampons personnalisés spécifiques à une protéine
|
US11384399B2
(en)
|
2015-09-29 |
2022-07-12 |
Htg Molecular Diagnostics, Inc. |
Methods for subtyping diffuse large B-cell lymphoma (DLBCL)
|
US20190062394A1
(en)
|
2015-10-10 |
2019-02-28 |
Intrexon Corporation |
Improved Therapeutic Control of Proteolytically Sensitive, Destabilized Forms of Interleukin-12
|
CN108368543B
(zh)
|
2015-10-12 |
2023-06-13 |
领先细胞医疗诊断有限公司 |
高噪声样品中原位检测核苷酸变体及相关的组合物和方法
|
CN108368542B
(zh)
|
2015-10-19 |
2022-04-08 |
多弗泰尔基因组学有限责任公司 |
用于基因组组装、单元型定相以及独立于靶标的核酸检测的方法
|
WO2017072757A1
(fr)
|
2015-10-25 |
2017-05-04 |
Yeda Research And Development Co. Ltd. |
Anticorps ciblant la quiescine sulfhydryle oxydase (qsox1) et leurs utilisations
|
AU2016347652A1
(en)
|
2015-10-26 |
2018-05-24 |
Cell Cure Neurosciences Ltd. |
Preparation of retinal pigment epithelium cells
|
CA3187317A1
(fr)
|
2015-10-27 |
2017-05-04 |
Jay Pharma, Inc. |
Compositions comprenant du cannabidiol et un des seconds agents therapeutiques pour le traitement du cancer
|
IL242380A0
(en)
|
2015-10-29 |
2016-02-01 |
Yeda Res & Dev |
A method for inducing the division of cardiomyocytes and treating heart diseases
|
WO2017077539A1
(fr)
|
2015-11-03 |
2017-05-11 |
Ariel-University Research And Development Company Ltd. |
Compositions destinées à la régénération et à la réparation de tissu nerveux
|
FI3373968T3
(fi)
|
2015-11-09 |
2024-07-17 |
Childrens Hospital Philadelphia |
Glypikaani 2 syövän merkkiaineena ja terapeuttisena kohteena
|
EP3374524A4
(fr)
|
2015-11-11 |
2019-06-26 |
Ramot at Tel-Aviv University Ltd. |
Procédés de détection de la 5-hydroxyméthylcytosine et diagnostic du cancer
|
MA41013A
(fr)
|
2015-11-20 |
2017-08-30 |
4D Pharma Res Ltd |
Compositions comprenant des souches bactériennes
|
GB201520497D0
(en)
|
2015-11-20 |
2016-01-06 |
4D Pharma Res Ltd |
Compositions comprising bacterial strains
|
GB201520638D0
(en)
|
2015-11-23 |
2016-01-06 |
4D Pharma Res Ltd |
Compositions comprising bacterial strains
|
GB201520631D0
(en)
|
2015-11-23 |
2016-01-06 |
4D Pharma Res Ltd |
Compositions comprising bacterial strains
|
WO2017094001A1
(fr)
|
2015-11-30 |
2017-06-08 |
Kadimastem Ltd |
Procédés de différenciation et de purification de cellules endocrines pancréatiques
|
MX2018006613A
(es)
|
2015-12-02 |
2019-01-30 |
Stcube & Co Inc |
Anticuerpos y moleculas que se unen inmunoespecificamente a btn1a1 y los usos terapeuticos de los mismos.
|
JP7227007B2
(ja)
|
2015-12-02 |
2023-02-21 |
ストサイエンシス, インコーポレイテッド |
グリコシル化btla(b-及びt-リンパ球減弱因子)に特異的な抗体
|
EP3176183A1
(fr)
|
2015-12-02 |
2017-06-07 |
Yeda Research and Development Co. Ltd |
Compositions et procédés pour traiter un cancer non résistant à un inhibiteur de la tyrosine kinase (tki)
|
EP3383418B1
(fr)
|
2015-12-04 |
2021-10-20 |
Board of Regents, The University of Texas System |
Peptides slc45a2 pour l'immunothérapie
|
ES2924732T3
(es)
|
2015-12-16 |
2022-10-10 |
Univ Ramot |
Partículas que comprenden epiplón descelularizado
|
JOP20200228A1
(ar)
|
2015-12-21 |
2017-06-16 |
Novartis Ag |
تركيبات وطرق لخفض تعبير البروتين tau
|
EP3393524B1
(fr)
|
2015-12-22 |
2022-04-06 |
The Regents of The University of Colorado, A Body Corporate |
Protection d'arn de la dégradation à l'aide d'arn viraux modifiés
|
IL260331B1
(en)
|
2015-12-28 |
2024-06-01 |
B G Negev Technologies And Applications Ltd At Ben Gurion Univ |
Compounds and methods for the treatment of amyotrophic lateral sclerosis
|
EP3400068A1
(fr)
|
2016-01-06 |
2018-11-14 |
Yeda Research and Development Co., Ltd. |
Compositions et méthodes pour le traitement d'affections malignes, autoimmunes et inflammatoires
|
WO2017122203A1
(fr)
|
2016-01-11 |
2017-07-20 |
Technion Research & Development Foundation Limited |
Méthodes de détermination du pronostic de septicémie et traitement associé
|
WO2017125931A1
(fr)
|
2016-01-21 |
2017-07-27 |
The State Of Israel, Ministry Of Agriculture & Rural Development, Agricultural Research Organization (Aro) (Volcani Center) |
Plantes parthénocarpiques et procédés de production de celles-ci
|
IL243839B
(en)
|
2016-01-28 |
2018-01-31 |
Sp Nano Ltd |
Conductive wires
|
IL243838A
(en)
|
2016-01-28 |
2017-07-31 |
Sp Nano Ltd |
The composition containing sp1 protein and carbon nanoparticles and its uses
|
WO2017130205A1
(fr)
|
2016-01-31 |
2017-08-03 |
Hadasit Medical Research Services And Development Ltd. |
Populations de cellules souches pluripotentes ayant une composition de chromosomes sexuels non identiques et leurs utilisations
|
WO2017134671A1
(fr)
|
2016-02-04 |
2017-08-10 |
Yeda Research And Development Co. Ltd. |
Peptides et leur utilisation dans le traitement de maladies, troubles ou affections associés à un p53 mutant
|
CN109196113B
(zh)
|
2016-02-11 |
2022-10-04 |
奇根科学有限责任公司 |
合成测序中的多酚添加剂
|
US10036011B2
(en)
|
2016-02-11 |
2018-07-31 |
Qiagen Waltham, Inc. |
Scavenger compounds for improved sequencing-by-synthesis
|
WO2017138008A2
(fr)
|
2016-02-14 |
2017-08-17 |
Yeda Research And Development Co. Ltd. |
Procédés de modulation de l'exocytose de protéines et utilisations associées en thérapie
|
ES2771223T3
(es)
|
2016-02-14 |
2020-07-06 |
Yeda Res & Dev |
Diagnóstico, predicción y tratamiento de la obesidad recidivante basados en el microbioma
|
MX2018009984A
(es)
|
2016-02-16 |
2019-01-21 |
Yissum Res Dev Co Of Hebrew Univ Jerusalem Ltd |
Análogos no proteínicos de fenilananina para la inhibicion del crecimiento de cianobacterias y plantas.
|
US20200200735A9
(en)
|
2016-02-22 |
2020-06-25 |
Ursure, Inc. |
System and method for detecting therapeutic agents to monitor adherence to a treatment regimen
|
JP2019511919A
(ja)
|
2016-02-23 |
2019-05-09 |
ブローディ,チャヤ |
がん幹細胞の作製およびその使用
|
US10975417B2
(en)
|
2016-02-23 |
2021-04-13 |
Dovetail Genomics, Llc |
Generation of phased read-sets for genome assembly and haplotype phasing
|
MX2018009216A
(es)
|
2016-02-25 |
2018-11-09 |
Dupont Nutrition Biosci Aps |
Metodo para producir un hidrolizado de proteina empleando una tripeptidil peptidasa de aspergillus fumigatus.
|
AU2017224122B2
(en)
|
2016-02-26 |
2024-04-11 |
The Board Of Regents Of The University Of Texas System |
Connexin (Cx) 43 hemichannel-binding antibodies and uses thereof
|
IL296874A
(en)
|
2016-03-01 |
2022-11-01 |
Yissum Res Dev Co Of Hebrew Univ Jerusalem Ltd |
Antibodies specific for the human poliovirus receptor
|
WO2017149547A1
(fr)
|
2016-03-03 |
2017-09-08 |
Memed Diagnostics Ltd. |
Analyse d'arn pour diagnostiquer un type d'infection
|
EA035949B1
(ru)
|
2016-03-04 |
2020-09-04 |
4Д ФАРМА ПиЭлСи |
Применение композиции, содержащей бактериальный штамм вида blautia hydrogenotrophica, и способ лечения или предотвращения висцеральной гиперчувствительности
|
GB201612191D0
(en)
|
2016-07-13 |
2016-08-24 |
4D Pharma Plc |
Compositions comprising bacterial strains
|
US20190216891A1
(en)
|
2016-03-06 |
2019-07-18 |
Yeda Research And Development Co., Ltd. |
Method for modulating myelination
|
IL244649A0
(en)
|
2016-03-17 |
2016-06-30 |
Yeda Res & Dev |
Methods for the isolation of barrel-like proteases and the identification of peptides that are cleaved by Alidan
|
EP3433262A4
(fr)
|
2016-03-25 |
2019-11-20 |
Muralidhar Reddy Moola |
Synthèse combinatoire et développement de biomarqueurs
|
CN109195991B
(zh)
|
2016-03-29 |
2023-10-31 |
斯特库比股份有限公司 |
对糖基化pd-l1特异的双重功能抗体及其使用方法
|
CN109195990A
(zh)
|
2016-03-30 |
2019-01-11 |
Musc研究发展基金会 |
通过靶向糖蛋白a重复优势蛋白(garp)治疗和诊断癌症以及单独或联合提供有效免疫疗法的方法
|
US10421785B2
(en)
|
2016-04-11 |
2019-09-24 |
Bar-Ilan University |
Delta receptor agonist peptides and use thereof
|
DE202017007130U1
(de)
|
2016-04-27 |
2019-08-29 |
Gen-Probe Inc. |
Lysereagenz für Blutzellen
|
WO2017194589A1
(fr)
|
2016-05-10 |
2017-11-16 |
Vib Vzw |
Inhibition du dysfonctionnement synaptique précoce à médiation par tau
|
SG11201810088SA
(en)
|
2016-05-13 |
2018-12-28 |
Dovetail Genomics Llc |
Recovering long-range linkage information from preserved samples
|
AU2017268248A1
(en)
|
2016-05-16 |
2018-12-13 |
President And Fellows Of Harvard College |
Aqueous biomolecule coupling on CO2-plasma-activated surfaces
|
ES2886627T3
(es)
|
2016-05-22 |
2021-12-20 |
Yeda Res & Dev |
Métodos de uso de células pulmonares para trasplante e inducción de tolerancia
|
IL245861A0
(en)
|
2016-05-25 |
2016-09-04 |
Yeda Res & Dev |
Use of substances to treat drug-resistant tumors
|
US20190100732A1
(en)
|
2016-06-02 |
2019-04-04 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Assay for the removal of methyl-cytosine residues from dna
|
EP3464322B1
(fr)
|
2016-06-05 |
2023-04-05 |
Tel HaShomer Medical Research Infrastructure and Services Ltd. |
Nouvelles molécules destinées au traitement de l'inflammation
|
WO2017214068A1
(fr)
|
2016-06-05 |
2017-12-14 |
Berg Llc |
Systèmes et procédés de stratification de patient et identification de biomarqueurs potentiels
|
US20190160152A1
(en)
|
2016-06-09 |
2019-05-30 |
Opko Biologics Ltd. |
Long-acting oxyntomodulin formulation and methods of producing and administering same
|
EP3472342A1
(fr)
|
2016-06-19 |
2019-04-24 |
Yissum Research Development Company of the Hebrew University of Jerusalem Ltd. |
Criblage de la résistance à la chimiothérapie dans des cellules haploïdes humaines
|
JP7334043B2
(ja)
|
2016-06-27 |
2023-08-28 |
イェダ リサーチ アンド ディベロップメント カンパニー リミテッド |
メモリーt細胞から作られるベト細胞
|
CN109416357B
(zh)
|
2016-06-30 |
2022-07-15 |
西门子医疗系统荷兰有限公司 |
用于检测包含多个细胞的体液样本中的分析物的设备、系统和方法
|
EA201892809A1
(ru)
|
2016-07-01 |
2019-06-28 |
Карлсберг А/С |
Способ скрининга мутанта в популяции организмов с применением подхода объединения в пулы и разделения
|
EP4184167A1
(fr)
|
2016-07-10 |
2023-05-24 |
MeMed Diagnostics Ltd. |
Diagnostic précoce d'infections
|
CN109661578B
(zh)
|
2016-07-10 |
2022-05-10 |
米密德诊断学有限公司 |
用于区分细菌和病毒感染的蛋白质特征
|
IL246722A0
(en)
|
2016-07-11 |
2016-09-29 |
Yeda Res & Dev |
Combined treatment to increase endogenous synthesis of nitric oxide
|
CN118085104A
(zh)
|
2016-07-11 |
2024-05-28 |
Opko生物科学有限公司 |
长效凝血因子及其制备方法
|
CN109689893A
(zh)
|
2016-07-11 |
2019-04-26 |
博纳斯治疗公司 |
用于组织再生的细胞组合物
|
IL291373B2
(en)
|
2016-07-11 |
2023-10-01 |
Yissum Res Dev Co Of Hebrew Univ Jerusalem Ltd |
Methods and systems for growing cells in culture
|
TW201821093A
(zh)
|
2016-07-13 |
2018-06-16 |
英商4D製藥有限公司 |
包含細菌菌株之組合物
|
EP4434516A2
(fr)
|
2016-07-18 |
2024-09-25 |
Ramot at Tel-Aviv University Ltd. |
Plate-forme modulaire pour agents thérapeutiques ciblés
|
WO2018017673A1
(fr)
|
2016-07-20 |
2018-01-25 |
Stcube, Inc. |
Méthodes de traitement et de thérapie du cancer utilisant une combinaison d'anticorps qui se lient à pd-l1 glycosylé
|
AU2017300579B2
(en)
|
2016-07-20 |
2023-02-09 |
Katholieke Universiteit Leuven, K.U.Leuven R&D |
Therapeutic agents for neurological and psychiatric disorders
|
WO2018020489A1
(fr)
|
2016-07-24 |
2018-02-01 |
Yeda Research And Development Co. Ltd. |
Méthodes et kits pour analyser des fragments de liaison à l'adn liés à l'adn
|
US10982252B2
(en)
|
2016-08-08 |
2021-04-20 |
Technology Innovation Momentum Fund (Israel) Limited Partnership |
Bacterial systems for analyzing ubiquitylated polypeptides
|
EP3497239A4
(fr)
|
2016-08-10 |
2020-02-26 |
Ramot at Tel-Aviv University Ltd. |
Analyse de l'état de méthylation et du nombre de copies
|
EP4033248B1
(fr)
|
2016-08-10 |
2024-04-10 |
MeMed Diagnostics Ltd. |
Système et procédé d'analyse de mx1 et crp dans le sang
|
IL264825B
(en)
|
2016-08-14 |
2022-08-01 |
Univ Ramot |
Exosomes from mesenchymal cells for the treatment of neurological diseases
|
IL247368A0
(en)
|
2016-08-18 |
2016-11-30 |
Yeda Res & Dev |
Diagnostic and therapeutic uses of exosomes
|
WO2018037416A1
(fr)
|
2016-08-25 |
2018-03-01 |
Yeda Research And Development Co. Ltd. |
Procédés et compositions pour le traitement de maladies auto-immunes
|
EP3510047A1
(fr)
|
2016-09-07 |
2019-07-17 |
Yissum Research and Development Company of the Hebrew University of Jerusalem Ltd. |
Anticorps anti-nkp46 et leur utilisation thérapeutique
|
US11485971B2
(en)
|
2016-09-14 |
2022-11-01 |
Yeda Research And Development Co. Ltd. |
CRISP-seq, an integrated method for massively parallel single cell RNA-seq and CRISPR pooled screens
|
WO2018060998A1
(fr)
|
2016-09-29 |
2018-04-05 |
Memed Diagnostics Ltd. |
Méthodes de pronostic et de traitement
|
IL248468A0
(en)
|
2016-10-13 |
2017-01-31 |
Technion Res & Dev Foundation |
Use of caspase-3 inhibitors and caspase-3 activators in the preparation of medical preparations for cancer treatment and wound healing
|
IL248385A0
(en)
|
2016-10-18 |
2017-02-01 |
Yeda Res & Dev |
Treatment of circadian rhythm disorder
|
WO2018085679A1
(fr)
|
2016-11-04 |
2018-05-11 |
Stave James W |
Détection directe de micro-organismes dans des échantillons de patient par dosage immunologique
|
EP3538093B1
(fr)
|
2016-11-09 |
2023-10-25 |
Qiagen Sciences, LLC |
Mélanges photoprotecteurs utilisés comme réactifs d'imagerie dans le séquençage par synthèse
|
US20190359956A1
(en)
|
2016-11-10 |
2019-11-28 |
Yeda Research And Development Co. Ltd. |
Phosphotriesterases for treating or preventing organophosphate exposure associated damage
|
MX2021014356A
(es)
|
2016-11-23 |
2022-11-24 |
Chemocentryx Inc |
Metodo para tratar glomeruloesclerosis segmentaria focal.
|
US11542508B2
(en)
|
2016-11-28 |
2023-01-03 |
Yeda Research And Development Co. Ltd. |
Isolated polynucleotides and polypeptides and methods of using same for expressing an expression product of interest
|
CN110199031A
(zh)
|
2016-11-29 |
2019-09-03 |
基因组影像公司 |
设计用于分析感兴趣的遗传区域中的特定事件的一组多核苷酸序列的方法
|
EP3548015A1
(fr)
|
2016-11-30 |
2019-10-09 |
Yeda Research and Development Co. Ltd. |
Méthodes de traitement de maladies et de la toxicité hépathique
|
EP3548106B1
(fr)
|
2016-12-01 |
2023-01-04 |
Ramot at Tel-Aviv University Ltd. |
Traitement combiné pour lésions nerveuses
|
GB201621123D0
(en)
|
2016-12-12 |
2017-01-25 |
4D Pharma Plc |
Compositions comprising bacterial strains
|
WO2018129214A1
(fr)
|
2017-01-04 |
2018-07-12 |
Complete Genomics, Inc. |
Séquençage par étapes par des terminateurs réversibles non marqués ou des nucléotides naturels
|
EP3571295A1
(fr)
|
2017-01-18 |
2019-11-27 |
Yeda Research and Development Co. Ltd |
Cellules veto génétiquement modifiées et leur utilisation en immunothérapie
|
RU2665631C2
(ru)
|
2017-01-25 |
2018-09-03 |
Общество с ограниченной ответственностью "Секвойя Дженетикс" |
Способ специфической идентификации последовательностей днк
|
CA3051512A1
(fr)
|
2017-01-26 |
2018-08-02 |
Zlip Holding Limited |
Unite de liaison a l'antigene cd47 et ses utilisations
|
US20190390278A1
(en)
|
2017-01-26 |
2019-12-26 |
Oklahoma Medical Research Foundation |
Biomarkers for systemic lupus erythematosus disease activity, and intensity and flare
|
AU2018214946A1
(en)
|
2017-01-31 |
2019-08-08 |
Vanderbilt University |
Generation of human allergen-and helminth-specific IgE monoclonal antibodies for diagnostic and therapeutic use
|
IL250479A0
(en)
|
2017-02-06 |
2017-03-30 |
Sorek Rotem |
Genetically engineered cells expressing a disarm system that confers resistance to phages and methods for their production
|
IL250916A0
(en)
|
2017-03-02 |
2017-06-29 |
Geiger Benjamin |
Methods for growing t cells in culture and their use
|
EP3592868B1
(fr)
|
2017-03-06 |
2022-11-23 |
Novartis AG |
Méthodes de traitement du cancer à expression d'ubb réduite
|
WO2018167780A1
(fr)
|
2017-03-12 |
2018-09-20 |
Yeda Research And Development Co. Ltd. |
Méthodes de diagnostic et de traitement du cancer
|
EP3596469A1
(fr)
|
2017-03-12 |
2020-01-22 |
Yeda Research and Development Co., Ltd. |
Procédés de diagnostic et de pronostic du cancer
|
IL269363B2
(en)
|
2017-03-16 |
2024-02-01 |
Lineage Cell Therapeutics Inc |
Methods for measuring medical effects of treating retinal diseases
|
FI3607050T3
(fi)
|
2017-04-05 |
2023-11-20 |
Yeda Res & Dev |
Ex vivo viljelyjärjestelmä ja menetelmiä sen käyttämiseksi
|
CN108823287B
(zh)
|
2017-04-28 |
2019-04-12 |
厦门大学 |
一种检测靶核酸序列的方法
|
IL252151A0
(en)
|
2017-05-07 |
2017-07-31 |
Fainzilber Michael |
Treatment of stress disorders
|
US12091445B2
(en)
|
2017-05-10 |
2024-09-17 |
Ariel Scientific Innovations Ltd. |
Methods of purifying antibodies
|
ES2939298T3
(es)
|
2017-05-21 |
2023-04-20 |
Medical Res Infrastructure & Health Services Fund Tel Aviv Medical Ct |
Combinación de marcadores para el diagnóstico del cáncer
|
MA48939B1
(fr)
|
2017-05-22 |
2021-06-30 |
4D Pharma Res Ltd |
Compositions comprenant des souches bactériennes
|
WO2018216011A1
(fr)
|
2017-05-23 |
2018-11-29 |
Technion Research & Development Foundation Limited |
Agents inhibant la dimérisation de gads et leurs procédés d'utilisation
|
WO2018215782A1
(fr)
|
2017-05-24 |
2018-11-29 |
4D Pharma Research Limited |
Compositions comprenant des souches bactériennes
|
WO2018222689A1
(fr)
|
2017-05-31 |
2018-12-06 |
Stcube & Co., Inc. |
Anticorps et molécules se liant de manière immunospécifique à btn1a1 et leurs utilisations thérapeutiques
|
WO2018220582A1
(fr)
|
2017-05-31 |
2018-12-06 |
Tropic Biosciences UK Limited |
Méthodes de sélection de cellules comprenant des événements d'édition de génome
|
GB201708665D0
(en)
|
2017-05-31 |
2017-07-12 |
Tropic Biosciences Uk Ltd |
Compositions and methods for increasing extractability of solids from coffee beans
|
GB201708662D0
(en)
|
2017-05-31 |
2017-07-12 |
Tropic Biosciences Uk Ltd |
Compositions and methods for increasing shelf-life of banana
|
JP2020522512A
(ja)
|
2017-05-31 |
2020-07-30 |
ストキューブ アンド シーオー., インコーポレイテッド |
Btn1a1に免疫特異的に結合する抗体及び分子を用いて癌を治療する方法
|
US11542331B2
(en)
|
2017-06-06 |
2023-01-03 |
Stcube & Co., Inc. |
Methods of treating cancer using antibodies and molecules that bind to BTN1A1 or BTN1A1-ligands
|
ES2826394T3
(es)
|
2017-06-09 |
2021-05-18 |
Siemens Healthcare Diagnostics Products Gmbh |
Ensayo de activación para el diagnóstico de una trombocitopenia inducida por heparina
|
WO2018229764A1
(fr)
|
2017-06-13 |
2018-12-20 |
Yeda Research And Development Co. Ltd. |
Traitement de la sclérose en plaques avancée ou progressive
|
HUE053488T2
(hu)
|
2017-06-14 |
2021-06-28 |
4D Pharma Res Ltd |
Baktériumtörzseket tartalmazó készítmények
|
LT3638271T
(lt)
|
2017-06-14 |
2021-01-11 |
4D Pharma Research Limited |
Kompozicijos, apimančios bakterines padermes
|
MD3600364T2
(ro)
|
2017-06-14 |
2020-12-31 |
4D Pharma Res Ltd |
Compoziții care conţin tulpină bacteriană din genul Megasphaera și utilizări ale acestora
|
EP3652342A1
(fr)
|
2017-07-13 |
2020-05-20 |
Yissum Research and Development Company of the Hebrew University of Jerusalem Ltd. |
Détection d'adn spécifique d'un tissu
|
EP3652343A1
(fr)
|
2017-07-13 |
2020-05-20 |
Yissum Research Development Company of the Hebrew University of Jerusalem Ltd. |
Stratégie de pcr en gouttelettes à double sonde pour la détection spécifique de molécules d'adn circulantes spécifiques d'un tissu
|
EP3652344A1
(fr)
|
2017-07-13 |
2020-05-20 |
Yissum Research and Development Company of the Hebrew University of Jerusalem Ltd. |
Cibles d'adn à titre de marqueurs de méthylation spécifiques de tissu
|
WO2019018747A1
(fr)
|
2017-07-20 |
2019-01-24 |
Trustees Of Boston University |
Dosage de détection du ténofovir
|
US11530413B2
(en)
|
2017-07-21 |
2022-12-20 |
Novartis Ag |
Compositions and methods to treat cancer
|
IL253642A0
(en)
|
2017-07-24 |
2017-09-28 |
Seger Rony |
Combined treatment for cancer
|
ES2862434T3
(es)
|
2017-08-02 |
2021-10-07 |
Siemens Healthcare Diagnostics Products Gmbh |
Prueba de unión para el diagnóstico de trombocitopenia inducida por heparina
|
IL253984A0
(en)
|
2017-08-14 |
2017-09-28 |
Yeda Res & Dev |
Immunotherapy against aranviruses that bind through transferrin receptor 1 (tfr1
|
US10677728B2
(en)
|
2017-08-17 |
2020-06-09 |
Elitechgroup B.V. |
Duplex stabilizing fluorescence quenchers for nucleic acid probes
|
US11692166B2
(en)
|
2017-08-23 |
2023-07-04 |
Technion Research & Development Foundation Limited |
Compositions and methods for improving alcohol tolerance in yeast
|
CN111094352A
(zh)
|
2017-08-25 |
2020-05-01 |
戊瑞治疗有限公司 |
B7-h4抗体及其使用方法
|
WO2019042153A1
(fr)
|
2017-09-01 |
2019-03-07 |
四川科伦博泰生物医药股份有限公司 |
Anticorps bispécifique recombinant
|
US11981723B2
(en)
|
2017-09-05 |
2024-05-14 |
GLAdiator Biosciences, Inc. |
Method of targeting exosomes
|
US11464784B2
(en)
|
2017-09-15 |
2022-10-11 |
The Regents Of The University Of California |
Inhibition of aminocylase 3 (AA3) in the treatment of cancer
|
EP3684929A1
(fr)
|
2017-09-19 |
2020-07-29 |
Tropic Biosciences UK Limited |
Modification de la spécificité de molécules d'arn non codantes pour le silençage de l'expression génique dans des cellules eucaryotes
|
WO2019066461A2
(fr)
|
2017-09-29 |
2019-04-04 |
Seegene, Inc. |
Détection de séquences d'acides nucléiques cibles par analyse par clivage et extension de pto
|
EP3692152A4
(fr)
|
2017-10-04 |
2021-12-01 |
The Broad Institute, Inc. |
Procédés et compositions permettant de modifier la fonction et la structure de boucles et/ou de domaines de chromatine
|
WO2019075086A1
(fr)
|
2017-10-11 |
2019-04-18 |
Chemocentryx, Inc. |
Traitement de la glomérulosclérose segmentaire focale avec des antagonistes du ccr2
|
EP3694545A4
(fr)
|
2017-10-11 |
2021-12-01 |
Board Of Regents, The University Of Texas System |
Anticorps pd-l1 humains et leurs procédés d'utilisation
|
AU2018364630A1
(en)
|
2017-11-09 |
2020-05-21 |
Pinteon Therapeutics Inc. |
Methods and compositions for the generation and use of humanized conformation-specific phosphorylated tau antibodies
|
IL255664A0
(en)
|
2017-11-14 |
2017-12-31 |
Shachar Idit |
Hematopoietic stem cells with enhanced properties
|
WO2019106667A1
(fr)
|
2017-11-29 |
2019-06-06 |
Weedout Ltd. |
Compositions, kits et procédés de lutte contre les mauvaises herbes du genre amaranthus
|
EP3717032B1
(fr)
|
2017-11-29 |
2023-02-15 |
Ramot at Tel-Aviv University Ltd. |
Procédés de traitement prophylactique ou thérapeutique de choc neurogénique
|
WO2019106680A1
(fr)
|
2017-12-03 |
2019-06-06 |
Yeda Research And Development Co. Ltd. |
Traitement d'une maladie cardiaque ischémique
|
CN109870581B
(zh)
|
2017-12-04 |
2021-05-04 |
厦门万泰凯瑞生物技术有限公司 |
一种定量检测HBsAg的试剂盒及方法
|
EP3723786A4
(fr)
|
2017-12-15 |
2021-09-08 |
Syngenta Participations Ag |
Ligands non-anticorps pour la détection de protéines cibles
|
EP3723785A1
(fr)
|
2017-12-17 |
2020-10-21 |
Yeda Research and Development Co. Ltd |
Modulateurs du complexe signalosome cop9 (csn) et leurs utilisations
|
WO2019130313A1
(fr)
|
2017-12-28 |
2019-07-04 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Procédé pour reproduire des rythmes circadiens sur une puce microfluidique
|
WO2019156758A2
(fr)
|
2018-01-05 |
2019-08-15 |
Vanderbilt University |
Neutralisation à médiation par anticorps du virus chikungunya
|
EP3514541A1
(fr)
|
2018-01-17 |
2019-07-24 |
Siemens Healthcare Diagnostics Products GmbH |
Procédé de détermination quantitative d'un inhibiteur du tnf-alpha thérapeutique
|
IL257225A
(en)
|
2018-01-29 |
2018-04-09 |
Yeda Res & Dev |
Treatment of sarcoma
|
IL257269A
(en)
|
2018-01-31 |
2018-04-09 |
Olender Tsviya |
Signaling is directed to the endoplasmic reticulum
|
WO2019155459A1
(fr)
|
2018-02-08 |
2019-08-15 |
Yeda Research And Development Co. Ltd. |
Inhibiteurs du protéasome 20s
|
WO2019155465A1
(fr)
|
2018-02-08 |
2019-08-15 |
Yeda Research And Development Co. Ltd. |
Procédés d'identification et d'utilisation d'agents pour traiter des maladies associées à un dysfonctionnement de la barrière intestinale
|
WO2019155041A1
(fr)
|
2018-02-12 |
2019-08-15 |
Vib Vzw |
ANTICORPS COMPLEXES Gβγ ET LEURS UTILISATIONS
|
US20200408771A1
(en)
|
2018-02-22 |
2020-12-31 |
The United States Of America,As Represented By The Secretary,Department Of Health And Human Services |
Cd153 and/or cd30 in infection
|
WO2019162945A1
(fr)
|
2018-02-23 |
2019-08-29 |
Carmel Haifa University Economic Corporation Ltd. |
Méthodes de traitement d'un trouble de la mémoire et d'un dysfonctionnement cognitif
|
US20200408761A1
(en)
|
2018-02-28 |
2020-12-31 |
The Medical Research, Infrastructure and Health Services Fund of the Tel Aviv Medical Center |
Methods of diagnosing and treating bladder cancer
|
AU2019228600A1
(en)
|
2018-03-02 |
2020-09-24 |
Five Prime Therapeutics, Inc. |
B7-H4 antibodies and methods of use thereof
|
WO2019175869A1
(fr)
|
2018-03-12 |
2019-09-19 |
Yeda Research And Development Co. Ltd |
Traitement d'une maladie cardiaque
|
US20210214445A1
(en)
|
2018-03-23 |
2021-07-15 |
Board Of Regents, The University Of Texas System |
Dual specificity antibodies to pd-l1 and pd-l2 and methods of use therefor
|
IL258467A
(en)
|
2018-03-29 |
2018-07-04 |
Ilana Kolodkin Gal |
Methods of disrupting a biofilm and/or preventing formation of same
|
WO2019186558A1
(fr)
|
2018-03-29 |
2019-10-03 |
Technion Research And Development Foundation Limited |
Vésicules comprenant un inhibiteur de pten et leurs utilisations
|
EP3774047A1
(fr)
|
2018-03-29 |
2021-02-17 |
Yeda Research and Development Co. Ltd |
Utilisation de gradients de champ électrique pour commander l'expression génique
|
EP4063519B1
(fr)
|
2018-04-09 |
2023-09-13 |
Advanced Cell Diagnostics, Inc. |
Procédés d'amélioration supplémentaire de l'amplification de signal pour la détection in situ d'acides nucléiques
|
CN112004941B
(zh)
|
2018-04-20 |
2023-10-27 |
Seegene株式会社 |
用于检测样品中的多个靶核酸序列的方法及装置
|
US11884725B2
(en)
|
2018-04-24 |
2024-01-30 |
Ampsource Biopharma Shanghai Inc. |
Antibody against TIM-3 and application thereof
|
GB201807192D0
(en)
|
2018-05-01 |
2018-06-13 |
Tropic Biosciences Uk Ltd |
Compositions and methods for reducing caffeine content in coffee beans
|
EP3788138A1
(fr)
|
2018-05-02 |
2021-03-10 |
Novartis AG |
Régulateurs de cellules souches pluripotentes humaines et leurs utilisations
|
IL259392A
(en)
|
2018-05-15 |
2018-08-01 |
Yeda Res & Dev |
Vaccination with cancer neo-antigens
|
WO2019220441A1
(fr)
|
2018-05-15 |
2019-11-21 |
Hadasit Medical Research Services And Development Ltd. |
Compositions et méthodes de traitement du cancer résistant à un agent anticancéreux
|
US20210121491A1
(en)
|
2018-05-27 |
2021-04-29 |
Biolinerx Ltd. |
Agi-134 combined with a checkpoint inhibitor for the treatment of solid tumors
|
EP3802526A1
(fr)
|
2018-05-29 |
2021-04-14 |
ELITechGroup, Inc. |
Composés de carborhodamine et leurs procédés de préparation
|
CA3102975A1
(fr)
|
2018-06-07 |
2019-12-12 |
The State Of Israel, Ministry Of Agriculture & Rural Development, Agricultural Research Organization (Aro) (Volcani Center) |
Procedes de regeneration et de transformation de cannabis
|
US11827892B2
(en)
|
2018-06-07 |
2023-11-28 |
The State Of Israel, Ministry Of Agriculture & Rural Development, Agricultural Research Organization (Aro) (Volcani Center) |
Nucleic acid constructs and methods of using same
|
WO2019244107A1
(fr)
|
2018-06-21 |
2019-12-26 |
Daiichi Sankyo Company, Limited |
Compositions comprenant des fragments de liaison à l'antigène cd3 et leurs utilisations
|
US11873322B2
(en)
|
2018-06-25 |
2024-01-16 |
Yeda Research And Development Co. Ltd. |
Systems and methods for increasing efficiency of genome editing
|
AU2019297677A1
(en)
|
2018-07-04 |
2021-02-25 |
Ukko Inc. |
Methods of de-epitoping wheat proteins and use of same for the treatment of celiac disease
|
US20210269860A1
(en)
|
2018-07-08 |
2021-09-02 |
Yeda Research And Development Co. Ltd. |
Person-specific assessment of probiotics responsiveness
|
CN112351989B
(zh)
|
2018-07-11 |
2024-03-26 |
免疫制药有限公司 |
肽化合物及其治疗用途
|
EP3814385A4
(fr)
|
2018-07-11 |
2022-04-06 |
KAHR Medical Ltd. |
Protéine de fusion du variant de sirpalpha-4-1bbl et procédés d'utilisation associés
|
JP7479343B2
(ja)
|
2018-07-31 |
2024-05-08 |
コルプラント リミテッド |
タバコのトランスジェニックイベント、並びにその検出方法およびその使用
|
IL261156A
(en)
|
2018-08-14 |
2020-02-27 |
Fass Deborah |
Chimeric quiescin sulfhydryl oxidase (qsox1) antibodies and uses of same
|
WO2020039440A1
(fr)
|
2018-08-24 |
2020-02-27 |
Yeda Research And Development Co. Ltd. |
Procédés de modulation de la polarisation de macrophages m2 et leur utilisation en thérapie
|
EP3849608B1
(fr)
|
2018-09-13 |
2023-08-30 |
The Board of Regents of The University of Texas System |
Nouveaux anticorps anti-lilrb4 et leurs utilisations
|
CN113038951B
(zh)
|
2018-09-20 |
2024-04-30 |
耶达研究及发展有限公司 |
治疗肌萎缩侧索硬化的方法
|
US20210338767A1
(en)
|
2018-09-25 |
2021-11-04 |
Biolinerx Ltd. |
Methods of selecting treatment for cxcr4-associated cancer
|
KR102220701B1
(ko)
|
2018-09-28 |
2021-03-03 |
(주)나노헬릭스 |
형광기반의 다중 융해 분석을 이용한 증폭 산물의 다중 분석방법
|
WO2020069424A1
(fr)
|
2018-09-28 |
2020-04-02 |
Centrillion Technologies, Inc. |
Terminateurs réversibles à liaison disulfure
|
EA202191033A1
(ru)
|
2018-10-15 |
2021-12-21 |
Юниверсити Оф Массачусетс |
Программируемое редактирование оснований днк посредством слитых белков nme2cas9-дезаминаза
|
CA3116539C
(fr)
|
2018-10-18 |
2023-10-03 |
Oklahoma Medical Research Foundation |
Biomarqueurs d'indice immunitaire d'activite de maladie du lupus erythemateux dissemine (sle) qui caracterise une activite de maladie
|
CN112912396B
(zh)
|
2018-10-22 |
2023-03-14 |
上海吉倍生物技术有限公司 |
抗cldn18.2抗体及其用途
|
SG11202103124WA
(en)
|
2018-10-23 |
2021-04-29 |
Glycardial Diagnostics S L |
Antibodies specific for glycosylated apoj and uses thereof
|
IL262658A
(en)
|
2018-10-28 |
2020-04-30 |
Memorial Sloan Kettering Cancer Center |
Prevention of age related clonal hematopoiesis and diseases associated therewith
|
CN111196851B
(zh)
|
2018-11-20 |
2021-11-16 |
厦门万泰凯瑞生物技术有限公司 |
针对人抗缪勒管激素的特异性抗体及其应用
|
IL263184A
(en)
|
2018-11-21 |
2020-05-31 |
Yarden Yosef |
Method of treating cancer and compositions for same
|
US20220089776A1
(en)
|
2018-11-28 |
2022-03-24 |
Oregon Health & Science University |
Therapeutic factor xii antibody
|
EP4369356A3
(fr)
|
2018-11-30 |
2024-07-24 |
Caris MPI, Inc. |
Profilage moléculaire de nouvelle génération
|
EP3904386A4
(fr)
|
2018-12-28 |
2022-09-07 |
Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. |
Anticorps et son utilisation
|
EP3914698A1
(fr)
|
2019-01-23 |
2021-12-01 |
Yeda Research and Development Co. Ltd |
Milieux de culture pour cellules souches pluripotentes
|
WO2020185312A2
(fr)
|
2019-01-25 |
2020-09-17 |
President And Fellows Of Harvard College |
Compositions et procédé de synthèse d'acides nucléiques
|
IL264768A
(en)
|
2019-02-10 |
2020-08-31 |
Sagi Irit |
ANTI-MATRIX METALLOPROTEINASE 7 (MMP-7) inhibitory antibody and its use
|
IL264854A
(en)
|
2019-02-14 |
2020-08-31 |
Bahat Anat |
Spt5 inhibitors and methods of use thereof
|
EP3924501A4
(fr)
|
2019-02-15 |
2022-11-23 |
Advanced Cell Diagnostics, Inc. |
Procédés de détection multiplexe d'acides nucléiques par hybridation in situ
|
EP3927807A1
(fr)
|
2019-02-21 |
2021-12-29 |
Yissum Research Development Company of the Hebrew University of Jerusalem Ltd. |
Procédés de génération d'organoïdes pour criblage à haut rendement de médicaments
|
WO2020170240A1
(fr)
|
2019-02-21 |
2020-08-27 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Procédé de réduction d'une néphrotoxicité induite par des médicaments
|
WO2020178822A1
(fr)
|
2019-03-05 |
2020-09-10 |
The State Of Israel, Ministry Of Agriculture & Rural Development, Agricultural Research Organization (Aro) (Volcani Center) |
Oiseaux à édition de génome
|
GB201903520D0
(en)
|
2019-03-14 |
2019-05-01 |
Tropic Biosciences Uk Ltd |
Modifying the specificity of non-coding rna molecules for silencing genes in eukaryotic cells
|
GB201903519D0
(en)
|
2019-03-14 |
2019-05-01 |
Tropic Biosciences Uk Ltd |
Introducing silencing activity to dysfunctional rna molecules and modifying their specificity against a gene of interest
|
GB201903521D0
(en)
|
2019-03-14 |
2019-05-01 |
Tropic Biosciences Uk Ltd |
No title
|
IL265486A
(en)
|
2019-03-19 |
2020-09-30 |
Yeda Res & Dev |
Bistable type ii opsins and uses thereof
|
WO2020194317A1
(fr)
|
2019-03-28 |
2020-10-01 |
Yeda Research And Development Co. Ltd. |
Méthode de traitement de troubles liés aux lipides
|
WO2020202142A2
(fr)
|
2019-03-31 |
2020-10-08 |
Yeda Research And Development Co. Ltd. |
Composés anti-viraux et anti-tumoraux
|
JP2022528595A
(ja)
|
2019-04-16 |
2022-06-15 |
シチュアン ケルン-バイオテック バイオファーマシューティカル カンパニー リミテッド |
抗FXI/FXIa抗体及びその使用
|
CA3138566A1
(fr)
|
2019-04-30 |
2020-11-05 |
Larimar Therapeutics, Inc. |
Marqueurs sensibles a la frataxine pour determiner l'efficacite d'une therapie de remplacement de frataxine
|
IL266433B
(en)
|
2019-05-02 |
2020-11-30 |
Sagi Irit |
Compositions comprising the propeptide of lysyl oxidase and uses thereof
|
US20220220559A1
(en)
|
2019-05-13 |
2022-07-14 |
Yeda Research And Development Co. Ltd. |
Cell-free mirna biomarkers for prognosis and diagnosis of neurodegenerative diseases
|
IL266728B
(en)
|
2019-05-19 |
2020-11-30 |
Yeda Res & Dev |
Identification of recurrent mutant neopeptides
|
WO2020234888A1
(fr)
|
2019-05-22 |
2020-11-26 |
Hadasit Medical Research Services And Development Ltd. |
Procédés de culture de cellules pluripotentes humaines
|
CN114599675B
(zh)
|
2019-05-28 |
2024-08-16 |
上海科技大学 |
用于治疗clouston型外胚层发育不良2的组合物和方法
|
EP3983531A1
(fr)
|
2019-06-12 |
2022-04-20 |
Hadasit Medical Research Services and Development Ltd. |
Procédés de génération d'oligodendrocytes
|
WO2020255124A1
(fr)
|
2019-06-16 |
2020-12-24 |
Yeda Research And Development Co. Ltd. |
Méthode de stabilisation de l'arn intracellulaire
|
WO2020261281A1
(fr)
|
2019-06-27 |
2020-12-30 |
Ramot At Tel-Aviv University Ltd. |
Anticorps semaphorine 3a et leurs utilisations
|
AU2020302791A1
(en)
|
2019-06-27 |
2022-02-03 |
Dovetail Genomics, Llc |
Methods and compositions for proximity ligation
|
EP3994268A1
(fr)
|
2019-07-04 |
2022-05-11 |
Ukko Inc. |
Alpha gliadine sans épitope et son utilisation pour la gestion de la maladie coeliaque et de la sensibilité au gluten
|
WO2021005599A1
(fr)
|
2019-07-11 |
2021-01-14 |
Kahr Medical Ltd. |
Hétérodimères et procédés d'utilisation correspondants
|
IL268111A
(en)
|
2019-07-16 |
2021-01-31 |
Fainzilber Michael |
Methods of treating pain
|
US20220281960A1
(en)
|
2019-07-16 |
2022-09-08 |
Ramot At Tel-Aviv University Ltd. |
Compositions and methods for the treatment of tuberculosis
|
AU2020317009A1
(en)
|
2019-07-19 |
2022-02-03 |
The Board Of Trustees Of The Leland Stanford Junior University |
Chimeric antigen receptors containing Glypican 2 binding domains
|
EP4004037A1
(fr)
|
2019-07-26 |
2022-06-01 |
Vanderbilt University |
Anticorps monoclonaux humains dirigés contre l'entérovirus d68
|
EP4004548A1
(fr)
|
2019-07-29 |
2022-06-01 |
Yeda Research and Development Co. Ltd |
Procédés de traitement et de diagnostic du cancer du poumon
|
EP4004212A1
(fr)
|
2019-07-30 |
2022-06-01 |
The State of Israel, Ministry of Agriculture & Rural Development, Agricultural Research Organization (ARO) (Volcani Institute) |
Méthodes de régulation de la synthèse de cannabinoïdes chez la plante ou dans des cellules et plantes et cellules ainsi produites
|
EP4014046A1
(fr)
|
2019-08-12 |
2022-06-22 |
Yeda Research and Development Co. Ltd |
Test sanguin de réparation de l'adn pour prédire la réponse de patients atteints d'un cancer du poumon à une immunothérapie
|
WO2021033176A1
(fr)
|
2019-08-22 |
2021-02-25 |
Ariel Scientific Innovations Ltd. |
Procédés mis à l'échelle de purification d'anticorps
|
EP4021463A1
(fr)
|
2019-08-27 |
2022-07-06 |
Yeda Research and Development Co. Ltd |
Traitement de la vaginose bactérienne
|
WO2021048852A1
(fr)
|
2019-09-11 |
2021-03-18 |
Yeda Research And Development Co. Ltd. |
Méthodes de traitement du cancer du sein
|
US20220331363A1
(en)
|
2019-09-20 |
2022-10-20 |
Shanghai GenBase Biotechnology Co., Ltd. |
Bcma-targeted antibody and chimeric antigen receptor
|
IL269674B
(en)
|
2019-09-25 |
2020-08-31 |
Roy Bar Ziv |
Assembling protein complexes on a chip
|
EP4041767A1
(fr)
|
2019-09-26 |
2022-08-17 |
StCube & Co. |
Anticorps spécifiques dirigés contre ctla-4 glycosylée et leurs procédés d'utilisation
|
JP2022550243A
(ja)
|
2019-09-30 |
2022-12-01 |
シチュアン ケルン-バイオテック バイオファーマシューティカル カンパニー リミテッド |
抗pd-1抗体及びその使用
|
JP2022552282A
(ja)
|
2019-10-09 |
2022-12-15 |
エスティーキューブ アンド カンパニー |
グリコシル化lag3に対して特異的な抗体およびその使用方法
|
JP2023502317A
(ja)
|
2019-10-10 |
2023-01-24 |
カールスバーグ アグシャセルスガーブ |
変異体植物の調製方法
|
WO2021080629A1
(fr)
|
2019-10-23 |
2021-04-29 |
Elitechgroup, Inc. |
Procédés d'amplification par déplacement de brin isotherme véritable
|
IL270306A
(en)
|
2019-10-30 |
2021-05-31 |
Yeda Res & Dev |
Prevention and treatment of pre-myeloid and myeloid malignancies
|
US20240117386A1
(en)
|
2019-10-31 |
2024-04-11 |
Yeda Research And Development Co. Ltd. |
Engineered autotrophic bacteria for co2 conversion to organic materials
|
WO2021095031A2
(fr)
|
2019-11-11 |
2021-05-20 |
Ibi-Ag Innovative Bio Insecticides Ltd. |
Nanocorps de lutte contre les insectes et leurs utilisations
|
IL293148A
(en)
|
2019-11-19 |
2024-07-01 |
Protalix Ltd |
Removal of constructs from transduced cells
|
IL270800A
(en)
|
2019-11-20 |
2021-05-31 |
Yeda Res & Dev |
A method for treating Alzheimer's disease
|
US10792360B1
(en)
|
2019-11-21 |
2020-10-06 |
Chemocentryx, Inc. |
Compositions and methods for treating inflammatory bowel disease using CCR9 inhibitor and anti-TNF-alpha blocking antibodies
|
JP2023504270A
(ja)
|
2019-12-02 |
2023-02-02 |
カリス エムピーアイ インコーポレイテッド |
汎がんのプラチナ反応予測子
|
CN115176027A
(zh)
|
2019-12-12 |
2022-10-11 |
哈佛大学校长及研究员协会 |
用于光指导的生物分子条形码化的组合物和方法
|
JP2023505408A
(ja)
|
2019-12-13 |
2023-02-09 |
シチュアン ケルン-バイオテック バイオファーマシューティカル カンパニー リミテッド |
抗tslp抗体及びその使用
|
KR20220143005A
(ko)
|
2019-12-20 |
2022-10-24 |
노바록 바이오테라퓨틱스 리미티드 |
항-인터루킨-23 p19 항체 및 이의 사용 방법
|
IL271656A
(en)
|
2019-12-22 |
2021-06-30 |
Yeda Res & Dev |
System and methods for identifying cells that have undergone genome editing
|
WO2021130753A1
(fr)
|
2019-12-22 |
2021-07-01 |
Yeda Research And Development Co. Ltd. |
Diagnostic de la démence frontotemporale
|
CN113046420B
(zh)
|
2019-12-26 |
2022-10-04 |
厦门大学 |
一种不对称扩增多个靶核酸的方法
|
EP3842452A1
(fr)
|
2019-12-26 |
2021-06-30 |
Universitat Autònoma de Barcelona |
Protéines d'échafaudage et nanoconjugués thérapeutiques à base de nidogène
|
CN113046421B
(zh)
|
2019-12-26 |
2022-09-30 |
厦门大学 |
一种不对称扩增靶核酸的方法
|
IL271778A
(en)
|
2019-12-31 |
2021-06-30 |
Ichilov Tech Ltd |
Methods for treating atopic dermatitis
|
WO2021137231A1
(fr)
|
2019-12-31 |
2021-07-08 |
Kahr Medical Ltd. |
Procédés de culture de lymphocytes t avec un polypeptide de fusion 4-1bbl et leurs utilisations
|
WO2021137230A1
(fr)
|
2019-12-31 |
2021-07-08 |
Kahr Medical Ltd. |
Procédés de culture de lymphocytes t et leurs utilisations
|
CN113061165A
(zh)
|
2020-01-02 |
2021-07-02 |
厦门大学 |
EB病毒BNLF2b基因编码多肽及其检测用途
|
IL272074B1
(en)
|
2020-01-15 |
2024-08-01 |
Immunity Pharma Ltd |
Peptide compounds and their use in methods of treating diseases
|
IL272194A
(en)
|
2020-01-22 |
2021-07-29 |
Yeda Res & Dev |
Multi-target antibodies for use in the treatment of diseases
|
WO2021152584A1
(fr)
|
2020-01-28 |
2021-08-05 |
Ariel Scientific Innovations Ltd. |
Procédés d'analyse de membranes cellulaires
|
WO2021152586A1
(fr)
|
2020-01-30 |
2021-08-05 |
Yeda Research And Development Co. Ltd. |
Procédés d'analyse du microbiome, du profil d'immunoglobuline et de l'état physiologique
|
WO2021152587A1
(fr)
|
2020-01-30 |
2021-08-05 |
Yeda Research And Development Co. Ltd. |
Traitement d'une maladie hépatique aiguë à l'aide d'inhibiteurs de tlr-mik
|
IL272390A
(en)
|
2020-01-30 |
2021-08-31 |
Yeda Res & Dev |
Cancer treatment methods
|
IL272389A
(en)
|
2020-01-30 |
2021-08-31 |
Yeda Res & Dev |
Kits containing antibodies to PD-L1 and their uses in therapy
|
WO2021156490A2
(fr)
|
2020-02-06 |
2021-08-12 |
Vib Vzw |
Liants du coronavirus
|
KR20220151168A
(ko)
|
2020-02-09 |
2022-11-14 |
엔엘씨 파르마 엘티디 |
Sars-cov-2에 대한 신속한 검출 테스트
|
IL272586A
(en)
|
2020-02-10 |
2021-08-31 |
Yeda Res & Dev |
A method for cell cluster analysis
|
KR20220140568A
(ko)
|
2020-02-11 |
2022-10-18 |
벤더르빌트 유니버시티 |
중증 급성 호흡기 증후군 코로나바이러스 2(SARS-CoV-2)에 대한 인간 단일클론 항체
|
WO2021167908A1
(fr)
|
2020-02-17 |
2021-08-26 |
Board Of Regents, The University Of Texas System |
Procédés d'expansion de lymphocytes infiltrant les tumeurs et leur utilisation
|
EP4110794A1
(fr)
|
2020-02-25 |
2023-01-04 |
Vib Vzw |
Modulateurs allostériques de la kinase à répétitions riches en leucines 2
|
WO2021173674A1
(fr)
|
2020-02-26 |
2021-09-02 |
A2 Biotherapeutics, Inc. |
Polypeptides ciblant des complexes mage-a3 peptide-mhc et leurs méthodes d'utilisation
|
WO2021186431A1
(fr)
|
2020-03-16 |
2021-09-23 |
Yeda Research And Development Co. Ltd. |
Analogues peptidiques et leur utilisation dans le traitement de maladies, troubles ou états associés à une protéine p53 mutante
|
WO2021195385A1
(fr)
|
2020-03-26 |
2021-09-30 |
Vanderbilt University |
Anticorps monoclonaux humains dirigés contre le coronavirus du syndrome respiratoire aigu sévère 2 (sras-cov-2)
|
PT4045533T
(pt)
|
2020-03-26 |
2024-02-14 |
Univ Vanderbilt |
Anticorpos monoclonais humanos para síndrome respiratória aguda grave coronavírus 2 (sars-cov-2)
|
EP4126226A1
(fr)
|
2020-03-29 |
2023-02-08 |
Yeda Research and Development Co. Ltd |
Variants de bêta-glucocérébrosidase destinés à être utilisés dans le traitement de la maladie de gaucher
|
TW202203916A
(zh)
|
2020-03-31 |
2022-02-01 |
美商卡默森屈有限公司 |
使用ccr9抑制劑及抗il—23阻斷抗體治療發炎性腸道疾病的組成物及方法
|
EP4125440A1
(fr)
|
2020-03-31 |
2023-02-08 |
Biomuse Ltd. |
Bactéries destinées à la prévention et au traitement de lésions pulmonaires induites par la fumée
|
EP4133107A1
(fr)
|
2020-04-06 |
2023-02-15 |
Yeda Research and Development Co. Ltd |
Méthodes de diagnostic du cancer et de prédiction de la réactivité à une thérapie
|
EP4132479A1
(fr)
|
2020-04-07 |
2023-02-15 |
Ramot at Tel-Aviv University Ltd. |
Compositions contenant du cannabidiol et leurs utilisations
|
AU2021255132A1
(en)
|
2020-04-13 |
2022-12-08 |
Exoprother Medical Ltd. |
Cell-derived vesicles comprising wild-type P53 protein for antiviral therapy
|
US20210322483A1
(en)
|
2020-04-16 |
2021-10-21 |
Ichilov Tech Ltd. |
Cell-derived particles presenting heterologous cd24 and use thereof in therapy
|
EP4139456A4
(fr)
|
2020-04-22 |
2024-05-22 |
President And Fellows Of Harvard College |
Procédés isothermes, compositions, kits et systèmes de détection d'acides nucléiques
|
WO2021229577A1
(fr)
|
2020-05-12 |
2021-11-18 |
Collplant Ltd. |
Collagène utilisé comme outil d'administration d'agents antiviraux à base de métaux
|
MX2022014332A
(es)
|
2020-05-15 |
2022-12-13 |
Sichuan Kelun Biotech Biopharmaceutical Co Ltd |
Conjugado anticuerpo-farmaco, metodo de preparacion del mismo y uso del mismo.
|
IL274811B
(en)
|
2020-05-20 |
2021-05-31 |
Yeda Res & Dev |
Spatial information is developed for the analysis of individual cells
|
EP4168438A4
(fr)
|
2020-06-22 |
2024-07-10 |
Univ Ramot |
Modules de protéine à sous-unités multiples, cellules exprimant ceux-ci et leurs utilisations
|
WO2021260675A1
(fr)
|
2020-06-24 |
2021-12-30 |
Yeda Research And Development Co. Ltd. |
Agents pour sensibiliser des tumeurs solides à un traitement
|
EP3939999A1
(fr)
|
2020-07-14 |
2022-01-19 |
Fundación del Sector Público Estatal Centro Nacional de Investigaciones Oncológicas Carlos III (F.S.P. CNIO) |
Anticorps neutralisant la sous-unité alpha du récepteur de l'interleukine 11 (il11ra) et leurs utilisations
|
IL276599A
(en)
|
2020-08-09 |
2022-03-01 |
Yeda Res & Dev |
T cell receptor unique to mage-a1 and its uses
|
IL276627A
(en)
|
2020-08-10 |
2022-03-01 |
Yeda Res & Dev |
Compositions for diagnosis and treatment of coronavirus infections
|
US20230309480A1
(en)
|
2020-08-18 |
2023-10-05 |
International Rice Research Institute |
Methods of increasing outcrossing rates in gramineae
|
WO2022047359A1
(fr)
|
2020-08-31 |
2022-03-03 |
Berg Llc |
Biomarqueurs protéiques du cancer du pancréas
|
IL277488A
(en)
|
2020-09-21 |
2022-04-01 |
Yeda Res & Dev |
Weight regulation method
|
WO2022064494A2
(fr)
|
2020-09-23 |
2022-03-31 |
Yeda Research And Development Co. Ltd. |
Méthodes et compositions pour traiter des infections à coronavirus
|
IL277743A
(en)
|
2020-10-01 |
2022-04-01 |
Yeda Res & Dev |
A method for diagnosing breast cancer
|
KR20230113283A
(ko)
|
2020-10-05 |
2023-07-28 |
프로탈릭스 리미티드 |
다이서-유사 넉아웃 식물 세포
|
WO2022074656A1
(fr)
|
2020-10-07 |
2022-04-14 |
Protalix Ltd. |
Dnase à action prolongée
|
EP4228637A1
(fr)
|
2020-10-15 |
2023-08-23 |
Yeda Research and Development Co. Ltd |
Méthode de traitement des cancers myéloïdes
|
IL278401A
(en)
|
2020-10-29 |
2022-05-01 |
Yeda Res & Dev |
Polynucleotides for editing RNA and a method for using them
|
EP4240856A2
(fr)
|
2020-11-09 |
2023-09-13 |
1E Therapeutics, Ltd. |
Méthodes de traitement ou de prévention d'infections bactériennes faisant appel à une séquence catalytique
|
GB202105804D0
(en)
|
2020-11-20 |
2021-06-09 |
Univ Cape Town |
Use of microvirin in the identification of mycobacterium tuberculosis mannose-capped lipoarabinomannan
|
WO2022115498A1
(fr)
|
2020-11-26 |
2022-06-02 |
Ukko Inc. |
Sous-unité de gluténine modifiée à poids moléculaire élevé et ses utilisations
|
CA3200167A1
(fr)
|
2020-12-04 |
2022-06-09 |
Jonathan S. Wall |
Procede de diagnostic de maladies amyloides
|
IL279559A
(en)
|
2020-12-17 |
2022-07-01 |
Yeda Res & Dev |
Controlling the ubiquitination process of mlkl for disease treatment
|
IL304047A
(en)
|
2020-12-28 |
2023-08-01 |
1E Therapeutics Ltd |
Silencing target sites in the p21 mRNA sequence
|
IL304068A
(en)
|
2020-12-28 |
2023-08-01 |
1E Therapeutics Ltd |
DNA enzymes against p21 messenger RNA
|
CA3203886A1
(fr)
|
2020-12-31 |
2022-07-07 |
Yanni CONG |
Proteine liant un antigene lifr humain, son procede de preparation et son utilisation
|
WO2022149142A2
(fr)
|
2021-01-10 |
2022-07-14 |
Supermeat The Essence Of Meat Ltd. |
Agrégats de cellules souches pluripotentes et microtissus obtenus à partir de ceux-ci pour l'industrie de la viande cultivée
|
US20240083843A1
(en)
|
2021-01-14 |
2024-03-14 |
Yeda Research And Development Co. Ltd. |
Methods of producing vitamin d
|
IL280340B
(en)
|
2021-01-21 |
2022-04-01 |
Yeda Res & Dev |
Antibodies, peptides and their combinations for the treatment and prevention of corona virus infections
|
GB2603166A
(en)
|
2021-01-29 |
2022-08-03 |
Thelper As |
Therapeutic and Diagnostic Agents and Uses Thereof
|
WO2022170971A1
(fr)
|
2021-02-09 |
2022-08-18 |
苏州宜联生物医药有限公司 |
Conjugué à substance bioactive, son procédé de préparation et son utilisation
|
JP2024506955A
(ja)
|
2021-02-18 |
2024-02-15 |
イェダ リサーチ アンド デベロップメント カンパニー リミテッド |
ワクチンを作製する方法
|
IL305314A
(en)
|
2021-02-18 |
2023-10-01 |
Yeda res & development co ltd |
A genetically engineered bacterium for vaccine production
|
CA3211270A1
(fr)
|
2021-02-19 |
2022-08-25 |
Vib Vzw |
Liants de recepteur de mannose-6-phosphate independants des cations
|
EP4302777A1
(fr)
|
2021-03-05 |
2024-01-10 |
Shanghai Genbase Biotechnology Co., Ltd. |
Anticorps anti-cldn6 et son utilisation
|
CN117729942A
(zh)
|
2021-03-08 |
2024-03-19 |
伊缪诺金公司 |
用于增加靶向adam9的免疫缀合物治疗癌症的功效的方法
|
CA3207635A1
(fr)
|
2021-03-09 |
2022-09-15 |
Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. |
Proteine de liaison a ror1 et son utilisation
|
IL281561A
(en)
|
2021-03-16 |
2022-10-01 |
Yeda Res & Dev |
Methods and devices for growing mouse embryos outside the uterus
|
WO2022208369A1
(fr)
|
2021-03-30 |
2022-10-06 |
Biomx Ltd. |
Bactériophage de pseudomonas et ses utilisations
|
CA3214833A1
(fr)
|
2021-04-06 |
2022-10-13 |
Bpgbio, Inc. |
Marqueurs proteiques pour le pronostic de la progression du cancer du sein
|
IL307530A
(en)
|
2021-04-06 |
2023-12-01 |
Bpgbio Inc |
Estrogen receptor-like (ER) breast cancer protein markers LUMINAL A (LA) and LUMINAL B1 (LB1)
|
CN118661103A
(zh)
|
2021-04-06 |
2024-09-17 |
布普格生物制药公司 |
雌激素受体(er)阳性样和雌激素受体(er)阴性样乳腺癌的蛋白质标志物
|
IL282188A
(en)
|
2021-04-08 |
2022-11-01 |
Yeda Res & Dev |
Combined use of ketamine and bretigabine for the treatment of psychiatric disorders
|
CA3215979A1
(fr)
|
2021-04-19 |
2022-10-27 |
Ghassan SAED |
Methodes de detection ou de traitement de troubles hyperproliferatifs de l'endometre et de l'ovaire
|
JP2024520907A
(ja)
|
2021-05-12 |
2024-05-27 |
バイオエムエックス・リミテッド |
ブドウ球菌バクテリオファージ及びその使用
|
IL283563A
(en)
|
2021-05-30 |
2022-12-01 |
Yeda Res & Dev |
Profiling of amps for the diagnosis, monitoring and treatment of microbiome-related diseases
|
CA3219233A1
(fr)
|
2021-06-06 |
2022-12-15 |
Ravid STRAUSSMAN |
Traitement combine du cancer
|
IL309333A
(en)
|
2021-06-13 |
2024-02-01 |
Yissum Res Dev Co Of Hebrew Univ Jerusalem Ltd |
A method for reprogramming cells
|
KR20240035997A
(ko)
|
2021-06-16 |
2024-03-19 |
시드엑스 테크놀로지스 인코포레이티드 |
마티올라 종자들을 선별하는 방법들
|
NL2028466B1
(en)
|
2021-06-16 |
2022-12-21 |
Sakata Holland B V |
Methods of sorting matthiola seeds
|
CA3223344A1
(fr)
|
2021-07-02 |
2023-01-05 |
Tropic Biosciences UK Limited |
Retardement ou prevention du brunissement de bananes
|
WO2023288046A1
(fr)
|
2021-07-15 |
2023-01-19 |
President And Fellows Of Harvard College |
Compositions et méthodes associées à des cellules comprenant des particules adhérées
|
JP2024526837A
(ja)
|
2021-07-18 |
2024-07-19 |
ガミダ セル リミテッド |
治療用nk細胞集団
|
WO2023002492A1
(fr)
|
2021-07-22 |
2023-01-26 |
Yeda Research And Development Co. Ltd. |
Optimisation de codon d'acides nucléiques
|
EP4377352A2
(fr)
|
2021-07-30 |
2024-06-05 |
Vib Vzw |
Liants du récepteur mannose-6-phosphate indépendants des cations pour la dégradation ciblée de protéines
|
EP4380973A2
(fr)
|
2021-08-02 |
2024-06-12 |
Yeda Research and Development Co. Ltd. |
Anticorps pour le traitement du cancer
|
EP4380966A2
(fr)
|
2021-08-03 |
2024-06-12 |
Genicity Limited |
Complexe tcr modifié et ses procédés d'utilisation
|
EP4130028A1
(fr)
|
2021-08-03 |
2023-02-08 |
Rhazes Therapeutics Ltd |
Complexe tcr modifié et leurs procédés d'utilisation
|
WO2023018621A1
(fr)
|
2021-08-10 |
2023-02-16 |
Gamida-Cell Ltd. |
Cellules nk modifiées, leurs procédés de production et leurs utilisations
|
GB202112866D0
(en)
|
2021-09-09 |
2021-10-27 |
Tropic Biosciences Uk Ltd |
Resistance to fusarium wilt in a banana
|
GB202112865D0
(en)
|
2021-09-09 |
2021-10-27 |
Tropic Biosciences Uk Ltd |
Resistance to black sigatoka disease in banana
|
IL286430A
(en)
|
2021-09-14 |
2023-04-01 |
Yeda Res & Dev |
Multispecific antibodies for use in the treatment of diseases
|
EP4403645A1
(fr)
|
2021-09-17 |
2024-07-24 |
Seegene, Inc. |
Détection d'une séquence d'acide nucléique cible à l'aide d'un oligonucléotide marqueur porteur de base non naturelle synthétique
|
KR20240099319A
(ko)
|
2021-10-26 |
2024-06-28 |
카리부 바이오사이언시스 인코포레이티드 |
엑소뉴클레아제-커플링된 실시간 엔도뉴클레아제 활성 검정
|
CA3236778A1
(fr)
|
2021-11-02 |
2023-05-11 |
Erik SONTHEIMER |
Proteines de fusion a domaine nme2cas9 incruste
|
AU2022392804A1
(en)
|
2021-11-19 |
2024-05-02 |
Mirobio Limited |
Engineered PD-1 antibodies and uses thereof
|
WO2023105526A1
(fr)
|
2021-12-08 |
2023-06-15 |
Yeda Research And Development Co. Ltd. |
Cellules progénitrices pulmonaires multipotentes pour la régénération pulmonaire
|
WO2023106866A1
(fr)
|
2021-12-10 |
2023-06-15 |
주식회사 씨젠 |
Amorce à boucle marquée comprenant un système de double marquage interactif simple brin, et procédé d'amplification isotherme d'acide nucléique l'utilisant
|
TW202334206A
(zh)
|
2022-01-25 |
2023-09-01 |
大陸商蘇州宜聯生物醫藥有限公司 |
一種針對Her3的抗體、偶聯物及其用途
|
GB202201137D0
(en)
|
2022-01-28 |
2022-03-16 |
Thelper As |
Therapeutic and diagnostic agents and uses thereof
|
AU2023214198A1
(en)
|
2022-01-31 |
2024-08-15 |
Genevant Sciences Gmbh |
Ionizable cationic lipids for lipid nanoparticles
|
EP4238988A1
(fr)
|
2022-03-01 |
2023-09-06 |
Consejo Superior De Investigaciones Científicas |
Anticorps dirigés contre le sars-cov-2 et leurs utilisations
|
EP4239338A1
(fr)
|
2022-03-03 |
2023-09-06 |
Siemens Healthcare Diagnostics Products GmbH |
Essai général destiné à la détermination de l'état du système de coagulation sanguine
|
US20230365708A1
(en)
|
2022-04-01 |
2023-11-16 |
Board Of Regents, The University Of Texas System |
Dual specificity antibodies to human pd-l1 and pd-l2 and methods of use therefor
|
GB202204813D0
(en)
|
2022-04-01 |
2022-05-18 |
Bradcode Ltd |
Human monoclonal antibodies and methods of use thereof
|
US20230357851A1
(en)
|
2022-04-06 |
2023-11-09 |
Larimar Therapeutics, Inc. |
Frataxin-sensitive markers for monitoring frataxin-replacement therapy
|
US20230416361A1
(en)
|
2022-04-06 |
2023-12-28 |
Mirobio Limited |
Engineered cd200r antibodies and uses thereof
|
WO2023209708A1
(fr)
|
2022-04-25 |
2023-11-02 |
Yeda Research And Development Co. Ltd. |
Compositions pour modifier la signalisation de messager secondaire de l'adp-ribose cyclique
|
WO2023239710A1
(fr)
|
2022-06-08 |
2023-12-14 |
Onkure, Inc. |
Benzopyrimidin-4 (3h)-ones en tant qu'inhibiteurs de pi3k
|
WO2023240201A1
(fr)
|
2022-06-08 |
2023-12-14 |
Larimar Therapeutics, Inc. |
Marqueurs sensibles à la frataxine pour surveiller la progression et le traitement du syndrome de leigh
|
WO2023239940A1
(fr)
|
2022-06-10 |
2023-12-14 |
Research Development Foundation |
Variants de fc igg1 sélectifs de fcriib modifiés et leurs utilisations
|
WO2024028794A1
(fr)
|
2022-08-02 |
2024-02-08 |
Temple Therapeutics BV |
Méthodes de traitement de troubles de l'endomètre et de l'hyperprolifération ovarienne
|
WO2024040020A1
(fr)
|
2022-08-15 |
2024-02-22 |
Absci Corporation |
Enrichissement de cellule spécifique à une activité d'affinité quantitative
|
WO2024038160A1
(fr)
|
2022-08-18 |
2024-02-22 |
Vib Vzw |
Moyens et méthodes pour moduler l'excitabilité neuronale
|
EP4325224A1
(fr)
|
2022-08-18 |
2024-02-21 |
Siemens Healthcare Diagnostics Products GmbH |
Essai d'activation plaquettaire destiné au diagnostic d'une thrombocytopénie induite à l'héparine
|
WO2024054469A1
(fr)
|
2022-09-08 |
2024-03-14 |
Onkure, Inc. |
Isoquinolones utilisés en tant qu'inhibiteurs de pi3k
|
WO2024064024A1
(fr)
|
2022-09-19 |
2024-03-28 |
Onkure, Inc. |
Dérivés de ((4-oxo-3,4-dihydroquinazolin-8-yl)méthyl)amine utilisés en tant qu'inhibiteurs de p13k pour le traitement du cancer
|
WO2024064002A1
(fr)
|
2022-09-20 |
2024-03-28 |
Onkure, Inc. |
Inhibiteur de hdac oki-179 destiné au traitement de cancers résultant d'une mutation de la voie mapk
|
WO2024068744A1
(fr)
|
2022-09-27 |
2024-04-04 |
Vib Vzw |
Antiviraux dirigés contre le virus parainfluenza humain
|
WO2024081345A1
(fr)
|
2022-10-14 |
2024-04-18 |
Onkure, Inc. |
Benzopyrimidin-4(3h)-ones utilisées en tant qu'inhibiteurs de pi3k
|
WO2024102466A2
(fr)
|
2022-11-11 |
2024-05-16 |
Igan Biosciences |
Agents polypeptidiques de protéase iga
|
WO2024124041A1
(fr)
|
2022-12-07 |
2024-06-13 |
Advanced Cell Diagnostics, Inc. |
Détection multiplexée de cibles d'acides nucléiques
|
WO2024178172A1
(fr)
|
2023-02-23 |
2024-08-29 |
University Of Rochester |
Agents et méthodes de production de molécules de fil d'adn à extrémités fermées
|